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A B S T R A C T
Background
Over 35 million people are estimated to be living with dementia in the world and the societal costs are very high. Case management is a
widely used and strongly promoted complex intervention for organising and co-ordinating care at the level of the individual, with the aim
of providing long-term care for people with dementia in the community as an alternative to early admission to a care home or hospital.
Objectives
To evaluate the eJectiveness of case management approaches to home support for people with dementia, from the perspective of the
diJerent people involved (patients, carers, and staJ) compared with other forms of treatment, including ‘treatment as usual’, standard
community treatment and other non-case management interventions.
Search methods
We searched the following databases up to 31 December 2013: ALOIS, the Specialised Register of the Cochrane Dementia and Cognitive
Improvement Group,The Cochrane Library, MEDLINE, EMBASE, PsycINFO, CINAHL, LILACS, Web of Science (including Science Citation Index
Expanded (SCI-EXPANDED) and Social Science Citation Index), Campbell Collaboration/SORO database and the Specialised Register of
the Cochrane EJective Practice and Organisation of Care Group. We updated this search in March 2014 but results have not yet been
incorporated.
Selection criteria
We include randomised controlled trials (RCTs) of case management interventions for people with dementia living in the community and
their carers. We screened interventions to ensure that they focused on planning and co-ordination of care.
Data collection and analysis
We used standard methodological procedures as required by The Cochrane Collaboration. Two review authors independently extracted
data and made 'Risk of bias' assessments using Cochrane criteria. For continuous outcomes, we used the mean diJerence (MD) or
standardised mean diJerence (SMD) between groups along with its confidence interval (95% CI). We applied a fixed- or random-eJects
model as appropriate. For binary or dichotomous data, we generated the corresponding odds ratio (OR) with 95% CI. We assessed
heterogeneity by the I2 statistic.
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Main results
We include 13 RCTs involving 9615 participants with dementia in the review. Case management interventions in studies varied. We found
low to moderate overall risk of bias; 69% of studies were at high risk for performance bias.
The case management group were significantly less likely to be institutionalised (admissions to residential or nursing homes) at six months
(OR 0.82, 95% CI 0.69 to 0.98, n = 5741, 6 RCTs, I2 = 0%, P = 0.02) and at 18 months (OR 0.25, 95% CI 0.10 to 0.61, n = 363, 4 RCTs, I2 = 0%,
P = 0.003). However, the eJects at 10 - 12 months (OR 0.95, 95% CI 0.83 to 1.08, n = 5990, 9 RCTs, I2 = 48%, P = 0.39) and 24 months (OR
1.03, 95% CI 0.52 to 2.03, n = 201, 2 RCTs, I2 = 0%, P = 0.94) were uncertain. There was evidence from one trial of a reduction in the number
of days per month in a residential home or hospital unit in the case management group at six months (MD -5.80, 95% CI -7.93 to -3.67, n
= 88, 1 RCT, P < 0.0001) and at 12 months (MD -7.70, 95% CI -9.38 to -6.02, n = 88, 1 RCT, P < 0.0001). One trial reported the length of time
until participants were institutionalised at 12 months and the eJects were uncertain (hazard ratio (HR): 0.66, 95% CI 0.38 to 1.14, P = 0.14).
There was no diJerence in the number of people admitted to hospital at six (4 RCTs, 439 participants), 12 (5 RCTs, 585 participants) and 18
months (5 RCTs, 613 participants). For mortality at 4 - 6, 12, 18 - 24 and 36 months, and for participants' or carers' quality of life at 4, 6, 12
and 18 months, there were no significant eJects. There was some evidence of benefits in carer burden at six months (SMD -0.07, 95% CI
-0.12 to -0.01, n = 4601, 4 RCTs, I2 = 26%, P = 0.03) but the eJects at 12 or 18 months were uncertain. Additionally, some evidence indicated
case management was more eJective at reducing behaviour disturbance at 18 months (SMD -0.35, 95% CI -0.63 to -0.07, n = 206, 2 RCTs I2
= 0%, P = 0.01) but eJects were uncertain at four (2 RCTs), six (4 RCTs) or 12 months (5 RCTs).
The case management group showed a small significant improvement in carer depression at 18 months (SMD -0.08, 95% CI -0.16 to -0.01,
n = 2888, 3 RCTs, I2 = 0%, P = 0.03). Conversely, the case management group showed greater improvement in carer well-being in a single
study at six months (MD -2.20 CI CI -4.14 to -0.26, n = 65, 1 RCT, P = 0.03) but the eJects were uncertain at 12 or 18 months. There was some
evidence that case management reduced the total cost of services at 12 months (SMD -0.07, 95% CI -0.12 to -0.02, n = 5276, 2 RCTs, P = 0.01)
and incurred lower dollar expenditure for the total three years (MD= -705.00, 95% CI -1170.31 to -239.69, n = 5170, 1 RCT, P = 0.003). Data
on a number of outcomes consistently indicated that the intervention group received significantly more community services.
Authors' conclusions
There is some evidence that case management is beneficial at improving some outcomes at certain time points, both in the person with
dementia and in their carer. However, there was considerable heterogeneity between the interventions, outcomes measured and time
points across the 13 included RCTs. There was some evidence from good-quality studies to suggest that admissions to care homes and
overall healthcare costs are reduced in the medium term; however, the results at longer points of follow-up were uncertain. There was
not enough evidence to clearly assess whether case management could delay institutionalisation in care homes. There were uncertain
results in patient depression, functional abilities and cognition. Further work should be undertaken to investigate what components of
case management are associated with improvement in outcomes. Increased consistency in measures of outcome would support future
meta-analysis.
P L A I N   L A N G U A G E   S U M M A R Y
Case management approaches to home support for people with dementia
Background: Many people are aJected by dementia and the numbers are expected to rise as populations age. Most types of dementia are
characterised by loss of memory and impairment in other cognitive functions, accompanied by functional impairment and diJiculties in
performing activities of daily living. The increasing number of people with dementia means more demand for both informal and formal
sources of care. The extent of support provided depends on factors such as living situation, patient's and carer's characteristics, service
provision, and availability of social networks. There are also wider financial costs of care, for example carers missing work for appointments
or crises, becoming part-time workers, or leaving work altogether. Developing interventions such as case management, which enhances
the co-ordination between diJerent agencies involved in community care, might oJer the support necessary to cover some of the needs
of people with dementia and their carers. How case management is organised and implemented varies widely, and access to this type of
care is influenced by long-term care funding policies and cultural variations in diJerent countries. Case management has been tested in
people with dementia and in carers in a number of countries and healthcare systems, but it is not clear whether current evidence supports
its eJectiveness.
Study characteristics: We found 13 randomised controlled trials (RCTs), including 9615 participants with dementia worldwide. Eleven
RCTs also included carers. Studies were conducted in diJerent countries, varied in size and healthcare systems and compared various types
of case management interventions with usual care or augmented usual care.
Key findings: Some studies examined the benefit of case management in reducing admissions to residential or nursing homes
(institutionalisation). We found benefits at six months and 18 months but not at 12 and 24 months. However, when only studies which
were clearly focused upon delaying institutionalisation or prolonging the period of community care were included we found a reduction
in institutionalisation at 12 months. Some studies examined the benefits of case management in terms of reduced hospital length of stay,
and there was evidence to suggest that it might increase at six months. Some studies indicated that case management was more eJective
at reducing behaviour disturbance at 18 months, reducing carer burden and depression and improving carer well-being at six months
and social support at 12 months. Case management increases the use of community services but there was some indication that overall
Case management approaches to home support for people with dementia (Review)
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healthcare costs may be reduced in the first year. Some studies reported that case management was no more eJective than usual care in
improving patient depression, functional abilities or cognition. There was not enough evidence to clearly assess whether case management
could increase the length of time until people with dementia were admitted to care homes.
Quality of the evidence: There were some problems regarding the methods of the studies. Similarly, the diJerent ways in which the case
management interventions were provided and the diJerences in outcome measurements made it diJicult to draw clear conclusions.
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Summary of findings for the main comparison.   Case management versus usual care for people with dementia
Case management versus usual care for people with dementia
Patient or population: people with dementia
Settings: community
Intervention: case management1
Comparison: treatment as usual, standard community treatment, other non-case management or waiting list controls
Illustrative comparative risks* (95% CI)
Assumed risk Corresponding risk
Outcomes
treatment as
usual, stan-
dard commu-
nity treat-
ment, oth-
er non-case
management
or waiting
list controls
case management
Relative ef-
fect
(95% CI)
No of Partici-
pants
(studies)
Quality of the
evidence
(GRADE **)
Comments
Institutionalised
(number of partic-
ipants admitted to
residential or nurs-
ing homes) at 10 -
12 months
189 per 1000 198 per 1000
(169 to 211)
OR 0.95 
(0.83 to 1.08)
5990
(9 studies)
⊕⊕⊝⊝
low2,3
No significant advantage in the case
management group. When a sensi-
tivity analysis was performed upon
5 studies (Chien- Hong Kong 2008;
Chien - Hong Kong 2001; Chu - Cana-
da; Eloniemi-Sulkava 2001; Elonie-
mi-Sulkava 2009) where the goals of
the intervention were focused upon
delaying institutionalisation, those in
the case management group were sig-
nificantly less likely to be institution-
alised (OR 0.29, 95% CI 0.15 to 0.55, n =
464, I2 = 0%, P = 0.0002).
Time to institu-
tionalisation at 12
months
See comment See comment Not estimable 125
(1 study)
⊕⊕⊝⊝
low4,5
Only one trial reported the length of
time until participants were institu-
tionalised (Eloniemi-Sulkava 2009)
and showed a non-significant differ-
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ence between the two groups (HR:
0.66%, 95% CI 0.38 to 1.14, P = 0.14).
Hospital admission
(number of partici-
pants admitted) at
12 months
236 per 1000 213 per 1000
(131 to 264)
OR 0.87 (0.59
to 1.3)
585
(5 studies)
⊕⊕⊕⊝
moderate7
No significant advantage in the case
management group.
Mortality (num-
ber of deaths) at 12
months
80 per 1000 80 per 1000
(68 to 95)
OR 1.00 (0.83
to 1.2)
6112
(8 studies)
⊕⊕⊕⊕
high
No significant advantage in the case
management group.
Quality of life (par-
ticipants) at 12
months
  The mean quality of life (partici-
pants) - At 12 months in the inter-
vention groups was
0.05 standard deviations higher
(0.13 lower to 0.22 higher)
SMD 0.05
(-0.13 to 0.22)
511
(3 studies)
⊕⊕⊕⊕
high
No significant differences between
groups were detected
Quality of life (car-
ers) at 12 months
  The mean quality of life (carers) -
At 12 months in the intervention
groups was
0.21 standard deviations higher
(0.06 to 0.37 higher)
SMD 0.21
(0.06 to 0.37)
681
(5 studies)
⊕⊕⊕⊝
moderate6
Quality of life was significantly im-
proved or higher in the intervention
group. This difference did not remain
when the two studies (Chien- Hong
Kong 2008; Chien - Hong Kong 2001)
were removed.
.
Carer burden at 10 -
12 months
  The mean carer burden - At 10 -
12 months (change from base-
line / end point) in the intervention
groups was
0.05 standard deviations lower
(0.12 lower to 0.01 higher)
SMD -0.05
(-0.12 to 0.01)
3772
(7 studies)
⊕⊕⊝⊝
low7,8
Outcome favours case management
although not to a significant extent.
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; OR: Odds ratio; HR: Hazard ratio;
**GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
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1We included all randomised controlled trials of case management interventions for people with dementia of any type who lived in the community and their carers. We screened
interventions to ensure that they predominantly focused on planning and co-ordination of care. There was wide variation in the components of case management and how it
was delivered.
21 trial rated at high risk of bias and another trial analysis was not consistent with randomisation. Other trials had 1 or more risks of bias.
3Heterogeneity: I2 = 51%, P = 0.39.
41 study with high rates of comorbidity (Charlson co-morbidity index (SD): Intervention 2.4 (1.5), Control 2.4 (1.8)).
51 study - intervention group: n = 63; control group n = 62.
6Heterogeneity: I2 = 80%; P = 0.0006.
71 trial rated at high risk of bias.
8Heterogeneity: I2 = 80%; P = 0.09.
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B A C K G R O U N D
Globally, the number of people aJected by dementia is anticipated
to rise exponentially as populations age (Lobo 2000), representing
one of the greatest challenges to health and social services. It is
estimated that, worldwide, 35.6 million people have dementia and
that this number is projected to almost double every 20 years,
to 65.7 million in 2030 and 115.4 million in 2050 (Alzheimer’s
Disease International 2009; WHO 2012). In 2001, 5.4% of the
population aged 60 or over in Western Europe had dementia (Ferri
2005). Several meta-analyses show similar estimated dementia
prevalence rates, rising exponentially with increasing age; 1% in
people aged between 60 and 64 years to 34% in people aged
between 90 and 94. Incidence rates of dementia per 100 person-
years range from 1 at 60 to 64 years to 65 to 70 at between 90 and 94
years (Fratiglioni 2001). Furthermore, most people with dementia
live in developing countries (60% in 2001, rising to 71% by 2040);
numbers in developed countries are forecast to increase by 100%
between 2001 and 2040, but by more than 300% in India, China, and
their south Asian and western Pacific neighbours (Ferri 2005).
The annual societal costs of dementia in the UK have been
estimated at GBP 23 billion (Luengo-Fernandez 2010) and more
recently at GBP 21 billion (Knapp 2014). This divides into 20%
healthcare costs and 45% social care costs (publicly and privately
funded) and 35% unpaid carer costs (Knapp 2014). Worldwide,
most people with dementia live in the community. Most developing
countries do not have a specific strategy to face the challenges
of dementia, and community services for older people are very
limited. In contrast, increasing numbers of developed countries
have policies about dementia care. In general, these policies
emphasise the importance of caring for highly dependent older
people for as long as possible at home (Australian Health Ministers
Conference 2006; Eagar 2007; Hofman 1991; Royal Commission
1999: Tsutsui 2007; Wimo 2007). Case management has become
integral to dementia care strategies (Australian Health Ministers
Conference 2006; Department of Health 2008; Diwan 2001b;
Hofmarcher 2007; Ikegami 2002; Somme 2012; Tsutsui 2007). For
example, case management has featured prominently as a strategy
for co-ordinating dementia care in France, where the aim was to
have 1000 co-ordinators whose role has been created on the basis
of current case management evidence (French Ministry of Health
2008). How case management is organised and implemented varies
widely, and access to this type of care is influenced by long-
term care funding policies of diJerent countries. A recent report
funded by the Department of Health for England concluded that if
case management is used to co-ordinate care overall costs would
increase by around GBP 225 million, comprising a saving of around
GBP 1.15 billion on health and social care costs but an increase of
almost GBP 1.4 billion in the imputed costs of unpaid care (Knapp
2014).
Description of the condition
Dementia is defined as a progressive syndrome (group of
symptoms) characterised by neuropsychological impairments,
psychiatric and behavioural symptoms and reduced ability to
perform activities of daily life (Burns 2003). These deficits cause
significant impairment in social or occupational functioning, and
represent a significant decline from a previous level of functioning
(American Psychiatric Association 2000).
The increasing number of people with dementia makes for a
growing demand for care, which may come from informal and
formal sources. The extent and nature of support provided
depends on several factors such as living situation, patient's
and carer's characteristics, service provision, and availability of
social networks. Carers have a key role in diagnosis, particularly
with background and historical information. Some research also
suggests that co-resident carers could be replacing support
provided through social services. Furthermore, they may reduce
the likelihood of the person with dementia to access formal social
and health support, which may disadvantage both of them (Nelson
2002). Reasons why carers do not use formal services include: the
stigma associated with the diagnosis of dementia, perceived lack of
need, care recipient’s refusal to accept help from services, service
characteristics, and lack of knowledge about service availability
(Brodaty 2005; Moriarty 1999). All of these findings show people
with dementia to be a highly vulnerable group. Case management,
which is intended to enhance the co-ordination between diJerent
agencies involved in community care, might improve the overall
level of care and support for people with dementia and their carers.
Description of the intervention
In this review, case management is defined as any intervention
delivered in the community (not in hospital or residential
care settings) predominantly focused on the planning and co-
ordination of care required to meet the identified needs of the
person with dementia. The review was guided by this definition,
as case management (also known as care management) is
oVen used fairly loosely in the literature. Although definitions
vary enormously, case management has been defined as “an
intervention using a human service professional (typically a
nurse or social worker) to arrange and monitor an optimum
package of long term care services” (Applebaum 1990). A
number of researchers define case management in a multifaceted
way, including: functions (co-ordination and linkage); goals
(maintaining vulnerable people at home or independently); core
tasks (case finding, assessment, etc); target group; diJerentiating
features (intensity of involvement, breadth of services overseen,
duration of involvement); and multilevel response (client-level
goals and system-level goals) (Challis 1995; Challis 2002). Although
planned variations within these definitions constitute models of
case management, there may be substantial geographical variation
in how case management is implemented, along with variation
in the health structures in which it operates. The terms case
management and care management have oVen been employed
interchangeably. Care management can be defined as a strategy
for organising and co-ordinating care services at the level of the
individual patient. It involves mobilising and influencing various
agencies and services to achieve clearly-formulated goals, rather
than each provider pursuing separate and perhaps diverse goals
(Challis 1993).
How the intervention might work
Frail older people or those with dementia, requiring long-term care
in their own homes, have a great variety of needs stemming from
the degree and type of mental impairment suJered, the extent
of their physical disability, the amount of family and neighbourly
support available, and the time, duration and preferences for
types of care. The range of services available to support people
with dementia at home varies across diJerent countries. The
most common services include: home care (support with general
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domestic tasks and with self care), day centres (support with
leisure activities), home-delivered meals, and respite care (a short
break away from the carer). Health services might include: nursing,
counselling, occupational therapy, aids to mobility and mental
health care. The voluntary sector also oJers diJerent kinds of
help including: information, telephone help lines, befriending and
carers' support groups.
The wide variety of needs may not correspond to the relatively
inflexible and limited range of services available. The help provided
may oVen be only a partial solution to people's needs and may
not necessarily respond to their preferences. Furthermore, these
services are oVen organisationally highly fragmented, coming from
a wide range of sources both formal and informal, including health
and social care services, family, friends and neighbours. As a
consequence, the picture of resource provision for the frail older
person may be a series of piecemeal contributions from a range
of diJerent services, with no one service or professional having
an unambiguous responsibility for taking a broader view of need
beyond their own particular remit. Assessment and care plans
tend, therefore, to be ‘service-oriented’ rather than ‘client-centred’,
piecemeal and not holistic, defining needs in terms of available
services rather than individual problems. Even where appropriate
assessments and care plans are eJected, they are rarely closely
monitored and therefore fail to keep pace with changes in the
health and dependency of the elderly person (Challis 2003; Reuben
2006).
The lack of any one person clearly responsible for cementing
together these fragmented services into a coherent package is a
significant factor in reducing the capability to prevent admission
to institutional care. However, an integrated system of care for
an individual elderly person has to be consciously created. It is
likely neither to happen spontaneously nor to arise from simply
improving the individual services that constitute the care package.
In short, a more eJective and eJicient long-term care system
may require both an enhancement of the content of services
and also improved case management (Challis 1986). It is likely
that the presence of behaviours such as wandering, resistance to
accepting help in performing activities of daily living, disruptive
behaviours that interfere with others’ activities (especially those
of the carer), and physical and verbal aggression, will require
increased intervention from the case manager as maintaining an
adequate care plan for that client may become problematic (Diwan
2001a; Diwan 2001b). The impact of case management may lead to
a reduction in carer stress as well as improving care, and thereby
have the eJect of extending the stay in the community for the
person with dementia.
Why it is important to do this review
Some research has indicated that early provision of in-home
support and case management for people with dementia can
decrease institutionalisation (Challis 2002; Chu 2000; Gaugler
2005); however, this eJect may decrease over time (Eloniemi-
Sulkava 2001). Indeed, institutionalisation is more likely to
be avoided if carers feel supported (Schoenmakers 2008). No
systematic reviews have specifically addressed whether this is
actually the case. Although a number of reviews and meta-analyses
of non-pharmacological interventions for people with dementia
have been published, few specifically focus on case management
interventions or on people with dementia maintaining community
residence (Parker 2008; Spijker 2008; Thompson 2007; Van Citters
2004). Similarly, reviews which focus on case management do not
specifically address people with dementia (Dieterich 2010; Hesse
2014; Hutt 2004; Marshall 1997). One review found no evidence
for savings in healthcare expenditures or for reductions in hospital
utilisation (Pimouguet 2010). Another review indicated that the
factors that appear to be related to greater case management
eJicacy are the integration between the health and social service
organisations and the intensity of case management (Somme
2012). Both of these reviews were descriptive and did not perform
any meta-analyses.
O B J E C T I V E S
Primary objective
To evaluate the eJectiveness of case management approaches to
home support for people with dementia from the perspective of
the diJerent people involved (patients, carers, and staJ) compared
with other forms of treatment, including ‘treatment as usual’,
standard community treatment and other non-case management
interventions.
Secondary objective
To study whether other potential mediating variables aJect case
management outcomes (e.g. key structural and organisational
features of case management interventions and also the
methodological characteristics of studies).
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered all relevant randomised controlled trials (RCTs), and
economic evaluations conducted alongside the RCTs. We judged
that the RCTs located were suJicient in number and participants
to perform meta-analysis and to justify the exclusion of quasi-
randomised studies, such as controlled before-and-aVer studies
(CBAs) and interrupted time series (ITSs) of case management
interventions.
Types of participants
People of any age and gender with dementia of any type, including
Alzheimer's disease, vascular dementia or mixed Alzheimer's and
vascular dementia, who live in the community (excluding people
in institutions receiving 24-hour care) and their carers. We include
studies that focus on patients only or both patient and carer dyads,
whereas we exclude those that focused exclusively on carers.
Types of interventions
Experimental intervention
Any case management intervention delivered in the community
(not in hospital or in residential care settings) that predominantly
focused on the planning and co-ordination of care required to meet
the identified needs of the person with dementia. This may or may
not have been part of multi-component interventions.
Control
'Treatment as usual', standard community treatment, other non-
case management or waiting-list controls. This may include any
method of care such as primary health care (services that are
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oJered in the community, e.g. general practitioners, and not in
hospitals or specialist centres, and are usually the first point of
contact for a patient). This may occur in isolation or along with
referrals and management by mental health professionals, who
may or may not be part of a community mental health team for
elderly people.
Types of outcome measures
Outcome measures related either to patients or to patient-carer
dyads. We do not include studies which focus exclusively on carer
outcomes. For the analysis, outcomes were grouped into 3/3 - 4; 4
- 6/6; 10 - 12/12; 18; 24; 36 months. In the Discussion section, we
further define short-term outcomes as those measured at less than
12 months, medium-term as equal to or greater than 12 months but
less than 18 months, and longer-term as greater than or equal to 18
months.
Primary outcomes
People with dementia/care recipients
1.1 Institutionalised (number of people admitted to residential or
nursing homes)
1.2 Institutionalised (nursing home stays, mean number of days per
month)
1.3 Time to institutionalisation
1.4 Hospital admission (mean number of nights)
1.5 Hospital admissions: (number of people admitted to hospital)
1.6 Mortality (number of deaths, participants) as reported at each
time point in trials
1.7 Quality of life (participants)
Carers
1.8 Quality of life (carers)
1.9 Carer burden
Secondary outcomes
People with dementia/care recipients
2.1 Cognition measures
2.2 Behavioural measures
2.3 Depression/mood measures
2.4 Function/dependency measures
Carers
2.5 Carer distress (behaviour) measures
2.6 Carer depression/mood measures
2.7 Carer well-being
2.8 Social support measures
2.9 Carer satisfaction with health plan
2.10 Carer satisfaction with care
2.11 Leaving the study early
Service use/costs
3.1 - 3.3 Use of services (participants)
3.4 - 3.6 Cost of services (participants)
3.7 - 3.9 Health service use by carers and informal care
3.10 - 3.11 Cost of services (carers)
Outcomes included in the 'Summary of findings' table
We have constructed a Summary of findings for the main
comparison for the following outcomes: number of dementia
patients institutionalised at 10 to 12 months; time to
institutionalisation at 12 months; hospital admission at 12 months;
mortality at 12 months; participants' quality of life at 12 months;
care-givers' quality of life at 12 months; and care-givers' burden.
Search methods for identification of studies
Electronic searches
See Cochrane Dementia and Cognitive Improvement Group for
methods used in reviews.
We searched the ALOIS, Specialised Register of the Cochrane
Dementia and Cognitive Improvement Group (CDCIG) on 31
December 2013. This register contains records from the following
major healthcare databases:The Cochrane Library, MEDLINE,
EMBASE, PsycINFO, CINAHL and LILACS, and many ongoing clinical
trial databases and other grey literature sources.
The search terms used to identify relevant studies on dementia
for the Group’s Specialised Register can be found in the Group’s
module on The Cochrane Library. We used the following search
terms for database searches: old*, elder*, aged, patient care
management, patient care team, case management, intensive
case management, care management, managed care programs,
community mental health team, specialist mental health service,
community mental health, community mental health services,
community mental health centres, community care, long term care,
community-based long-term care, dementia care, intermediate
care, crisis resolution, crisis intervention, home treatment, home
care, home nursing, home care services, care coordination, care
pathway, managed care, outreach, assertive outreach, disease
management, carer support, family intervention, Admiral Nursing,
assessment and service arrangement, health services for the aged,
geriatric health service, family-based therapy.
We also searched The Cochrane Library, MEDLINE, EMBASE,
PsycINFO, CINAHL, LILACS, ongoing clinical trial databases and
other grey literature sources for the most recent records. The search
terms used to identify relevant studies on dementia for the Group's
Specialised Register were combined with the terms listed above
(see Appendix 1 for the search strategies).
We also searched the following sources: Web of Science (including
Science Citation Index Expanded (SCI-EXPANDED) and Social
Science Citation Index), Campbell Collaboration/SORO database.
We also searched the Specialised Register of the Cochrane EJective
Practice and Organisation of Care Group using the search terms:
dementia OR demented OR Alzheimer in any field.
Case management approaches to home support for people with dementia (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
9
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
We ran a pre-publication top-up search on 5 March 2014. We have
put one publication identified as potentially relevant to this review
(Samus 2014) into Studies awaiting classification and will fully
assess and incorporate it as appropriate at update.
Searching other resources
We contacted first authors of identified RCTs that were potentially
suitable for inclusion in order to request additional information
on related new, unpublished, or in-press studies that we had not
identified in the main search. We also cross-checked the reference
lists and citation reports of trials and relevant systematic reviews
identified by the above methods.
Data collection and analysis
Selection of studies
Two pairs of review authors (SR and JH) and (JH and CM)
independently examined the titles and abstracts of citations
obtained from the original search in accordance with the defined
inclusion criteria, and discarded the irrelevant articles. Two review
authors (SR and DC) examined citations from the updated searches
(completed in February 2012, February 2013 and December 2013).
We obtained the full text of the citation for further evaluation
where it was not possible to accept or reject on the basis of the
title or abstract by either review author. Two review authors again
independently examined the full texts and undertook a repeated
assessment for inclusion into the review. Where we disagreed
on acceptance or rejection, we reached a consensus through
discussion between the whole review team. We attempted to obtain
additional information from the study authors. Details of all studies
which initially appeared to meet the inclusion criteria but which
we later excluded on retrieval of the full-text are given in the
Characteristics of excluded studies tables. We kept a record of the
reasons for exclusion.
Data extraction and management
The review authors SR, CM and ST extracted data, and either SR
or RM undertook a double extraction. We used a standardised data
extraction form and recorded the following characteristics:
• Country of conduct.• Study design, randomisation method.• The number of participants eligible for inclusion in each study,
number randomised, and reasons for exclusion.• The number of participants evaluated at follow-up(s) and the
follow-up time points.• Participant characteristics including age, gender, comorbidities,
diagnosis and type of dementia, dementia severity, type of
health care or community setting, reason for case management
and method of identification for eligibility for case management.• Case management interventions: categorised according to
established domains such as goals, roles and range of tasks,
breadth of services spanned, intensity of intervention, duration,
skill mix, training required, delivery method (team/individual
worker), case load size, and whether the intervention was
provided in a standardised way.• Comparison interventions: standard care, no intervention, or
other type of case management.• Outcomes: both primary and secondary outcomes relevant to
this review; outcomes not usable for this review.
• Confounding variables; these may have been related
to dementia treatment, dementia severity and other
comorbidities.
We extracted the following summary statistics for continuous
outcome measures at each time point: the mean change from
baseline (if reported); the standard deviation (SD) of the mean
change, and the number of participants for each treatment group
at each assessment. We defined the baseline assessment as the
latest available assessment prior to randomisation, but no longer
than two months before randomisation. We used the Abrams 2005
technique to impute the standard deviation of the mean change
(see Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011), section 16.1.3.2). Where changes from baseline were
not reported, we extracted the mean, the standard deviation and
the number of people in each treatment group at each time point.
We considered combining end-point and change from baseline
data unless diJerent scales were used, as standardised mean
diJerences (SMDs) are not statistically permissible. If diJerent
scales were used we opted for the type of data that was reported
more frequently. For dichotomous outcome data (e.g. admitted to
hospital/not admitted), we extracted the number in each outcome
category at each time point. Where outcome measures arose
from ordinal rating scales and the rating scales had a reasonably
large number of categories (more than 10), we treated the data
as continuous variables arising from a normal distribution. For
each outcome measure, to allow an intention-to-treat analysis, we
sought the data irrespective of compliance, whether or not the
participant was subsequently deemed ineligible or was otherwise
excluded from treatment or follow-up. If intention-to-treat data
were not available in the publication, we sought 'on-treatment'
data (i.e. the data of those who completed the trial). To facilitate
comparison between trials we converted variables that could be
reported in diJerent metrics, such as days in hospital (mean days
per year, per week or per month) to a common metric (e.g. mean
days per month). We extracted data for all time points reported in
each study.
We obtained additional data or information or both relating to the
intervention and its implementation for eight trials: Bass - Ohio;
Callahan - Indianapolis; Chu - Canada; Dias - Goa India; Eloniemi-
Sulkava 2001; Eloniemi-Sulkava 2009; Jansen - Netherlands;
Vickrey - California. We did not contact authors of studies identified
in the top-up search for this information (Chien - Hong Kong 2001;
Lam - Hong Kong).
Assessment of risk of bias in included studies
Five review authors worked independently to assess and score the
studies' methodological quality in order to identify any potential
sources of systematic bias. At least two review authors (from CM,
ST, JH, SR and RM) assessed each included study for risk of bias
using the tool described in the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2011). This tool covers sequence
generation, allocation concealment, blinding and completeness
of outcome data, selective reporting, and other biases. If the
raters disagreed, we sought consensus with the involvement of
another member of the review team. We contacted authors where
inadequate details of trial methods were provided in the study
reports, in order to obtain further information; otherwise we
assigned a rating of 'unclear'. For cluster-randomised clinical trials,
we followed Chapter 16.3 of the Cochrane Handbook for Systematic
Reviews of Interventions to identify design-specific biases.
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Measures of treatment e=ect
For continuous outcomes measured with a single scale, we
calculated the mean diJerence (MD) between groups and its
95% confidence interval. If diJerent scales were used to measure
the same construct, then we calculated the standardised mean
diJerence (SMD). For dichotomous data, we calculated odds ratios
(ORs) and their 95% confidence intervals (CI).
Unit of analysis issues
Where there were repeated observations on participants in long-
term studies, we included outcomes at diJerent time points in
separate analyses. Where outcomes from diJerent studies were
measured at similar time points, we combined them. We used the
following time points in the analyses: 3 months/3 - 4 months; 4
- 6 months/6 months; 10 - 12 months/12 months; 18 months; 24
months; 36 months.
Cluster-randomised trials
As case management may be implemented as an organisational
intervention, cluster-randomised trials may be used as a way of
avoiding bias associated with contamination. Randomisation may
be by clinician or by practice. We identified studies using cluster
randomisation and we adjusted the precision of the analysis based
on these studies in the meta-analysis using the 'eJective sample
size' method outlined in the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2011). We calculated the eJective
sample size of groups in each cluster trial to be the original sample
size divided by the 'design eJect'. The design eJect was calculated
by '1+ (M - 1) ICC', where M represents the average cluster size
and ICC is the intraclass correlation coeJicient. For dichotomous
data, we divided both the total number of participants and the
number experiencing the event by the same design eJect. For
continuous data, only the sample size was reduced and means and
standard deviations remained unchanged (see Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011) section
16.3.6). Where clustering had been appropriately incorporated
into the analysis of primary studies, i.e. using a method which
accounted for intraclass correlation, we presented these data
as if from a non-cluster-randomised study, but adjusted for the
clustering eJect. If the ICC was not reported we assumed it to be 0.1
(Ukoumunne 1999).
Studies with multiple treatment groups
Where a study reported multiple case management or comparison
interventions, we combined all relevant experimental intervention
groups of the study into a single group, and all relevant control
intervention groups into a single control group (Higgins 2011).
Dealing with missing data
We attempted to obtain missing data from trial authors. Where
standard deviations for continuous outcomes were not reported,
and were not available from the authors, we calculated them from
the standard errors of the mean (SEM). If this was not possible, we
used the SD from other studies in the review for the same outcome
measures.
We describe the amount and kind of missing data related to
participants' dropout that could be retrieved from the original
authors in the Characteristics of included studies table, and we
discuss their impact. The potential impact of the missing data on
the results depends on the extent of missing data, the pooled
estimate of the treatment eJect and the variability of the outcomes.
In some measures data have been inflated (e.g. we inflated monthly
service use data for hospital admissions to the relevant time period
such as six months, 12 months, etc) in order to allow us to combine
such data with others in one meta-analysis.
To assess 'leaving the study early' in included studies, we calculated
the proportion of randomised participants in each arm who leV the
study early (including those who died or were institutionalised) at
each of the time points 3 - 4, 6, 12, 18, 24 and 36 months.
Assessment of heterogeneity
We examined statistical heterogeneity between trials using the Chi2
statistic (a Chi2 P value of less than 0.10 has been considered
indicative of significant heterogeneity) and the I2 statistic (Higgins
2003). The I2 statistic is an estimate of the percentage of total
variation across studies that can be attributed to heterogeneity
rather than to chance. This statistic is interpreted as follows: 0%
to 40% might not be important, 30% to 60% might represent
moderate levels of heterogeneity, 50% to 90% might represent
substantial levels of heterogeneity, and 75% to 100% considerable
heterogeneity (Deeks 2011).
Assessment of reporting biases
Reporting biases arise when the dissemination of research findings
is influenced by the nature and direction of results (Egger 1997). We
are aware that funnel plots may be useful in investigating small-
study eJects but are of limited power to detect such eJects when
there are few studies. We examined the funnel plot of one of our
primary outcomes to test for asymmetry, which can indicate a
number of issues including: selection bias (such as publication
bias), poor methodological quality, and true heterogeneity. We
also report any instances of selective outcome reporting in the
Assessment of risk of bias in included studies.
Data synthesis
Where possible, the results tables report the absolute diJerences
and relative per cent diJerences in outcomes between the
intervention and control groups, as well as the absolute changes
corrected for baseline diJerences between the control and
intervention groups.
We combined data when we considered that outcomes in individual
studies were similar. We used a fixed-eJect model to provide a
pooled estimated eJect from continuous and binary data. When we
detected significant heterogeneity (an I2 statistic of 50% or more)
we used a random-eJects model for analysis.
Subgroup analysis and investigation of heterogeneity
We explored heterogeneity in each meta-analysis.
If data were clearly heterogeneous, we checked to ensure that they
had been correctly extracted and entered and that there were no
unit-of-analysis errors. If the high levels of heterogeneity remained,
we explored it using two prespecified characteristics of studies that
may be associated with heterogeneity:
1. Variations in implementation or content of the case management
interventions.
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2. Quality of the study: we defined low-quality studies as being at
high risk of bias for allocation concealment (Higgins 2011).
If these characteristics failed to account for the heterogeneity,
we continued to investigate for other possible sources. If we
identified other characteristics of the studies which accounted
for heterogeneity, we discuss these post hoc reasons and the
sensitivity of the estimate of eJect size for the primary outcome to
the inclusion and exclusion of the relevant studies. If heterogeneity
remained considerable (i.e. above 75%, Deeks 2011) we did not
report the results in a meta-analysis.
GRADE and 'Summary of findings' table:
We used GRADE soVware to describe the quality of the overall body
of evidence for each outcome in the Summary of findings for the
main comparison. Quality is defined as the degree of confidence
which can be placed in the estimates of treatment benefits and
harms. There are four possible ratings: 'high', 'moderate', 'low' and
'very low'. Rating evidence as 'high quality' implies that we are
confident in our estimate of the eJect, and further research is very
unlikely to change this. A rating of 'very low' quality implies that
we are very uncertain about the obtained summary estimate of the
eJect.
The GRADE approach rates evidence from RCTs which do not have
serious limitations as 'high quality'. However, several factors can
lead to the downgrading of the evidence to 'moderate', 'low' or 'very
low'. The degree of downgrading is determined by the seriousness
of these factors: study limitations (risk of bias); inconsistency;
indirectness of evidence; imprecision; and publication bias (Guyatt
2008; Higgins 2011)
Sensitivity analysis
We conducted sensitivity analyses to assess the eJects of excluding
studies considered to be at high risk of bias, based on concealment
of allocation methods. We repeated the analysis of any relevant
outcomes excluding any study rated as being at high risk of bias.
We report any significant diJerences in the results in the relevant
outcome section.
R E S U L T S
Description of studies
See Characteristics of included studies; Characteristics of
excluded studies; Characteristics of studies awaiting classification;
Characteristics of ongoing studies.
Results of the search
The electronic searches (see Appendix 1) were performed in
December 2008 and were updated in February 2012, February 2013
and 31 December 2013. We performed a prepublication top-up
search on 5 March 2014, but have not incorporated the findings of
that search into the results of the review.
SR, JH and CM screened the 10,440 references identified in the
original search (December 2008). Updated searches identified a
further 1211 (February 2012) and 820 (February 2013) references
respectively. We examined 147 papers in full text, of which we
excluded 99, as they were either not randomised controlled trials
(RCTs) or included participants who did not have dementia. We
excluded a further 34 studies (see flow diagram in Figure 1;
Characteristics of excluded studies) leaving 13 studies judged to
be eligible for inclusion in the review (Bass - Ohio; Callahan -
Indianapolis; Chien- Hong Kong 2008; Chien - Hong Kong 2001;
Chu - Canada; Dias - Goa India; Eloniemi-Sulkava 2001; Eloniemi-
Sulkava 2009; HinchliJe - UK; Jansen - Netherlands; Lam - Hong
Kong); Newcomer - US; Vickrey - California.
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Figure 1.   Study flow diagram.
 
The 13 included studies randomised a total of 9615 participants
(8095 from the Newcomer - US study). Four trials were based in the
US (Bass - Ohio; Callahan - Indianapolis; Newcomer - US; Vickrey
- California); four in Europe (Eloniemi-Sulkava 2001; Eloniemi-
Sulkava 2009; HinchliJe - UK; Jansen - Netherlands), three in Hong
Kong (Chien- Hong Kong 2008; Chien - Hong Kong 2001; Lam - Hong
Kong), one in Canada (Chu - Canada) and another in India (Dias -
Goa India).
We identified one relevant ongoing study (IliJe - UK). One report
(Samus 2014) from an updated search on 6th March 2014 has been
added to Studies awaiting classification.
All but one study (Lam - Hong Kong) required further outcome
information, and we contacted the authors of these studies,
obtaining additional data for 10 trials: Bass - Ohio; Callahan -
Indianapolis; Chien- Hong Kong 2008; Chien - Hong Kong 2001;
Chu - Canada; Dias - Goa India; Eloniemi-Sulkava 2001; Eloniemi-
Sulkava 2009; Jansen - Netherlands; Vickrey - California.
Included studies
Study length
All but three trials (Chien- Hong Kong 2008; Dias - Goa India;
HinchliJe - UK) had a duration of 12 months or more. Nine of the
remaining trials reported data at 12 months (Bass - Ohio; Callahan
- Indianapolis; Chien - Hong Kong 2001; Eloniemi-Sulkava 2001;
Eloniemi-Sulkava 2009; Jansen - Netherlands; Lam - Hong Kong;
Newcomer - US; Vickrey - California) and another study reported
data at 10 months (Chu - Canada). Where possible we report these
together. Three trials had a duration of 18 months (Callahan -
Indianapolis; Chu - Canada; Chien - Hong Kong 2001), two trials
lasted two years (Eloniemi-Sulkava 2001; Eloniemi-Sulkava 2009)
and the longest trial lasted three years (Newcomer - US).
Design
Most studies presented a parallel longitudinal design, although one
trial was a multi-arm parallel study (Newcomer - US) including
two diJerent case management models. Two studies were cluster-
randomised trials (Callahan - Indianapolis; Vickrey - California).
Seven studies were multicentre trials (Callahan - Indianapolis;
Chien- Hong Kong 2008; Chien - Hong Kong 2001; Dias - Goa
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India; Jansen - Netherlands; Newcomer - US; Vickrey - California).
Six studies were conducted at single centres (Bass - Ohio; Chu -
Canada; Eloniemi-Sulkava 2001; Eloniemi-Sulkava 2009; HinchliJe
- UK; Lam - Hong Kong).
Types of participants
Thirteen trials included a total of 9615 participants with dementia.
Four trials included participants only with Alzheimer's Disease
based on DSM-IV criteria (Callahan - Indianapolis; Chien- Hong
Kong 2008; Chien - Hong Kong 2001; Chu - Canada). The majority of
participants (75%) in another trial were diagnosed with Alzheimer's
Disease (Vickrey - California). Most trials involved participants with
various diagnoses of dementia (see Characteristics of included
studies).
Most trials stated the severity of the dementia or gave cognitive test
scores (the Mini Mental State Examination (MMSE) or the Blessed
Dementia Scale). Six studies included both mild and moderate
dementia severity (Bass - Ohio; Callahan - Indianapolis; Chien-
Hong Kong 2008; Chien - Hong Kong 2001; Dias - Goa India; Lam
- Hong Kong). Three studies included predominantly moderate
dementia severity (Eloniemi-Sulkava 2001; Eloniemi-Sulkava 2009;
Newcomer - US) and four studies included mostly mild dementia
severity (Chu - Canada; HinchliJe - UK; Jansen - Netherlands;
Vickrey - California). We did not pursue subgroup analyses by
dementia severity, as we considered that they were unlikely to
generate meaningful results given the small number of studies and
the diversity of case management interventions.
A number of studies reported on comorbidities in the included
participants (Bass - Ohio; Callahan - Indianapolis; Eloniemi-Sulkava
2009; Jansen - Netherlands; Vickrey - California). Other studies
excluded people with physical comorbidities. Eloniemi-Sulkava
2001 included only those participants not suJering from any other
severe diseases (e.g. stroke, cancer). Dias - Goa India excluded
people if they had severe comorbid physical health conditions. Lam
- Hong Kong also excluded people with significant concomitant
diseases with more than one hospital admission in the previous
twelve months.
Most studies included patient and carer dyads (Chien- Hong Kong
2008; Chien - Hong Kong 2001; Chu - Canada Dias - Goa India;
Eloniemi-Sulkava 2001; Eloniemi-Sulkava 2009; HinchliJe - UK;
Jansen - Netherlands; Lam - Hong Kong; Vickrey - California) or
included carers in the study (Bass - Ohio; Callahan - Indianapolis;
Newcomer - US).
Participants were recruited from primary care (Callahan -
Indianapolis; Jansen - Netherlands; Vickrey - California), from
outpatient, day care resources and other secondary care services
(Bass - Ohio; Chien- Hong Kong 2008; Chien - Hong Kong 2001;
Chu - Canada; Eloniemi-Sulkava 2001; Eloniemi-Sulkava 2009;
HinchliJe - UK; Lam - Hong Kong) or from public announcements in
newspapers (Eloniemi-Sulkava 2009; HinchliJe - UK).
Four studies reported the dementia medications used by the
participants: Callahan - Indianapolis; Chien - Hong Kong 2001;
Chien- Hong Kong 2008; Vickrey - California.
Types of interventions
We extracted information from trials according to the prespecified
case management characteristics in our review protocol. Where
possible we supplemented this by information provided by the
study authors. These details have been summarised in the
Characteristics of included studies tables and in four additional
tables (see Table 1; Table 2; Table 3; Table 4). We have attempted
to describe and categorise the trials with the aim of exploring
whether potential mediating variables (e.g. key structural and
organisational features of case management interventions) aJect
case management outcomes. This narrative assessment of the
evidence was challenging, as the studies examine interventions
which are both complex and variable and details were not always
reported or were unavailable from the study authors.
We attempted to categorise the 13 studies into a typology of
case management (Table 5). There were four studies where
the case manager encouraged self management of care and
tended to empower the carer to arrange their own care where
possible (Bass - Ohio; Chien- Hong Kong 2008; Chien - Hong Kong
2001; Dias - Goa India). There were two short-term (HinchliJe
- UK; Lam - Hong Kong) and seven longer-term interventions
where the case manager was more involved with and ensured
appropriate delivery of services (Callahan - Indianapolis; Chu -
Canada; Eloniemi-Sulkava 2001; Eloniemi-Sulkava 2009; Jansen -
Netherlands; Newcomer - US; Vickrey - California).
Goals
Although not always easy to discern from the papers, the reported
objectives of these case management interventions varied (see
Table 1). Eleven studies reported that a goal of the intervention
was to reduce carer depression,strain and burden, or to improve
carer mental health and quality of life (Bass - Ohio; Chien-
Hong Kong 2008; Chien - Hong Kong 2001; Chu - Canada;
Dias - Goa India; Eloniemi-Sulkava 2009; HinchliJe - UK; Jansen
- Netherlands; Lam - Hong Kong; Newcomer - US; Vickrey -
California). Five studies reported that a goal of the intervention was
to delay institutionalisation or prolong the period of community
care (Chien- Hong Kong 2008; Chien - Hong Kong 2001; Chu -
Canada; Eloniemi-Sulkava 2001; Eloniemi-Sulkava 2009). It is also
interesting to note that this was not a specific goal of the Dias -
Goa India study, as Goa does not have residential facilities to look
aVer people with dementia. Furthermore, because the Newcomer
- US demonstration was designed to improve carer well-being, no
a priori assumptions were made about the intervention's eJect on
rates of nursing home entry.
Four trials aimed to increase early use of home care and other
community services (Chien - Hong Kong 2001; Chu - Canada;
Newcomer - US; Vickrey - California) and four aimed to reduce
the number of neuropsychiatric symptoms/behavioural problems
(Callahan - Indianapolis; Dias - Goa India; Eloniemi-Sulkava 2009;
HinchliJe - UK).
Only one trial explicitly aimed to improve participants' quality of
life (Jansen - Netherlands). Four trials aimed to improve the quality
of care of the person with dementia (Callahan - Indianapolis;
Eloniemi-Sulkava 2009; Jansen - Netherlands; Vickrey - California).
Two trials aimed to initiate early long-term planning related to
issues such as housing, finance, legal matters, care-giving support
and respite services (Chu - Canada; Vickrey - California). One trial
aimed to improve carer sense of competence (Eloniemi-Sulkava
2009).
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Sta= mix
Case managers were employed from various professional groups
(Table 3). These were registered nurses (Chien- Hong Kong 2008;
Chien - Hong Kong 2001; Eloniemi-Sulkava 2001; Eloniemi-Sulkava
2009), district nurses (x 3) (Jansen - Netherlands), advanced
practice nurse (x 2) (Callahan - Indianapolis), social workers and
occupational therapists (Chu - Canada), social workers (Bass -
Ohio; Newcomer - US; Vickrey - California), a community-based
occupational therapist (Lam - Hong Kong), and a psychiatrist
(HinchliJe - UK). One study recruited health care advisors without
a professional qualification (Dias - Goa India). There were also
variations within studies, for example each site in the Newcomer
- US study was implemented in diJerent ways; the Illinois
programme employed nurses as case managers (Shelton 2001),
whereas other sites employed social workers, mental health
professionals, and gerontology specialists. As expected, nurses and
social workers were the most common occupational groups.
Many of the case managers worked within a multidisciplinary team:
(Callahan - Indianapolis; Chu - Canada; Dias - Goa India; Eloniemi-
Sulkava 2001; Eloniemi-Sulkava 2009; HinchliJe - UK; Lam - Hong
Kong; Newcomer - US). In Callahan - Indianapolis the primary
care physician and the care manager were supported through
two additional mechanisms. First, the care manager had weekly
meetings with a support team comprising a geriatrician, geriatric
psychiatrist, and a psychologist who reviewed the care of new
and active patients and monitored adherence to the standard
protocols. Second, the care manager was supported by a web-
based longitudinal tracking system that managed the schedule
for patient contacts, tracked the patient’s progress and current
treatments, and provided an instrument for communicating the
patient’s and carer’s current clinical status to the entire care team.
In HinchliJe - UK a multidisciplinary team (consultant psychiatrist,
psychologist, community psychiatric nurse, social worker and
pharmacist) generated an individualised plan aimed at reducing
the most distressing behaviours.
Case managers who did not work in a multidisciplinary team
were reported to work with another professional or within a
single discipline team. In Chien- Hong Kong 2008, each family was
assigned one case manager who, together with another nurse in
the centre, summarised the assessment data and in collaboration
with the carers prioritised problem areas and formulated a
multidisciplinary education programme for each family on eJective
dementia care; for example, cognitive stimulation. In Jansen -
Netherlands, three district nurses who specialised in geriatric care
acted as case managers of both participant and carer. In Bass - Ohio,
two part-time care consultants and one part-time care consultant
assistant/volunteer worked with 100 families. The case manager in
Vickrey - California operated as an individual worker.
Location
All case managers were based in the community, as this was one of
our inclusion criteria (Table 3). Three were based within a primary
care setting (Callahan - Indianapolis; Jansen - Netherlands; Vickrey
- California) and case managers in two studies were based in a
dementia resource centres (Chien- Hong Kong 2008; Chien - Hong
Kong 2001).
Training of case managers
Details relating to the training of case managers were reported in
six trials. In one study (Eloniemi-Sulkava 2009) the family care co-
ordinator (FCC) was a trained public health registered nurse with
advanced practice education (3½ years) and special education in
dementia care (one year). She and the geriatrician were trained
and tutored throughout the intervention by a dementia expert.
In Eloniemi-Sulkava 2001 the co-ordinator was a registered nurse
with a public health background who received extensive training,
support and advice in dementia care from dementia specialists.
The district nurse case managers in the Jansen - Netherlands
trial specialised in geriatric care and were trained in working
with the resident assessment instrument - home care (RAI-HC)
(a computerised multidimensional instrument), and in organising
family meetings. They also received two seminars on how to deal
with people with dementia and their informal carers. They met on a
monthly basis to discuss innovations and geriatric cases, and were
supervised by a staJ member of their home care organisation. In
Dias - Goa India, the health care advisors (HCAs) underwent one
week of intensive training through role play and interactive training
methods. The HCAs were trained in key skills including listening
and counselling, bereavement counselling, stress management
and health advice for common health problems. Case managers in
Chien- Hong Kong 2008 received 32 hours of formal training from
the researchers, and those in Chien - Hong Kong 2001 received an
unspecified amount of formal training by the research team. There
was no specific training given within the Bass - Ohio trial. Another
trial reported that the case managers, who were mostly social
workers, received formal training and used an Internet-based care
management soVware system for care planning and co-ordination
(Vickrey - California).
Mode of delivery of case management
Almost all trials used face-to-face visits, and many specified that
home visits were carried out (Chien- Hong Kong 2008; Chien -
Hong Kong 2001 Dias - Goa India; Eloniemi-Sulkava 2001; Eloniemi-
Sulkava 2009; HinchliJe - UK; Jansen - Netherlands). One study
operated solely on telephone-based case management which was
delivered within a partnership between a managed care health
system and an Alzheimer's Association (Bass - Ohio). In this study
20% of participants had a Kaiser case management visit during
the one-year period, and only 3% had more than one visit. A
number of other studies used telephone case management to
complete follow-up assessments (Vickrey - California) or to monitor
participants when home visits were not considered necessary
(Eloniemi-Sulkava 2009; Jansen - Netherlands; Lam - Hong Kong).
Intensity - caseload size
The intensity of case management input can be measured by
examining the caseload size (Table 3). Caseload size was reported
in eight of the trials and is described here in order of intensity.
In HinchliJe - UK the case manager, a psychiatrist, had a case
load of approximately 13 to 20 participants. In Dias - Goa India
there were 20 to 21 participants per home care advisor. In the
Jansen - Netherlands trial three nurses visited 99 participants and
their informal carers, which formed a small part of their overall
activities. In one of the two case management models that were
implemented in the Newcomer - US study, model B sites (higher
intensity of case management) had a target case manager-to-client
ratio of 1:30 and a slightly higher reimbursement limit of between
USD 430 and USD 699 per month per client. In Lam - Hong Kong,
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the case manager, a community-based occupational therapist, saw
59 participants over a period of four months. In the Eloniemi-
Sulkava 2009 trial there was one case manager to 60 participants,
and in Vickrey - California it was approximately 50 participant/
carer dyads per care manager. In Bass - Ohio there were two part-
time care consultants and one part-time care consultant assistant/
volunteer per 100 families. This trial was described as an 'intensive-
care management intervention' (Chodash 2006). In the other case
management model implemented in the Newcomer - US study,
model A sites (lower intensity of case management) operated with a
target case manager-to-client ratio of 1:100 in addition to a monthly
community service reimbursement limit or cap of between USD 290
and USD 489 per month per client.
Intensity - frequency of contact and duration
Intensity of case management can also be measured by examining
the frequency of contacts with case managers. We converted data
for each study to monthly contacts from the data reported, and
we present it in Table 3 for 11 of the studies. They ranged from
around one contact per month (Callahan - Indianapolis; Chu -
Canada; Eloniemi-Sulkava 2001; Eloniemi-Sulkava 2009; HinchliJe
- UK; Lam - Hong Kong; Vickrey - California) to two or more contacts
per month (Bass - Ohio; Chien- Hong Kong 2008; Chien - Hong Kong
2001; Dias - Goa India).
The duration of the intervention ranged from four months to two
years, and this matched the follow-up period for all but two studies
(Chien - Hong Kong 2001; Lam - Hong Kong). There were five studies
with interventions of six months or less (Chien- Hong Kong 2008;
Chien - Hong Kong 2001; Dias - Goa India; HinchliJe - UK; Lam -
Hong Kong), three studies with interventions of 12 months (Bass -
Ohio; Callahan - Indianapolis; Jansen - Netherlands) and the rest
were between 18 and 36 months (Chu - Canada; Eloniemi-Sulkava
2001; Eloniemi-Sulkava 2009; Newcomer - US; Vickrey - California).
The intervention period was shorter than the follow-up period in
the Chien - Hong Kong 2001 trial (intervention six months, final
follow-up 12 months) and the Lam - Hong Kong trial (intervention
four months, final follow-up 12 months). (See Appendix 2 for further
details)
Co-ordination of services
The case manager was formally responsible for co-ordination of
care and treatment between organisations and agencies (Table
3) in Chien- Hong Kong 2008; Chu - Canada; Eloniemi-Sulkava
2001; Eloniemi-Sulkava 2009; Jansen - Netherlands; Vickrey -
California. In Callahan - Indianapolis the geriatric nurse practitioner
co-ordinated participant and carer contact with other primary
care clinic appointments and made home visits to accommodate
participants’ schedules and needs. However, in the Bass - Ohio
trial, the care consultants contacted service agencies on behalf of
participants and care-givers with the aim of facilitating them.
Regarding the breadth of services spanned (the extent to which
case managers had a comprehensive role) in only four studies did it
appear that case managers were taking responsibility for managing
the wider care network (Chu - Canada; Eloniemi-Sulkava 2001;
Newcomer - US; Vickrey - California). By contrast, although there
was an element of co-ordination, other studies focused more on
the work of their own service (Callahan - Indianapolis; Chien - Hong
Kong 2001; Dias - Goa India; Eloniemi-Sulkava 2009; HinchliJe -
UK; Lam - Hong Kong), which represents a narrower focus of case
management responsibility.
Study protocols/treatment algorithms
The interventions for many of the trials were reported to rely
on the use of a protocol or manual to facilitate standardised
implementation (Bass - Ohio; Callahan - Indianapolis; Chu -
Canada; Eloniemi-Sulkava 2001; Eloniemi-Sulkava 2009; Jansen
- Netherlands Vickrey - California; available on web site
www.adc.ucla.edu/access/access.swf). Another trial was described
as a flexible stepped care model without a manual (Dias - Goa
India).
Other interventions
All interventions had multiple components of case management
and some were part of a wider intervention such as collaborative
care (Callahan - Indianapolis) or a disease management
programme (Chien- Hong Kong 2008; Vickrey - California). Some
had many components (Callahan - Indianapolis; Eloniemi-Sulkava
2001; Eloniemi-Sulkava 2009; Vickrey - California) and others had
fewer (Dias - Goa India)
Some trials tested the eJectiveness of interventions that
incorporated case management in a more complex intervention.
For example, treatment guidelines for Alzheimer's disease as
delivered through a collaborative care model in a primary care
setting (Callahan - Indianapolis). Intervention components were
based on the chronic care model and emphasised linkages
with community resources and multi-agency co-ordination.
Key components included dementia care managers, formal
procedures for communication within and between organisations
and agencies, as well as including: adherence to 23 dementia
guideline recommendations; Internet-based care management;
collaborative care planning with carers; carer self-management
support; ongoing follow-up; and provider education. Internet-
based care management soVware was also used in the Vickrey -
California trial.
Case management tasks
We separately assessed the tasks and components covered by the
case management intervention (Reilly 2010) for all the studies, and
summarise them in Table 4. Although the core tasks of assessment,
care planning and implementation/management were common to
all but one trial (Dias - Goa India), there was considerable variation
in their delivery. All but one of the trials (HinchliJe - UK) reported
that the implementation of the care plan was monitored. In Dias -
Goa India there were twice-monthly meetings with a psychiatrist to
review the participant's progress. There was greater variation when
it came to the coverage of tasks associated with more complex
care co-ordination, such as arranging and allocating services and
managing the care network. To some extent all studies apart from
four (Bass - Ohio; Chien- Hong Kong 2008; Chien - Hong Kong
2001; Dias - Goa India) stated that they arranged and allocated
services. These trials were more focused on: co-ordinating family
care; empowering the carers and people with dementia to make
use of their social support network, along with establishing support
from community groups or healthcare resources; and providing
emotional support to carers.
Case managers in only two trials held or managed a budget
for purchasing services (Eloniemi-Sulkava 2009; Newcomer - US).
It was noted in the Eloniemi-Sulkava 2001 trial that the carers
contacted the co-ordinator only 10 times outside working hours
in the two years. This was because the co-ordinator had no extra
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money to buy services for the participants and those services within
the financial means of the participants were used.
Case management components
Interventions in all trials included carer education, and most
included participant education components (Table 4); for example,
Bass - Ohio provided education and training programmes, support
groups, respite reimbursement, and a nationwide programme for
'wanderers'.
The role of the case manager in seven of the studies
included a medications review/management component: Callahan
- Indianapolis; Dias - Goa India; Eloniemi-Sulkava 2001; Eloniemi-
Sulkava 2009; HinchliJe - UK; Lam - Hong Kong; Vickrey - California.
For example, in the Callahan - Indianapolis study the programme
was integrated with primary care and the nurse practitioner worked
with the primary care physicians to evaluate symptoms or change
medications.
Case managers in all but two studies (Chien- Hong Kong 2008;
Lam - Hong Kong) provided emotional/therapeutic support to
participants or carers. Fewer were involved in advocating for the
participant (Bass - Ohio; Chu - Canada; Eloniemi-Sulkava 2001;
Eloniemi-Sulkava 2009; Lam - Hong Kong; Vickrey - California)
or providing advice regarding benefits, financial and legal issues
(Callahan - Indianapolis; Chu - Canada; Dias - Goa India; Eloniemi-
Sulkava 2009; Vickrey - California).
As noted earlier in the 'Types of interventions' section we also
attempted to categorise the 13 studies into a typology of case
management (Table 5).
Types of comparison group
Two studies used a waiting-list control where participants received
the intervention aVer six months (Dias - Goa India) and aVer 16
weeks (HinchliJe - UK). The features of standard care were variable
across trials run in diJerent countries at diJerent time periods
(Table 2). Eight trials described a fairly straightforward standard
care (Bass - Ohio; Chu - Canada; Eloniemi-Sulkava 2001; HinchliJe
- UK; Jansen - Netherlands; Lam - Hong Kong; Newcomer - US;
Vickrey - California) and are described in more detail in Table 2 and
in the Characteristics of included studies tables. The comparison
group in the remaining trials received augmented usual care
(Callahan - Indianapolis; Chien- Hong Kong 2008; Chien - Hong Kong
2001; Dias - Goa India; Eloniemi-Sulkava 2009).
Use of case management in usual care group
One study (Chu - Canada) provided appropriate data to allow us
to examine the diJerence in case management usage between
the groups. In this trial the control group also had access to case
management. The intervention group received a mean 16.7 hours
of case management per month (37/37 participants) compared to
nine hours for the control group (35/38 participants). However,
a significantly greater proportion of the intervention group had
access to case management compared to the control group at three
months (odds ratio (OR) 10.97, 95% confidence interval (CI) 3.47 to
34.65, n = 75, P < 0.0001), 10 months (OR 3.73, 95% CI 1.18 to 11.79,
P = 0.02) and 18 months (OR 4.14, 95% CI 1.56 to 10.97, P = 0.004).
The Bass - Ohio trial also reported data that were relevant but which
were in a format that we could not analyse.
We also noted in the Newcomer - US study that control group
cases might have been exposed to comparable benefits, such
as case management and community care benefits if they were
participating in state Medicaid programmes. For this reason, the
demonstration programmes were encouraged not to seek or
accept applications from those receiving Medicaid. They complied
with this request, but researchers were unable to prevent the
applicants from entering Medicaid programmes later. In total 7.5%
of the treatment group and 7.7% of the controls were Medicaid
programme recipients for some portion of the study observation
period. Statistical controls were used to adjust for the potential
eJect of Medicaid participation. Most of the Medicaid participation
occurred aVer the person with dementia entered a nursing home,
which was a censoring outcome. The direction of bias for those
entering Medicaid while still in the community would be to reduce
case management and community service treatment diJerences
relative to the controls.
Types of outcome measures
Many trials used diJerent scales in assessing treatment eJects for
various outcomes. We show only details of scales that provided
usable data in Table 6. Reasons for exclusion of data are given under
'Outcomes' in Characteristics of included studies. We considered
outcomes in relation to the impact of the intervention on the person
with dementia and on the family carer. Many trials had common
outcomes, such as cognition, mood, behaviour and dependency
of the person with dementia; mood, burden and well-being of
the carer; and service use. DiJerent scales were used in assessing
treatment eJects for various outcomes. We conducted statistical
pooling using standardised mean diJerences where appropriate.
Excluded studies
Of the 9159 records screened, we excluded 9013 on title and
abstract, and examined the full texts of 147 studies; we excluded 99
of these because they were not RCTs or they were not focused upon
people with dementia. The Characteristics of excluded studies table
lists trials which were potentially relevant (n = 34) but which did
not meet all the inclusion criteria for the review, together with
the reasons for which we excluded them. We excluded 25 because
the experimental intervention did not meet our inclusion criteria
for case management, three trials because the experimental
intervention or comparison intervention was hospital-based and
not delivered in the community (Baldwin - UK; Fabris - Italy;
Lu - China), and another three because they were focused only
upon carers of people with dementia (Weinberger - US; Kwak -
Georgia; Schoenmakers-Belgium), another two because of study
design (Aliberti - Las Vegas; Mostardt - Germany) and a further
study because both groups received case management (Callahan-
Indianapolis).
Ongoing studies
We are aware of only one currently ongoing study (IliJe - UK; see
Characteristics of ongoing studies). We have contacted the lead
author of this study and data were not available in time to include
in this review.
Studies awaiting classification
One study (Samus 2014) is awaiting classification, as this was not
possible within the timeframe of the review (Characteristics of
studies awaiting classification).
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Risk of bias in included studies
We obtained additional information relating to the risk of bias
of studies included in the review from authors of eight trials:
Bass - Ohio; Callahan - Indianapolis; Chu - Canada; Dias - Goa
India; Eloniemi-Sulkava 2001; Eloniemi-Sulkava 2009; Jansen -
Netherlands; Vickrey - California.
At least two review authors (from CM, JH, SR, RM, ST) independently
evaluated the methodological quality of each study, using The
Cochrane Collaboration's 'Risk of bias' tool (Higgins 2011). We
made judgements of risk of bias across nine domains (see Risk of
bias in included studies). We compared judgements and resolved
disagreements by discussion. The 'Risk of bias' summary is shown
in Figure 2 and Figure 3.
 
Figure 2.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.
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Figure 3.   Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
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Figure 3.   (Continued)
 
Allocation
1. Generation of random number sequence
Eleven studies provided detailed information about the methods
used for sequence generation. Most studies were classified at a
low risk of selection bias. The most frequent method used was a
random number table (Callahan - Indianapolis; Dias - Goa India;
Jansen - Netherlands; Lam - Hong Kong) or a computerised random
number generator (Newcomer - US; Vickrey - California). One study
used block randomisation (Eloniemi-Sulkava 2009) and another
used a random permuted block system (HinchliJe - UK). Three
studies were at risk of selection bias (Bass - Ohio; Chu - Canada;
Eloniemi-Sulkava 2001) and two studies did not supply enough
information for a determination (Chien- Hong Kong 2008; Chien -
Hong Kong 2001).
2.Allocation concealment
Seven studies were rated at low risk of bias for allocation
concealment, as they described the methods used. Most of them
used central randomisation (Callahan - Indianapolis; Eloniemi-
Sulkava 2009; Newcomer - US; Vickrey - California). One study used
numbered sealed envelopes (Eloniemi-Sulkava 2001). The rest of
the studies did not provide enough information, and we classified
them as at unclear risk (Chien- Hong Kong 2008; Chien - Hong Kong
2001; Dias - Goa India; HinchliJe - UK; Jansen - Netherlands) or at
high risk (Bass - Ohio; Chu - Canada).
Overall, most studies were free of selection bias due to use of
adequate methods for random sequence generation and allocation
concealment.
Blinding
1.Performance bias (blinding of participants)
Since case management is a non-pharmacological intervention,
we assumed that participants were not totally blind to treatment
assignment. In this respect, most of the studies were classified
as being at high risk (Bass - Ohio; Chu - Canada; Dias - Goa
India; Eloniemi-Sulkava 2001; Eloniemi-Sulkava 2009; HinchliJe -
UK; Jansen - Netherlands; Lam - Hong Kong; Newcomer - US) or
at unclear risk (Callahan - Indianapolis; Chien- Hong Kong 2008;
Chien - Hong Kong 2001). Only one study was rated as being
at low risk: Vickrey - California was a cluster-randomised trial,
so participants were unaware of clinic randomisation status until
baseline assessment and were not reminded of randomisation
status at follow-up.
2.Performance bias (blinding of personnel)
Case managers who carried out the intervention could not
be blinded to intervention allocation, so in this section we
considered whether personnel other than case managers and
outcome assessors were blinded to treatment assignment. Six
studies (Callahan - Indianapolis; Chien- Hong Kong 2008; Chien -
Hong Kong 2001; HinchliJe - UK; Lam - Hong Kong; Newcomer
- US) were rated at unclear risk because they did not mention
measures taken to blind personnel. Chu - Canada and Jansen
- Netherlands, responding to email communication, pointed out
that personnel such as physicians were not blind to participants'
allocation. Participants in Bass - Ohio could have volunteered
to their physicians or nurses whether they were assigned to the
intervention or control group over the course of the study. Three
studies (Eloniemi-Sulkava 2001; Eloniemi-Sulkava 2009; Vickrey -
California) were classified as being at low risk, due to blinding of
any or all staJ, physicians and care providers.
3.Detection bias (blinding of outcome assessment)
Out of the 13 studies, nine (69%) had blinded outcome assessors
(Bass - Ohio; Callahan - Indianapolis; Chien- Hong Kong 2008;
Chien - Hong Kong 2001; Eloniemi-Sulkava 2001; Eloniemi-Sulkava
2009; HinchliJe - UK; Jansen - Netherlands; Lam - Hong Kong)
and were classified as being at low risk. One study (Chu - Canada)
did not take any measures to blind the assessors, while Dias
- Goa India attempted to blind outcome assessors by keeping
information about allocation status in a separate oJice from the
outcome evaluation teams. In order to evaluate the masking
process, researchers were asked to guess the intervention status.
Two-thirds of the assessors guessed the allocation status correctly.
We classified two studies as unclear (Newcomer - US; Vickrey -
California). The authors in the Vickrey - California study pointed
out that "medical record abstractors could have discerned aspects
of the study intervention, and we did not assess the extent to
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which abstractors were blinded to intervention status" (email
communication sent 20th November 2010). The Newcomer - US
study did not report whether or not outcome assessors were
blinded.
Summary
We can conclude that all of the studies were subject to performance
bias inherent in any psychosocial intervention such as non-blinded
participants and non-blinded case managers. However, most of the
studies made an eJort to blind outcome assessors, which led to an
overall low risk of detection bias.
Incomplete outcome data
Only five studies were classified as being at low risk of attrition bias
(Callahan - Indianapolis; Chien - Hong Kong 2001; Eloniemi-Sulkava
2001; Eloniemi-Sulkava 2009; Lam - Hong Kong) as although they
had missing outcome data, this was balanced in numbers across
intervention groups, with similar reasons for missing data across
groups. We rated four studies at high risk. Bass - Ohio study had
some missing follow-up data for psychosocial outcomes. Also,
numbers allocated to the groups and numbers lost to follow-
up were not clearly reported. We rated Chu - Canada study as
high risk, since for some outcomes 'as treated' analyses were
performed, with substantial diJerences between the intervention
received and that assigned at randomisation. We rated Dias - Goa
India and Newcomer - US at high risk, due to the high rates of
missing data in both groups, even though this was balanced in
numbers across groups. Finally, we rated four studies as being at
unclear risk. Chien- Hong Kong 2008 did not state clearly either the
number of participants randomised or the attrition rates for each
group. HinchliJe - UK and Vickrey - California had an imbalance in
numbers and reasons for missing data across the groups. In Jansen
- Netherlands there was attrition at follow-up and some imbalance
in numbers of missing data across the groups at six months.
Selective reporting
We classified eight studies at low risk of selective reporting bias
(Chien- Hong Kong 2008; Chien - Hong Kong 2001; Dias - Goa
India; Eloniemi-Sulkava 2001; Eloniemi-Sulkava 2009; Jansen -
Netherlands; Lam - Hong Kong; Vickrey - California). We rated the
remaining five studies at high risk of reporting bias, as they did
not report data on all the outcomes that were specified within the
study. Even though Chu - Canada provided some of the information
requested, there were still some data missing on primary outcomes
such as total home care usage outcomes (standard deviations for
mean number of hours), total numbers institutionalised (standard
deviations), and length of time participants remained in the
community. In addition, activities of daily living (measured by
Alberta Assessment and Placement Instrument (AAPI)) were not
reported. Secondary outcomes were not reported by Bass - Ohio,
HinchliJe - UK and Newcomer - US. There was also a reporting bias
in Callahan - Indianapolis, with analysis that was not consistent
with randomisation, and the intraclass correlation coeJicients not
reported.
Other potential sources of bias
Of the 13 studies, we rated seven as being at unclear risk of other
biases. Three had problems regarding baseline diJerences between
the groups. Bass - Ohio did not report a test to assess baseline
diJerences, and HinchliJe - UK did not provide baseline data.
In Callahan - Indianapolis there were some baseline diJerences
between groups: a higher proportion of the augmented usual care
group were black: 40/69 (58%) compared to the intervention group
(35/84; 42%) (P = 0.05). A higher proportion of the augmented usual
care group were women (66/69; 96%) compared to the intervention
group (70/84; 83%) (P = 0.02). However, these diJerences were
adjusted for in subsequent analyses.
Some degree of contamination may have occurred in four
studies. In two studies (Chien- Hong Kong 2008,Chien - Hong
Kong 2001) even though the intervention was given to only the
experimental group, the two centres provided both groups with
routine dementia care. Also, in the Chu - Canada study, a significant
proportion of the control group received case management. In
Newcomer - US, some of the participants might have received case
management and community care benefits (as part of the Medicaid
programmes) while still in the community, consequently reducing
case management and community service treatment diJerences
relative to the controls.
E=ects of interventions
See: Summary of findings for the main comparison Case
management versus usual care for people with dementia
Primary outcomes:
Case management compared to usual care: e=ect on people
with dementia (care recipients)
1.1 Institutionalised (number of participants admitted to
residential or nursing homes)
(Figure 4, Analysis 1.1)
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Figure 4.   Forest plot of comparison: 1.1 Institutionalised (number of patients admitted to residential or nursing
homes) (as reported at each time point in trials)
 
1.1.1 At six months
Data were available for six studies (Callahan - Indianapolis; Chien-
Hong Kong 2008; Chien - Hong Kong 2001; Chu - Canada; Eloniemi-
Sulkava 2009; Newcomer - US) that reported the proportion of
participants who had an admission to either residential or nursing
homes at six months. Those in the case management group were
significantly less likely to be institutionalised (odds ratio (OR) 0.82,
95% confidence interval (CI) 0.69 to 0.98, n = 5741, I2 = 0%, P = 0.02).
However, these results were dominated by a single large study
(Newcomer - US). In order to test the robustness of our findings we
excluded Chu - Canada (rated as a low-quality study). Reanalysing
the data did not alter the results.
1.1.2 At 10 - 12 months
The proportion of participants who had an admission to either
residential or nursing homes at 10 to 12 months was reported
in nine studies (Callahan - Indianapolis; Chien- Hong Kong 2008;
Chien - Hong Kong 2001; Chu - Canada; Eloniemi-Sulkava 2001;
Eloniemi-Sulkava 2009; Jansen - Netherlands; Lam - Hong Kong;
Newcomer - US). At this time point we found no significant
diJerences between groups (OR 0.95, 95% CI 0.83 to 1.08, n =
5990, I2 = 48%, P = 0.43). However these data were moderately
heterogeneous (I2 = 48%, P = 0.43). When we used a random-
eJects model there were no significant diJerences between groups
(P = 0.09). We conducted a sensitivity analysis on those studies
which had reported that the goals of the intervention were focused
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upon delaying institutionalisation or prolonging the period of
community care. Five studies (Chien- Hong Kong 2008; Chien - Hong
Kong 2001; Chu - Canada; Eloniemi-Sulkava 2001; Eloniemi-Sulkava
2009) were included and the meta-analysis indicated that those
in the case management group were significantly less likely to be
institutionalised (OR 0.29 CI 0.15 to 0.55, n = 464, I2 = 0%, P = 0.0002).
1.1.3 At 18 months
Four studies provided 18-month data (Callahan - Indianapolis;
Chien- Hong Kong 2008; Chien - Hong Kong 2001; Chu - Canada).
The case management group were significantly less likely to be
institutionalised (OR 0.25, 95% CI 0.10 to 0.61, n = 363, I2 = 0%, P =
0.003).
1.1.4 At 24 months
Twenty-four-month data were available for two studies (Eloniemi-
Sulkava 2001; Eloniemi-Sulkava 2009). These showed no significant
diJerences between treatment groups (OR 1.03, 95% CI 0.52 to 2.03,
n = 201, I2 = 0%, P = 0.94).
1.2 Institutionalised (nursing home stays, mean number of days
per month)
(Analysis 1.2)
We found data on this outcome from two studies.
1.2.1 At six months
One small study (Chien- Hong Kong 2008) revealed a significant
reduction in the number of days per month in a residential home or
hospital unit in the case management group at six months (mean
diJerence (MD) -5.80, 95% CI -7.93 to -3.67, n = 88, P < 0.0001).
1.2.2 At 12 months
This study also revealed a significant reduction in the number of
days per month in a residential home or hospital unit in the case
management group at 12 months (MD -7.70, 95% CI -9.38 to -6.02,
n = 88, P < 0.0001).
1.2.3 At 18 months
Another study (Vickrey - California) reported the number of days per
month institutionalised and did not find any significant diJerences
between groups at 18 months (MD 0.17, 95% CI -0.92 to 1.26, n = 267,
P = 0.76). Data were skewed for this study.
1.3 Time to institutionalisation
(Analysis 1.3)
1.3.1 At 12 months
Only one trial reported the length of time until participants
were institutionalised (Eloniemi-Sulkava 2009), and showed no
significant diJerence between the two groups (hazard ratio (HR)
0.66, 95% CI 0.38 to 1.14, P = 0.14). The authors also note that the
diJerence between groups at 18 months was significant, however
we could not use these data in the review as the results were only
presented as a figure. Although data were not reported, the authors
of the Callahan - Indianapolis study also stated that the time to
nursing home placement did not diJer between groups.
1.4 Hospital admission (mean number of nights)
(Analysis 1.4)
Data were available from five studies for this outcome (Bass
- Ohio; Callahan - Indianapolis; Eloniemi-Sulkava 2009; Jansen
- Netherlands; Vickrey - California). Standard deviations were
imputed for one study (Callahan - Indianapolis) using standard
deviations from other studies (Jansen - Netherlands at six and
12 months and Eloniemi-Sulkava 2009 at 18 months). Data from
the 24-month follow-up could not be entered as the standard
deviations were not available and could not be imputed from
other studies. Hospital admission utilisation data (number of nights
per month) were inflated by 18 months for one study (Vickrey -
California) so that we could combine it with other studies. However,
heterogeneity remained high even when we excluded other studies,
so we have only reported the six-month results here.
1.4.1 Hospital admissions at six months
Data were available from three studies at six months (Callahan
- Indianapolis; Eloniemi-Sulkava 2009; Jansen - Netherlands).
We detected between-group diJerences in the number of nights
associated with hospital admissions with a small but significant
diJerence in favour of the control group (MD 0.63, 95% CI 0.40 to
0.86, n = 341, I2 = 40%, P = 0.00001).
1.4.2 Hospital admissions at 12 months
As there was considerable heterogeneity at 12 months, we have not
reported the meta-analysis as it would be misleading to quote an
average value for the intervention eJect.
1.4.3 Hospital admissions at 18 months
At 18 months there was considerable heterogeneity, so again we
have not reported the meta-analysis.
1.5 Hospital admissions: (number of participants admitted to
hospital)
(Analysis 1.5)
1.5.1 Admitted to hospital at six months
Data were available from four studies (Callahan - Indianapolis;
Chien- Hong Kong 2008; Chien - Hong Kong 2001; Eloniemi-Sulkava
2009) showing no significant diJerences between treatment groups
(OR 1.06, 95% CI 0.61 to 1.84, n = 439, I2 = 0%, P = 0.84).
1.5.2 Admitted to hospital at 12 months
Data were available from five studies (Bass - Ohio; Chien- Hong
Kong 2008; Chien - Hong Kong 2001; Callahan - Indianapolis;
Eloniemi-Sulkava 2009) showing no significant diJerences between
treatment groups (OR 0.87, 95% CI 0.59 to 1.30, n = 585, I2 = 3%,
P = 0.51). When we excluded Bass - Ohio (a low-quality study),
and reanalysed the data to test the robustness of our findings, the
results were unchanged.
1.5.3 Admitted to hospital at 18 months
Data were available from five studies (Callahan - Indianapolis;
Chien- Hong Kong 2008; Chien - Hong Kong 2001; Eloniemi-Sulkava
2009; Vickrey - California), showing no significant diJerences
between treatment groups (OR 0.76, 95% CI 0.53 to 1.10, n = 613, I2
= 14%, P = 0.14).
1.6 Mortality (number of participant deaths, as reported at each
time point in trials)
(Analysis 1.6)
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1.6.1 At 4 - 6 months
Data were available from eight studies (Callahan - Indianapolis; Chu
- Canada; Dias - Goa India; Eloniemi-Sulkava 2009; HinchliJe - UK;
Jansen - Netherlands; Lam - Hong Kong; Newcomer - US). By four
to six months, 87 deaths occurred in the 3030 people in the case
management group compared with 94 in the 2834 people in the
standard care group (OR 0.86, 95% CI 0.64 to 1.16, n = 5864, I2 = 1%,
P = 0.32).
Mortality was high (18 participants, 22%) for one trial (Dias - Goa
India).
1.6.2 At 12 months
Data were available from eight studies (Callahan - Indianapolis;
Chu - Canada; Eloniemi-Sulkava 2001; Eloniemi-Sulkava 2009;
Jansen - Netherlands; Lam - Hong Kong; Newcomer - US; Vickrey -
California). By 12 months, 252 deaths occurred in the 3173 people in
the case management group compared with 236 in the 2939 people
in the standard care group (OR 1.00, 95% CI 0.83 to 1.20, n = 6112,
I2 = 0%, P = 0.98).
1.6.3 At 18 - 24 months
Data were available from five studies (Callahan - Indianapolis;
Chien - Hong Kong 2001; Chu - Canada; Eloniemi-Sulkava 2001;
Eloniemi-Sulkava 2009). By 18 to 24 months 20 deaths occurred in
the 260 people in the case management group compared with 19 in
the 253 people in the standard care group (OR 1.00, 95% CI 0.52 to
1.92, n = 513, I2 = 4%, P = 1.00).
1.6.4 At 36 months
Data were available from one study (Newcomer - US). By 36 months,
941 deaths occurred in the 2682 people in the case management
group compared with 872 in the 2527 people in the standard care
group (OR 1.03, 95% CI 0.92 to 1.15, n = 5209, P = 0.66).
1.7 Quality of life (participants)
(Analysis 1.7)
We found three studies (Jansen - Netherlands; Lam - Hong Kong;
Vickrey - California) assessing quality of life of participants with
various scales at diJerent time points (Table 6).
1.7.1 At four months
At four months we detected no significant diJerences between
groups in the single study (Lam - Hong Kong) which used the
Personal Well-Being Index-Intellectual Disability (PWI-ID) (MD -3.74,
95% CI -12.42 to 4.94, n = 99, P = 0.40).
1.7.2 At six months
At six months there was no significant diJerence between groups
in the single study (Jansen - Netherlands) which used the Dementia
Quality of Life (DQOL) instrument (MD 0.26, 95% CI -0.45 to 0.97, n
= 58, P = 0.47).
1.7.3 At 12 months
At 12 months quality of life was measured using three scales: PWI-
ID (Lam - Hong Kong); DQOL (Jansen - Netherlands) and Health
Utilities Index Mark 3 (HUI3) (Vickrey - California). As with the
previous findings, results did not suggest significant diJerences
between groups (standardised mean diJerence (SMD) 0.05, 95% CI
-0.13 to 0.22, n = 511, I2 = 0%, P = 0.60).
1.7.4 At 18 months
The longer-term data at 18 months using the HUI3 did not show any
diJerence between the two groups in the Vickrey - California study
(MD 0.06, 95% CI -0.05 to 0.17, n = 225, P = 0.30).
Case management compared to usual care: e5ect on carers
1.8 Quality of life (carers)
(Analysis 1.8)
Five studies assessed carer quality of life with four diJerent
measures: World Health Organization Quality of Life (WHOQoL-
BREF) (Chien- Hong Kong 2008; Chien - Hong Kong 2001), Short
Form 36-item health survey (SF-36) (Jansen - Netherlands), EuroQol
5-Dimensions (EQ-5D) (Vickrey - California) and the Personal Well-
being index for adults (PWI-A) (Lam - Hong Kong) (Table 6).
1.8.1 At four months
At four months we found no significant diJerences between groups
in the single study (Lam - Hong Kong) which used the Personal Well-
Being Index for adults (PWI-A) (MD -0.25, 95% CI -0.66 to 0.15, n =
99, P = 0.21).
1.8.2 At six months
At six months there was no significant diJerence between groups
in a single study (Chien- Hong Kong 2008), (MD 0.33, 95% CI -0.09 to
0.75, n = 88, P = 0.13).
1.8.3 At 12 months
At 12 months carer quality of life was available from all five studies
using the four scales (WHOQoL-BREF, SF-36, EQ-5D and PWI-A).
Initially using a fixed-eJect model we found that carers in the case
management group had a significantly better quality of life (SMD
0.21 CI 0.06 to 0.37, n = 681). However these data were highly
heterogeneous (I2 = 80%, P = 0.0006). When we used a random-
eJects model there were no significant diJerences between groups
(P = 0.11). A sensitivity analysis indicated that two studies (Chien-
Hong Kong 2008; Chien - Hong Kong 2001) contributed most to
the variation among the studies. While the other three studies
demonstrated a statistical homogeneity (heterogeneity: Chi2 = 0.94,
df = 2 (P = 0.63); I2 = 0%) (SMD 0.02 CI -0.16 to -0.20, n = 501, I2 = 0%, P
= 0.84) we found no significant diJerence in quality of life between
the groups. One way of explaining why these two studies may be
out of line with the others may be helped by our categorisation of
the studies (Table 5). We describe these studies as ones in which the
case manager encouraged self management of care and tended to
empower the carer to arrange their own care where possible. These
studies also used the WHOQoL-BREF.
1.8.4 At 18 months
Similarly at 18 months for two studies, we found that carers in
the case management group had a significantly better quality of
life (SMD 0.25, 95% CI 0.04 to 0.46, n = 373), which was measured
using two scales (WHOQoL-BREF, EQ-5D) (Chien - Hong Kong 2001;
Vickrey - California). Again these data was highly heterogeneous
(I2 = 94%, P = 0.0001). When we applied a random-eJects model
there were no significant diJerences between groups (SMD 0.50,
95% CI -0.47 to 1.48, n = 373, I2 = 94%, P = 0.31). Re-analysing the
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results, excluding Chien - Hong Kong 2001 which was categorised
diJerently on our case management typology (Table 5) (see 1.8.3
above) leV a single study, Vickrey - California, showing no diJerence
between the groups (MD 0.01, 95% CI -0.09 to 0.11, n = 281, P = 0.85).
1.9 Carer burden
(Analysis 1.9; Figure 5)
 
Figure 5.   Forest plot of comparison: 1.9 Caregiver burden.
 
1.9.1 At 3 - 4 months
Three studies measured the change from baseline at three or
four months, using the Zarit burden Interview scale (ZBI) (Chu -
Canada; Dias - Goa India; Lam - Hong Kong). We found no significant
diJerences between groups (SMD -0.06, 95% CI -0.33 to 0.20, n = 228,
I2 = 0%, P = 0.63).
1.9.2 At six months
We include four studies which measured the change from baseline
to six months. These studies used the ZBI (Chu - Canada; Dias -
Goa India; Newcomer - US) and Family Caregiving Burden Inventory
(FCBI) (Chien- Hong Kong 2008). The findings significantly favoured
the case management intervention group (SMD -0.07 CI -0.12 to
-0.01, n = 4601, I2 = 26%, P = 0.03). When we excluded Chu - Canada
(a low-quality study), and reanalysed the data to test the robustness
of our findings, the results were unchanged (SMD -0.06, 95% CI -0.12
to 0.00, n = 4553, I2 = 0%, P = 0.04).
1.9.3 At 10 - 12 months
We include seven studies which measured the change from
baseline to 10 to 12 months. These studies used the ZBI (Chu -
Canada; Lam - Hong Kong; Newcomer - US), Family Caregiving
Burden Inventory (FCBI) (Chien- Hong Kong 2008; Chien - Hong
Kong 2001) and the Self-Perceived Pressure by Informal Care
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(SPPIC) questionnaire (Jansen - Netherlands). It was not clear what
measure was used in Eloniemi-Sulkava 2001; although further data
were sent by the authors they did not specify the measure used.
We detected no significant diJerences between groups (SMD -0.05,
95% CI -0.12 to 0.01, n = 3772, I2 = 80%, P = 0.09). However, if we
remove two studies (Chien- Hong Kong 2008; Chien - Hong Kong
2001) that were categorised diJerently on our case management
typology (Table 5), the heterogeneity is significantly reduced (I2 =
6%) and there are still no significant diJerences between the groups
(SMD -0.02, 95% CI -0.09 to 0.05, n = 3592, I2 = 20%, P = 0.55). When
we excluded a low-quality study (Chu - Canada), and reanalysed
the data to test the robustness of our findings, the results were
unchanged.
1.9.4 At 18 months
We include three studies measuring the change from baseline to
18 months. These studies used the ZBI (Chu - Canada; Newcomer -
US) and the FCBI measure (Chien - Hong Kong 2001). The findings
favoured the case management intervention group (SMD -0.08 CI
-0.16 to -0.01, n = 2860, I2 = 90%, P = 0.02). Sensitivity analysis
indicated that one study (Chien - Hong Kong 2001) which was
classified diJerently on our case management typology (Table 5)
contributes all the variation among the studies. When Chien -
Hong Kong 2001 is removed the heterogeneity disappears (I2 =
0%) and any significant diJerences between groups are removed
(SMD -0.06, 95% CI -0.13 to 0.02, n = 2768, I2 = 0%, P = 0.14). When
we excluded Chu - Canada (a low-quality study), and reanalysed
the data to test the robustness of our findings, the results were
unchanged, but heterogeneity increased to an I2 of 95%.
1.9.5 At 24 months
We include two studies measuring the change from baseline to
24 months. One study used the ZBI (Newcomer - US) and we
await clarification regarding which measure was used in Eloniemi-
Sulkava 2001. The findings favoured the case management
intervention group (SMD -0.03, 95% CI -0.11 to 0.04, n = 2931, I2 =
0%, P = 0.38).
1.9.6 At 36 months
One study measured the change from baseline to 36 months. This
study used the ZBI (Newcomer - US). The findings favoured the case
management intervention group (SMD -0.04, 95% CI -0.13 to 0.05, I2
= 0%, n = 1906, P = 0.33). It should be noted that there was a high
attrition rate from this study (64% in each group).
Secondary outcomes:
Case management compared to usual care: e5ect on people
with dementia/(care recipients)
2.1 Cognition measures
(Analysis 2.1)
2.1.1 At 3 - 4 months
At three to four months we found no significant diJerences between
groups in the two studies which used the Mini Mental State
Examination (MMSE) (Chu - Canada) and the Cantonese MMSE (Lam
- Hong Kong) (SMD -0.21, 95% CI -0.53 to 0.11, n = 154, I2 = 0%, P =
0.2).
2.1.2 At six months
At six months there were no significant diJerences between groups
in the three studies which used the English (Chu - Canada) and
Cantonese versions of the MMSE (Chien- Hong Kong 2008) and
the Telephone Interview for Cognitive Status (TICS) (Callahan -
Indianapolis) (SMD 0.03, 95% CI -0.21 to 0.27, n = 267, I2 = 0%, P =
0.82).
2.1.3 At 10 - 12 months
Similarly at 10 to 12 months, we detected no significant diJerences
between groups in the six studies which used the English (Chu
- Canada; Eloniemi-Sulkava 2001) and Cantonese versions of the
MMSE (Chien- Hong Kong 2008; Chien - Hong Kong 2001; Lam - Hong
Kong) and the TICS (Callahan - Indianapolis) (SMD 0.00, 95% CI -0.17
to 0.18, n = 518, I2 = 0%, P = 0.96).
2.1.4 At 18 months
At 18 months we found no significant diJerences between groups
in the three studies which used the English (Chu - Canada) and
Cantonese versions of the MMSE (Chien - Hong Kong 2001) and the
TICS (Callahan - Indianapolis) (SMD -0.02, 95% CI -0.27 to 0.22, n =
256, I2 = 0%, P = 0.85).
2.1.5 At 24 months
This was also the case for the one study that measured cognition at
24 months (Eloniemi-Sulkava 2001) (SMD 0.07, 95% CI -0.49 to 0.63,
n = 49, I2 = 0%, P = 0.79).
2.2 Behavioural measures
(Analysis 2.2; Figure 6)
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Figure 6.   Forest plot of comparison: 2.2 Behavioural measures (participants).
 
2.2.1 At 3 - 4 months
At three to four months there were no significant diJerences
between groups in the two studies which used the English (Dias
- Goa India) and the Chinese version of the Neuropsychiatric
Inventory (NPI) (Lam - Hong Kong) (SMD -0.13, 95% CI -0.44 to 0.18,
n = 165, I2 = 0%, P = 0.40).
2.2.2 At six months
We included four studies, measuring the change from baseline to
six months, which found a significant diJerence in favour of the
case management group in the four studies which used the English
NPI (Callahan - Indianapolis; Chien- Hong Kong 2008; Dias - Goa
India; Jansen - Netherlands) (SMD -0.20, 95% CI -0.41 to 0.01, n =
368, I2 = 83%, P = 0.06). If we remove two of the studies (Chien-
Hong Kong 2008; Dias - Goa India) that were classified diJerently
on our case management typology; the heterogeneity is eliminated
entirely and the diJerence is no longer significant (SMD 0.09, 95%
CI -0.17 to 0.36, n = 221, I2 = 0%, P = 0.49).
2.2.3 At 10 - 12 months
We include five studies, measuring the change from baseline to
10 to 12 months. There were no significant diJerences between
groups in these five studies which used the English (Callahan -
Indianapolis; Chien- Hong Kong 2008; Chien - Hong Kong 2001;
Jansen - Netherlands) and Chinese versions of the NPI (Lam - Hong
Kong) (SMD -0.38, 95% CI -0.56 to -0.19, n = 479, I2 = 81%, P =
0.0001). Again if we remove two of the studies (Chien- Hong Kong
2008; Chien - Hong Kong 2001) that were categorised diJerently
on our case management typology (Table 5), the heterogeneity
is significantly reduced (I2 = 36%) and the diJerence is no longer
significant (SMD -0.14, 95% CI -0.37 to 0.09, n = 299, I2 = 36%, P =
0.22).
2.2.4 At 18 months
We include two studies which measured the change from baseline
to 18 months or reported scores at 18 months. We found no
diJerences between groups in the two studies which used the NPI
(Callahan - Indianapolis; Chien - Hong Kong 2001) (SMD -0.35, 95%
CI -0.63 to -0.07, n = 206, I2 = 0%, P = 0.01).
2.3 Depression/mood measures
(Analysis 2.3)
2.3.1 At 3 - 4 months
At three to four months we found no significant diJerences
between groups in the two studies which used the Cornell Scale for
Depression in Dementia (CSDD) (Lam - Hong Kong) and Geriatric
Depression Scale (GDS) (Chu - Canada) (SMD 0.12 CI -0.19 to 0.43, n
= 164, I2 = 59%, P = 0.45).
2.3.2 At six months
At six months there were no significant diJerences between groups
in the two studies which used the CSDD (Callahan - Indianapolis)
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and GDS (Chu - Canada) (SMD 0.08, 95% CI -0.21 to 0.37, n = 185, I2
= 0%, P = 0.59).
2.3.3 At 10 - 12 months
At 10 to 12 months we found no significant diJerences between
groups in the three studies which used the CSDD (Callahan -
Indianapolis; Lam - Hong Kong) and GDS (Chu - Canada) (SMD -0.07,
95% CI -0.32 to 0.17, n = 259, I2 = 0%, P = 0.59).
2.3.4 At 18 months
At 18 months there were no significant diJerences between groups
in the two studies which used the CSDD (Callahan - Indianapolis)
and GDS (Chu - Canada) (SMD -0.02, 95% CI -0.33 to 0.29, n = 159,
I2 = 0%, P = 0.90).
2.4 Function/dependency measures
(Analysis 2.4)
2.4.1 At three months
At three months we found no significant diJerence between groups
in the one study which used the Everyday Abilities Scale for India
(EASI) (Dias - Goa India) (SMD -0.20, 95% CI -0.68 to 0.29, n = 66, P
= 0.43).
2.4.2 At six months
At six months there were no significant diJerences between groups
in the three studies which used the EASI (Dias - Goa India), the
Alzheimer’s Disease Co-operative Study/Activities of Daily Living
Inventory (ADCS-ADL) (Callahan - Indianapolis) and the Activities
of Daily Living (Barthel) (Eloniemi-Sulkava 2009) measures (SMD
-0.03, 95% CI -0.25 to 0.19, n = 318, I2 = 0%, P = 0.81).
2.4.3 At 12 months
At 12 months we detected no significant diJerences between
groups in the two studies which used the EASI (Dias - Goa India) and
the ADCS-ADL (Callahan - Indianapolis) (SMD 0.04, 95% CI -0.21 to
0.29, n = 251, I2 = 32%, P = 0.76).
2.4.4 At 18 months
At 18 months there was no significant diJerence between groups in
the one study which used the ADCS-ADL (Callahan - Indianapolis)
(SMD -0.09, 95% CI -0.46 to 0.28, n = 114, P = 0.62).
Case management compared to usual care: e5ect on carers
2.5 Carer distress (behaviour measure)
(Analysis 2.5)
2.5.1 At three months
At three months we found no significant diJerence between
groups in the one study which used the Neuropsychiatric Inventory
Caregiver Distress Scale NPI-D (Dias - Goa India (MD -2.50, 95% CI
-6.87 to 1.87, n = 66, P = 0.26).
2.5.2 At six months
At six months there were no significant diJerences between groups
in the two studies which used the NPI-D (Callahan - Indianapolis;
Dias - Goa India) (MD -0.20, 95% CI -3.23 to 2.82, n = 193, I2 = 0%, P
= 0.89).
2.5.3 At 10 - 12 months
At 10 to 12 months we found no significant diJerence between
groups in the one study which used the NPI-D (Callahan -
Indianapolis) (MD -1.90, 95% CI -6.00 to 2.20, n = 126, P = 0.36).
2.5.4 At 18 months
At 18 months there was no significant diJerence between groups in
the one study which used the NPI-D (Callahan - Indianapolis) (MD
-0.50, 95% CI -3.24 to 2.24, n = 114, P = 0.72).
2.6 Carer depression/mood measures
(Analysis 2.6)
2.6.1 At six months
At six months there were no significant diJerences between
groups in the four studies which used the Patient Health
Questionnaire-9 (PHQ-9) (Callahan - Indianapolis), the Centre for
Epidemiological studies Depression scale (CES-D) (Chu - Canada;
Jansen - Netherlands) and the Geriatric Depression Scale (GDS)
(Newcomer - US) (SMD -0.04, 95% CI -0.10 to 0.02, n = 4675, I2 = 0%,
P = 0.15).
2.6.2 At 10 - 12 months
At 10 to 12 months we found no significant diJerences between
groups in the five studies which used the PHQ-9 (Callahan -
Indianapolis), the CES-D (Chu - Canada; Jansen - Netherlands), the
CES-D modified (Bass - Ohio) and the GDS (Newcomer - US) (SMD
-0.04, 95% CI -0.11 to -0.02, I2 = 0%, n = 3705, P = 0.19).
When we excluded Bass - Ohio (a low-quality study) and reanalysed
the data the results were unchanged.
2.6.3 At 18 months
At 18 months the case management group showed greater
improvement in the depression/mood measures (CES-D) (Callahan
- Indianapolis), CES-D modified (Bass - Ohio) and the GDS
(Newcomer - US) (SMD -0.08, 95% CI -0.16 to -0.01, n = 2888, I2 = 0%,
P = 0.03).
2.6.4 At 24 months
One study (Newcomer - US) indicated that there was a non-
significant trend towards greater improvement in the case
management group at 24 months (SMD -0.06, 95% CI -0.14 to 0.01,
n = 2887, P = 0.08).
2.6.5 At 36 months
This study (Newcomer - US) indicated that there was no significant
diJerence between groups at 36 months (SMD -0.07, 95% CI -0.16
to 0.02, n = 1910, P = 0.15).
2.7 Carer well-being
(Analysis 2.7)
2.7.1 At 3 - 4 months
At three to four months we found no significant diJerences
between groups in the three studies which used the General Health
Questionnaire (GHQ) (Dias - Goa India; HinchliJe - UK; Lam - Hong
Kong) (MD -2.53, 95% CI -5.20 to 0.13, n = 203, I2 = 73%, P =
0.06). Excluding HinchliJe - UK, and reanalysing the data eliminated
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the heterogeneity across studies and still showed no diJerences
between groups (MD -1.18, 95% CI -2.69 to 0.33, n = 170, I2 = 0%, P
= 0.13).
2.7.2 At six months
At six months there was significantly greater improvement in the
case management group in the one study which used the GHQ (Dias
- Goa India) (MD -2.20, 95% CI -4.14 to -0.26, n = 65, P = 0.03).
2.7.3 At 12 months
At 12 months we noted a non-significant trend towards greater
improvement in the case management group in the one study
which used the GHQ (Lam - Hong Kong) (MD -1.90, 95% CI -4.11 to
0.31, n = 92, P = 0.09).
2.8 Social support measures
(Analysis 2.8)
2.8.1 At six months
At six months there was no significant diJerence between groups in
the one study which used the six-item Social Support Questionnaire
(SSQ6) (Chien- Hong Kong 2008) (SMD 0.18, 95% CI -0.24 to 0.60, n
= 88, P = 0.14).
2.8.2 At 12 months
At 12 months we found no significant diJerences between groups
in the three studies which used the SSQ6 (Chien- Hong Kong 2008;
Chien - Hong Kong 2001) and Medical Outcomes Study (MOS) Social
Support Survey (Vickrey - California) (SMD 0.17, 95% CI -0.00 to 0.34,
n = 541, I2 = 81%, P = 0.06 ). When Vickrey - California was excluded
from the analysis (categorised diJerently on our case management
typology Table 5), leaving two studies which used the SSQ6 (Chien-
Hong Kong 2008; Chien - Hong Kong 2001), heterogeneity was
eliminated and resulted in a significant diJerence between the
groups in favour of the case management group (SMD 0.58, 95% CI
0.28 to 0.88, n = 180, I2 = 0%, P = 0.0002).
2.8.3 At 18 months
At 18 months there were no significant diJerences between groups
in the two studies which used the SSQ6 (Chien - Hong Kong 2001)
and MOS Social Support Survey (Vickrey - California) (SMD 0.13,
95% CI -0.07 to 0.33, n = 382, I2 = 70%, P = 0.21).
2.9 Carer satisfaction with health plan
(Analysis 2.9)
Two studies reported results that could be examined for
satisfaction of carers. It is worth noting that one of these studies
(Bass - Ohio) did not report participant satisfaction data adequately
for the results to be used for this review.
The Bass - Ohio study, which was rated at high risk of bias,
evaluated carer satisfaction with Kaiser managed care services:
satisfaction was measured regarding types of services, quality of
services, and information. We could not use data on satisfaction
with information, as it was not reported fully for the control group.
There were no diJerences in changes from the baseline at 12
months, either for satisfaction with types of services (MD 0.02, 95%
CI -0.26 to 0.30, n = 157, P = 0.89) or for satisfaction with quality of
services (MD 0.04, 95% CI -0.17 to 0.25, n = 157, P = 0.70).
2.10 Carer satisfaction with care
(Analysis 2.10)
One study (Callahan - Indianapolis) assessed carer satisfaction
with the participant’s care with the question: “Over the last 3
months, how would you rate the quality of care [the patient] has
received overall from the primary care clinic?”. Individuals in the
intervention group were significantly more satisfied than those in
the control group at 12 months (OR 3.85, 95% CI 1.82 to 8.11, n = 153,
P = 0.0004) but there was no significant diJerence between groups
at 18 months (OR 1.43, 95% CI 0.73 to 2.80, n = 153, P = 0.30).
2.11 Leaving the study early
(Analysis 2.11)
If data for this outcome were not clearly presented in the tables, we
took relevant data from the text of each report. We included those
who were unwilling or unable to provide information (including
those who died, were institutionalised, and those who switched
treatment groups). Some studies reported completers only at each
time point and others were intention-to-treat (ITT), i.e. all originally
randomised. The implications of the data are that more weight is
given to the ITT findings.
2.11.1 At 3 - 4 months
There were no significant diJerences between treatment groups at
three to four months in three studies (Dias - Goa India; HinchliJe -
UK; Lam - Hong Kong) (OR 0.66, 95% CI 0.28 to 1.56, n = 223, I2 = 0%,
P = 0.34),
2.11.2 At six months
There were no significant diJerences between treatment groups at
six months in five studies (Callahan - Indianapolis; Dias - Goa India;
Eloniemi-Sulkava 2009; Jansen - Netherlands; Newcomer - US) (OR
0.99, 95% CI 0.86 to 1.14, n = 5728, I2 = 40%, P = 0.87).
2.11.3 At 12 months
There were no significant diJerences between treatment groups
at 12 months in seven studies (Callahan - Indianapolis; Eloniemi-
Sulkava 2001; Eloniemi-Sulkava 2009; Jansen - Netherlands; Lam -
Hong Kong; Newcomer - US; Vickrey - California) (OR 0.98, 95% CI
0.88 to 1.09, n = 6232, I2 = 26%, P = 0.68).
2.11.4 At 18 months
We found small but significant diJerences favouring the case
management group (i.e. lower) for data at 18 months in six studies
(Callahan - Indianapolis; Chien - Hong Kong 2001; Chien- Hong Kong
2008; Chu - Canada; Newcomer - US; Vickrey - California) (OR 0.88,
95% CI 0.79 to 0.98, n = 6034, I2 = 0%, P = 0.02). When we excluded
Chu - Canada (a low-quality study) and reanalysed the data to test
the robustness of our findings the results were unchanged.
2.11.5 At 24 months
There were small but significant diJerences favouring the case
management group (i.e. lower) for data at 24 months (Eloniemi-
Sulkava 2001; Eloniemi-Sulkava 2009; Newcomer - US) (OR 0.87,
95% CI 0.78 to 0.97, n = 5505, I2 = 0%, P = 0.01).
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2.11.6 At 36 months
By 36 months there was no significant diJerence between groups
in the one study with data (Newcomer - US) (OR 0.98, 95% CI 0.88
to 1.10, n = 5304, P = 0.33).
Case management compared to usual care: (service use and
cost secondary outcomes)
The section below provides a summary of these results. We report
full information in Appendix 3.
3.1 - 3.3 Use of services (participants)
(Analysis 3.1; Analysis 3.2; Analysis 3.3)
Data from service use and costs of care varied greatly between
studies, both in terms of the range of services but also the time
points evaluated. The range of services included assisted living, day
care, home care, information provision, respite care, physician or
nurse visits and accident and emergency visits. We also assessed
healthcare costs and societal costs. The pattern suggested that,
compared to the control group, people in the intervention group
tended to use more social care services, but a similar amount of
healthcare services. However, there was no consistent pattern in
relation to overall costs of care, although in some comparisons the
intervention group incurred fewer costs.
Four RCTs reported on diJerent aspects of community-based
services usage (Chu - Canada; Lam - Hong Kong; Newcomer - US;
Vickrey - California). All significant diJerences favoured greater use
of services in the case management group apart from one service
- assisted living housing use at 12 months (Newcomer - US). The
intervention group was significantly more likely to receive: home
care use at 12 and 18 months, day care use at 4 and 12 months,
respite care at 12 months, domestic paid helper use at 4 and
12 months, personal care use at 12 months, professional home
health aide use at 18 months, services or information from local
Alzheimer's Association at 18 months, services or information from
care-givers' resource centre at 18 months and participation in a
carer support group at 18 months.
Five RCTs reported on diJerent aspects of participant health
services usage (Bass - Ohio; Callahan - Indianapolis; Chu -
Canada; Jansen - Netherlands; Vickrey - California). There were
no diJerences between groups in most outcomes, apart from a
significantly higher number of physician or nurse visits in the
intervention group at 18 months (MD 5.40, 95% CI 0.51 to 10.29, n =
113, P = 0.03). There were no diJerences in the emergency visits at
12 or 18 months, physician visits at 6 and 12 months or direct care
(occupational therapy, physical therapy, social work, nursing and
respiratory therapy) at 18 months.
We found no significant diJerence between groups in the
one study (Jansen - Netherlands) that reported the number
of outpatients geriatric/psychiatric team/diagnostic service
consultations, medical specialist consultations, physiotherapist
consultations or social work consultations at 12 months.
3.4 - 3.6 Cost of services (participants)
(Analysis 3.4; Analysis 3.5; Analysis 3.6)
Three studies (Eloniemi-Sulkava 2009; Newcomer - US; Vickrey -
California) reported data on healthcare costs. Eloniemi-Sulkava
2009 compared total health and social costs between the groups
at 12 months. Costs were lower in the intervention group but this
diJerence was borderline significant (MD -7.99, 95% CI -16.86 to
0.89, n = 125, P = 0.08). The Vickrey - California trial showed no
significant diJerence in healthcare costs from the payer perspective
(including and excluding nursing home cost at 18 months) or from
the society perspective between case management and control
group.
Newcomer - US reported the eJects of case management
application on Medicare community services expenditures in year
one, year two and year three, and for the total three-year period.
Eloniemi-Sulkava 2009 reported total healthcare costs between the
groups at 12 months. We have used the SMD to accommodate the
two currencies (dollars and euros) for year one. When data were
pooled from these two studies (Eloniemi-Sulkava 2009; Newcomer
- US) at 12 months, a significant reduction in the total cost of
services was apparent between the groups (SMD -0.07, 95% CI -0.12
to -0.02, n = 5276, P = 0.01. There were no diJerences at years
two or three, although the lower expenditure in the pooled case
management groups was significantly lower than the control group
for the total three years in the Newcomer - US study (MD -705.00,
95% CI -1170.31 to -239.69, n = 5170, P = 0.003).
3.7 - 3.9 Health service use by carers and informal care
(Analysis 3.7; Analysis 3.8; Analysis 3.9).
One study (Newcomer - US) estimated the impact of a case
management intervention on health services usage for carers.
Carers' utilisation of services was reported for one of the sites
(Illinois) in the Newcomer - US study (Shelton 2001). Data on
hospitalisation rates and emergency visits were collected over a
three-year period. The risk of hospitalisation for the carers in the
intervention group was significantly lower than in the control group
(OR 0.51, 95% CI 0.33 to 0.81, n = 412, P = 0.005). The emergency
department visits were significantly lower in the intervention group
(OR 0.58, 95% CI 0.38 to 0.89, n = 412, P = 0.01). Carer health
service utilisation and Medicare expenditure data were presented
for one of the sites (Illinois) for the Newcomer - US study (Shelton
2001) (Analysis 3.8). One other study also reported the use of
services by carers (Jansen - Netherlands). There were no significant
diJerences for any of the continuous outcomes reported, including
annual hospital length of stay, number of admissions or primary
care physician or outpatient geriatric/psychiatric team, medical
specialist, physiotherapist consultations or informal carer time. We
found no significant diJerence in the time for paid or unpaid skilled
carers between the groups (Informal carer time spent care-giving
(hours)) (MD -5.10, 95% CI -789.73 to 779.53, n = 412, P = 0.99)
(Vickrey - California) (Analysis 3.9).
3.10 - 3.11 Cost of services (carers)
(Analysis 3.10; Analysis 3.11)
In the Newcomer - US study, Medicare Part A expenditure (inpatient
hospital, emergency department visits and skilled nursing home
inpatient care) was based on the allowed amounts from Medicare
claims for the period the person with Alzheimer's Disease was
enrolled in the demonstration. For most claims, this included
the amount paid by Medicare, plus additional amounts paid by
individuals. The Medicare Part A expenditure at the one-year follow-
up was lower for the case management group (combining A and B
models) but did not diJer significantly from standard care (MD USD
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-229.00, 95% CI -489.48 to 31.48, P = 0.08). By the two-year follow-up
there were no diJerences (MD USD 17.00, 95% CI -943.97 to 977.97,
P = 0.97), nor were there any diJerences by three years (MD USD
-325.00, 95% CI -770.89 to 120.89, P = 0.15). We observed similar
results for the case management group (combining A and B models)
for the entire three-year follow-up, combining all demonstration
sites in comparison to control (MD USD -167.00, 95% CI -946.28
to 612.28, P = 0.67). In one of the eight sites, Illinois, in which
the delivery of case management was facilitated via nurse care
managers rather than by social workers, the total cost was not much
lower than other sites. A total reduction of USD -436 (95% CI -2321
to 1049) was achieved compared to control over three years.
Although the average annualised Medicare reimbursement (annual
health service cost) during the Newcomer - US study for carers in
the intervention group (combining A and B models) was lower, the
diJerence was not significant (MD USD -681.00, 95% CI -1382.40
to 20.40, P = 0.06). The lower expenditure did not reach statistical
significance for any of the separate years or for the total three-year
follow-up period.
D I S C U S S I O N
We have comprehensively collated evidence from 13 randomised
controlled trials (RCTs) with a total of 9615 participants, which
compare the eJects of case management approaches for people
with dementia and their carers with usual care. All but three
of the RCTs had a duration of 12 months or more but  only six
trials lasted for 18 months or more.   The studies included in this
review came from a variety of countries and contexts, from the US,
Canada, Finland, Netherlands, Hong Kong, India and the UK; from
primary care practices, dementia resource centres, memory clinics,
outpatient clinics, and day centres; and were administered by case
managers from a range of professional groups.
We have summarised the results for short-, medium- and longer-
term to help with the interpretation of the results and to help
to guide future practice and research in this area. As this review
identified a relatively small number of eligible studies, not all
of which reported the same outcomes at the same time points,
we still have only a limited understanding of the eJects of case
management and how desired outcomes are achieved.   A few
main factors restrict our understanding: the heterogeneity of case
management interventions, limited process and cost evaluations,
and the methodological limitations of the studies. These issues
relate to the phenomenon of complex interventions and the
need for multiple and rigorous studies to examine both their
implementation and eJectiveness.
Summary of main results
Shorter-term outcomes (less than 12 months)
The shorter-term outcomes in this review indicate a reduction in
the proportion of people institutionalised at six months in the
intervention group, although these results were dominated by a
single large study (Newcomer - US). One study showed a reduction
in the number of days per month in a residential home/hospital unit
in the case management group in the short term (six months). At six
months the results suggested that case management may increase
hospital length of stay (by 0.86 days a month), the use of day care
and domestic paid care when compared with standard care.
Four studies indicated a small but significant improvement
in carer burden at six months but no eJect at three to
four months. No significant eJects were present in favour
of case management in the following outcomes in the short
term: time to institutionalisation; number of people admitted
to hospital; mortality; participant quality of life; cognition;
depression; behaviour; function; carer quality of life; carer distress;
mood; and social support.
Medium-term outcomes (equal to or greater than 12 months,
but less than 18 months)
Case management for people with dementia was not more eJective
in terms of reducing the proportion institutionalised at 12 months.
 However, in a sensitivity analysis to explore high heterogeneity, we
found that case management for people with dementia was more
eJective in reducing the proportion institutionalised at 12 months
when we included only studies which evaluated interventions
which were clearly focused upon delaying institutionalisation. One
study showed a reduction in the number of days per month in a
residential home/hospital unit in the case management group at
one year.
Case management was more eJective for quality of life outcomes in
carers at 12 months, but these analyses were also heterogeneous;
there was no eJect when the results were reanalysed excluding two
studies which were categorised as less intensive in our typology
of case management. Case management was more eJective in
improving social support for carers, and carers were more satisfied
with the quality of care received.
There was greater use of services in the case management group
in home care use, day care use, respite care, domestic paid helper
use and personal care use. One study also indicated a reduction
in assisted living housing use at 12 months (Newcomer - US). Data
from two studies at 12 months indicated a significant reduction in
the total cost of services for the case management group. Similarly,
pooled data from two studies indicated a significant reduction in
the total cost of services at 12 months in the case management
group.
There were no significant eJects in favour of case management
in the following outcomes in the medium term: time to
institutionalisation (there were no longer-term data available);
number of people admitted to hospital; mortality; participant
quality of life; cognition; depression; behaviour; function; carer
burden; carer quality of life; and carer mood.
Although not a prespecified outcome, we noted that the use of
prescribed medications (for participants) was recorded for both
groups in two of the studies. The use of cholinesterase inhibitors
was significantly greater in the intervention group in the Callahan
- Indianapolis study (OR 3.22, 95% CI 1.58 to 6.56, n = 153, P =
0.001) but there was no significant diJerence between groups in the
Vickrey - California study (OR 1.12, 95% CI 0.63 to 1.98, n = 219, P =
0.70). Vickrey - California also notes that although medication costs
could not be included in their cost analyses, there was an increase
of approximately 10 percentage points in the use of cholinesterase
inhibitors among participants in the intervention group at follow-
up versus no change among participants in the usual care group.
Individuals in the intervention group in the Callahan - Indianapolis
study were also significantly more likely to use antidepressants
at 12 months (OR 2.17, 95% CI 1.10 to 4.29, n = 153, P = 0.03).
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The intervention and control groups did not diJer in the use of
antipsychotics, sedative-hypnotics and memantine, and the rates
of use were low.
Longer-term outcomes (greater than or equal to18 months)
Case management was more eJective than usual care in reducing
the proportion institutionalised at 18 months, but not at 24 months,
or in reducing the mean number of nights institutionalised at 18
months. No longer-term data were available.
This review did not find evidence of any impact on mortality rate.
The longer-term data are quite informative where the study length
might balance the rarity of the event in detecting any diJerences
between the intervention eJects. The longest and largest trial
suggested that 35% versus 34% of participants had died at the
three-year follow-up (Newcomer - US).
Case management was more eJective than usual care at reducing
neuropsychiatric symptoms in people with dementia at the 18-
month follow-up period.  There were no longer-term data available
for neuropsychiatric symptoms in participants. Although there
were no significant overall eJects in favour of case management
for quality of life or carer burden outcomes,  one study did show
positive results for both of these outcomes in the longer term. No
significant eJects were found at 24 or 36 months for carer burden.
No longer-term results were available for carer quality of life.
We found no significant eJects in favour of case management for
the following outcomes in the longer term: participant quality of
life; cognition; depression; function and carer mood; number of
nights associated with hospital admissions; other health services
usage for participants apart from a greater number of physician and
nurse visits in the intervention group at 18 months in one study.
Single studies also showed that at 18 months case management
was more eJective than usual care at providing access to support in
the form of home care use, information services, and carer support
groups.
Case management was significantly more eJective at reducing
hospitalisations and emergency department visits for carers during
one three-year study. There was greater use of services in the
case management group in home care use, professional home
health aide use, services or information from local Alzheimer's
Association, services or information from care-givers' resource
centre and participation in a carer support group. No longer-term
data were available.
Although there were very little data available on health service
costs, the expenditure in the pooled case management groups was
significantly lower than in the control group for the total three
years in the Newcomer - US. These costs are for cases surviving
six months or more in the community aVer enrolment. We sought
mean monthly costs for all participants (including those who died
or were institutionalised in the first six months) from the study
authors, but these data were not available.  There was also some
indication that case management reduced the healthcare cost
including nursing home cost at 18 months, but this did not reach
statistical significance (P = 0.08) (Eloniemi-Sulkava 2009).
It is useful to explore some possible explanations for the results.
Firstly, although it could be expected that case management would
delay nursing home admission for people with dementia if care
needs are better assessed, monitored and followed up within an
integrated system of care, there were few intervention eJects for
this outcome. Providing case management in this context may
reduce carer stress and burden and through this may have the
eJect of extending the stay in the community by the person with
dementia. As noted in the Background to this review, a more
eJective and eJicient long-term care system may require both an
enhancement of the content of services and also improved case
management (Challis 1986). In some of the trials reviewed, the
former was sometimes diJicult to discern and the information
provided on the interventions may suggest that enhancement of
the content of services had not eventuated for participants in
many of the studies. Although use of many of the community-
based services was significantly higher in the intervention group,
it was not always clear whether the case manager reviewed the
care package and whether service packages changed in a timely
manner to reflect the changing needs of the person with dementia.
Furthermore, these data were available for nine studies, but only
five of them specified that reducing institutionalisation was a goal
of the intervention. Indeed, the Newcomer - US study was designed
to improve care-giver well-being, and no a priori assumptions had
been made about the demonstration's eJect on nursing home
entry rates. There were also a number of methodological diJiculties
with the reporting and recording of this outcome in some of
the studies. The timing of participant admission to residential or
nursing homes was not reported in all studies, and a number of
studies report cumulative data at the endpoint of the trial. More
trials should address this outcome at each follow-up point, which
would be fairly easy to collect and report in a CONSORT diagram.
Some of the studies (e.g. Callahan - Indianapolis; Eloniemi-
Sulkava 2009; Jansen - Netherlands) included a high proportion of
participants with a number of comorbidities, and indicated that
this might lead to admission to a nursing or care home in a shorter
period of time, whilst other studies were more likely to exclude
these patients (e.g. Eloniemi-Sulkava 2001; Lam - Hong Kong). The
Eloniemi-Sulkava 2009 study was described as "pragmatic in nature
with more liberal inclusion criteria than in many previous trials.
The characteristics of the patients with dementia illustrate that
they were older, they experienced more severe dementia, and more
behavioural and psychological symptoms of dementia (BPSDs)
than in many dementia drug trials or carer trials. Our participants
may, thus, represent “real life” situations better than many prior
studies."
The review indicates that case management improves
neuropsychiatric symptoms in participants with dementia at
the 18-month follow-up period. Two of the studies using the
neuropsychiatric inventory (NPI) at 18 months indicated an
approximate six-point reduction in the case management group
(MD -6.14, 95% CI -10.77 to -1.51, n = 153, I2 = 0%, P = 0.009).
Estimates have indicated that a one-point deterioration on the NPI
is associated with an additional USD 250 - 400 per year in direct
healthcare costs (Murman 2005). Neuropsychiatric symptoms are
among the most common predictors of institutionalisation (YaJe
2002). Case management approaches in a number of studies
(Callahan - Indianapolis; Dias - Goa India; Eloniemi-Sulkava 2009;
HinchliJe - UK) were characterised by behavioural management
techniques centred on individual participants’ behaviour and
psycho-education strategies intended to change carers’ behaviour,
both of which have been shown to be generally successful for
reducing neuropsychiatric symptoms, and the eJects of these
interventions last for months (Livingston 2005). Although there is
little compelling longer-term evidence that case management is
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cost-eJective, it is possible that given the positive eJects on some
outcomes, the intervention may represent a worthwhile approach
to improving the quality of dementia care and health outcomes for
people with dementia, and to reducing carer burden.
Overall completeness and applicability of evidence
This review includes 13 RCTs, and many of the outcomes do not
involve large numbers of people. Considering the number of people
who might be in receipt of or benefit from this intervention, case
management for people with dementia is not well evaluated,
particularly for those in developing countries.
We requested further information from authors of all the studies
that required additional details on outcomes reported. Although
extra information on the implementation of the case management
interventions was provided for seven of the trials, in most cases it
would be diJicult to replicate the interventions in another setting.
Few studies were provided by pre-existing teams or professionals,
and many studies may therefore have been contaminated by
the experimental setting. A significant proportion of the trials
compared the case management interventions with augmented
usual care and it may be that this augmented care is closer to usual
care in Europe and more applicable to everyday care.
The majority of studies presented data at one year (three RCTs) or
longer (seven RCTs). This is a reasonable length of time to assess
diJerences in intervention eJects; however, longer-term data are
needed to fully measure the impact on care home admissions.
Three studies presented data of six months or less.
Type of study design
Most studies were individually randomised trials, but two were
cluster-randomised; these had wider system-level collaborative
care interventions where the intervention is also applied to the
providers of care rather than solely to the individual participant.
Cluster-RCTs are recommended in these situations, as RCTs based
on individual participants may be vulnerable to contamination
(Ukoumunne 1999). Future versions of the review, with additional
studies, will need to explore in a sensitivity analysis whether the
outcomes are sensitive to the inclusion of such trials.
Access to forms of case management or other services were a
feature of some of the control groups for studies included in
this review.   The use of case management was measured among
the control groups for this review, and we found a significant
diJerence in the numbers receiving case management in the
intervention and control arms, but there may be some degree of
contamination in the results.  The Chu - Canada study reported
that the control group also had access to the standard home-care
programme.  It was noted in the Newcomer - US study that control
group cases may have been exposed to comparable benefits,
such as case management and community care benefits if they
were participating in the Medicaid programmes.   For this reason,
the demonstration programmes were encouraged not to seek or
accept applications from those receiving Medicaid. However, there
were still around 7% of participants each in the treatment and
control groups who were Medicaid recipients. Statistical controls
were put in place to adjust for the potential eJect of Medicaid
participation. Our results did not illuminate any particular eJects of
these diJerences in control conditions on the outcomes.  
Type of participants
There was a mix of trials from Europe, USA, Hong Kong, Canada
and India. Studies included a wide variability of participants and
carers, although only one study reported that a high proportion
of participants were socio-economically disadvantaged (Callahan
- Indianapolis). This variability reflected the severity of dementia;
six studies included both mild and moderate severity (Bass -
Ohio; Callahan - Indianapolis; Chien- Hong Kong 2008; Chien -
Hong Kong 2001; Dias - Goa India; Lam - Hong Kong). Three
studies included predominantly moderate (Eloniemi-Sulkava 2001;
Eloniemi-Sulkava 2009; Newcomer - US) and four studies included
mostly mild dementia (Chu - Canada; HinchliJe - UK; Jansen -
Netherlands; Vickrey - California). A number of trials reported
participants with significant comorbidities (Bass - Ohio; Callahan
- Indianapolis; Eloniemi-Sulkava 2009; Jansen - Netherlands;
Vickrey - California), whilst others excluded those with physical
comorbidities (Eloniemi-Sulkava 2001; Dias - Goa India; Lam -
Hong Kong). As we did not pursue subanalyses involving dementia
severity, further work may be necessary to ascertain whether the
severity of dementia or other subgroups are more or less likely to
benefit from case management.
Type of intervention
Case management is a complex intervention with multiple
components which facilitates access to treatment, services and
support both for people with dementia and for their carers. The
goals of the studies included in the review were varied; they
focused on reducing carer depression and burden, improving
carer quality of life, delaying institutionalisation, reducing the
number of neuropsychiatric symptoms/behavioural problems,
increasing early use of home care and other community services,
facilitating long-term planning, and improving carer competence in
caring. In many studies the case management interventions were
specifically targeted at predetermined outcomes (e.g. carer burden
or institutionalisation), and it is possible that other beneficial
eJects of the interventions were not measured.
Case managers delivering the intervention were from a range
of professional backgrounds (nurses, social workers, occupation
therapists, and psychiatrists) and were based in a variety of
settings, including primary care and dementia resource centres.
The training which the case managers received to deliver case
management also varied considerably between the trials, both in
the mode of provision of training and the content.   Only three
trials reported on provision of dementia training for their case
managers, and several of the studies did not report any details on
training for the case managers. The case manager was responsible
for co-ordination of care and treatment between organisations
and agencies.  It would appear that in only three of the studies
were the case managers taking responsibility for managing the
wider care network. In many other studies they appeared to be
more focused on co-ordinating the work of their own service
alone, which represents a narrower focus of case management
responsibility. Such diJerences in case manager involvement and
their range and breadth of responsibilities are likely to be critical
determinants of variations in outcome.
In this review, case management focused on the planning and
co-ordination of care required to meet the identified needs
of the person with dementia, although the forms of case
management diJered. The core tasks of assessment, care planning
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and implementation/management were common to all but one
trial, but there was considerable variation in their delivery. Most
studies used face-to-face contact to deliver case management,
but one used solely telephone contact. The intensity of the case
management varied; the frequency of contact between the case
managers and the participants/carers varied from one to two or
more contacts per month, and caseload size ranged between 13
and 100 participants. Length of intervention varied between four
months and two years. However, given the limited data available
for the long-term eJects of case management, it is diJicult to
conclude whether these observed eJects are due to the duration or
frequency of the intervention, or to other mediating variables.
In our second objective we aimed to study whether other potential
mediating variables aJect case management outcomes (e.g.
key structural and organisational features of case management
interventions, and also the methodological characteristics of
studies). We categorised the trial interventions according to many
components (Table 1; Table 3; Table 4; Table 5). Although this
enabled us to provide a synthesis of the context and characteristics
of the case management interventions, the design of the trials
did not permit us to identify components of the interventions
that might represent the most important active ingredients.
The fairly small numbers of studies that could be included in
many of the meta-analyses at each particular time point also
limited subgrouping on case management characteristics,making
it diJicult to meet our second objective. Since the case
management interventions varied considerably (e.g. content of
case management interventions; target populations; degree of
control and influence over allocation of care resources; and
intensity and duration) it was diJicult to interpret the results and
to link outcomes to the specific components of the interventions.
DiJerences in health care delivery in various countries, the impact
of culture on care, the attitude and acceptance of care and
institutional care should also be considered in future updates of
this review.
Quality of the evidence
The quality of the included studies is variable, but most were free
of selection bias due to the use of adequate methods for random
sequence generation and allocation concealment. However, all of
the studies included in the review were subject to some level
of performance bias, where either the participants or the case
managers or both were unblinded (Summary of findings for the
main comparison). Nine out of the 13 studies had blinded outcome
assessors and the others were either at high or unclear risk, but
overall there was a low risk of detection bias. There were large
variations in the sample sizes within studies. The Newcomer - US
study had 8095 participants, while HinchliJe - UK had only 40. Most
studies had between 100 and 200 participants.  There was some
attrition bias in some of the studies.
We found clinical and methodological heterogeneity in terms of
participants, interventions, comparisons and outcome measures.
Applying ’Risk of bias’ criteria to the studies has identified some
methodological limitations, although some of these (e.g. blinding
of participants and clinicians) reflect the reality of conducting
complex intervention trials in practice. Some studies rated at high
risk of bias for blinding of participants used self-reported outcomes
and service use data which may not be as vulnerable to bias
as an unblinded external observer. There was no evidence that
removing the two studies rated at high risk of bias (assessed in
terms of allocation concealment) had a large eJect on the estimate
of treatment eJect in the main analyses. As illustrated in Figure 2,
there is the impression of a low to moderate overall risk of bias in
these trials. This would mean, therefore, a low to moderate risk of
overestimating a positive eJect. Making judgements about quality
has been helped by a discernible improvement in the reporting of
trial methodology; the studies that were rated at high risk of bias
were conducted over a decade ago.
Some of the analyses, e.g. the number of hospital admissions
at 6,12 and 18 months, quality of life of carers at 12 and 18
months, carer burden at 12 and 18 months, had a high value I2
statistic, indicating either 'moderate' or 'substantial' heterogeneity
according to the recommended interpretation (Deeks 2011).
Since there are several limitations to this review, our conclusions
should be treated with caution. Although the number of included
participants is high, the number of included studies is relatively low.
We may therefore have missed true diJerences between groups.
There is heterogeneity between the participants' demographics,
types of dementia, intervention components, delivery methods,
outcome measures and follow-up periods.
Potential biases in the review process
The search terms for the Specialised Register of the Cochrane
Dementia and Cognitive Improvement Group (updated December
2013) should have been robust enough to detect relevant studies.
It is possible that we have failed to identify small studies, but
we think it unlikely that we would have missed large trials. We
attempted comprehensive literature searching, but the fact that
one citation has not yet been incorporated may be a source of
potential bias. Studies published in languages other than English,
and those with equivocal results, are oVen diJicult to find (Egger
1997). Our search was biased by use of English phrases. However,
given that the Specialised Register of the Cochrane Dementia
and Cognitive Improvement Group covers many languages but is
indexed in English, we feel that we are unlikely to have missed many
studies within the register. It is also worth noting that the review did
not include studies that were solely focused upon carers. This may
be something we will reconsider for future updates.
Some of the meta-analyses have been dominated by the largest
trial (Newcomer - US), and a funnel plot of the institutionalisation
outcome appears slightly asymmetrical (Figure 7), suggesting that
possible publication bias may be a factor for this outcome at least.
However, tests for funnel plot asymmetry are not recommended
when there are fewer than 10 studies in the meta-analysis, because
test power is usually too low to distinguish chance from real
asymmetry (Sterne 2011). Consideration should be given to the
possibility of publication bias in this review.  Trials which do not
produce positive findings appear less likely to be published, which
can lead to a biased set of studies being included in systematic
reviews. However, there is likely to be a low risk of publication
bias for this review, since our comprehensive search strategy did
not restrict searches to peer-reviewed journals only; for example,
the Jansen - Netherlands study, included in this review, was a
PhD thesis conducted in the Netherlands. We cannot rule out the
possibility that we have missed unpublished trials with negative
results. In future, publishing of trials based on their results should
be less of a problem, since many trials are now required to be
included in a recognised clinical controlled trials register and many
trial protocols are now being published.
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Figure 7.   Funnel plot of comparison: 1.1 Institutionalised (number of patients admitted to residential or nursing
homes)
 
The quality of reporting was variable. We contacted authors of
all studies where we identified missing outcome data. Given the
complexity of the outcomes and intervention, this led to multiple
requests for data. Some important data within the included studies
were not reported clearly or in a format that could be used in the
review, which is a shortcoming of the research community. Should
we acquire more data from existing studies, we would probably
know more about the eJects of this widely-implemented approach
of care.
Since publishing the protocol, we have made several changes as
a result of editorial discussions on the best way to report and
synthesise the data. In some cases protocol rules were not clear
enough, so that the need for subsequent clarification arose and
post hoc decisions had to be taken (DiJerences between protocol
and review). In particular we prespecified what characteristics of
studies could be associated with heterogeneity. The variability of
interventions, outcomes and participant groups meant that oVen
only a very small number of trials could be included in many of
the meta-analyses. For example, owing to the small number of
studies in the subgroups and the diversity of case management
interventions, the subgroup analyses involving dementia severity
were not pursued on the basis that they were unlikely to generate
meaningful or relevant results. In addition, we have further
specified how outcomes would be measured.
Agreements and disagreements with other studies or
reviews
An important strength of this review is the use of a stringent
definition of case management. A number of reviews have been
completed in this area, but they are less specific when defining
what case management is. The first review (Pimouguet 2010)
covered 12 trials, seven of which we also reviewed here (Bass - Ohio;
Callahan - Indianapolis; Chien- Hong Kong 2008; Chu - Canada;
Eloniemi-Sulkava 2001; Newcomer - US; Vickrey - California).
Like our review, Pimouguet 2010 noted the eJects of delaying
institutionalisation for people with dementia, but concluded that
there was not suJicient evidence to draw conclusions about the
eJects of case management on costs and resource utilisation.
The most recent review (Somme 2012) included six studies, five of
which we include in our review (Bass - Ohio; Callahan - Indianapolis;
Eloniemi-Sulkava 2001; Newcomer - US; Vickrey - California). We
excluded their sixth study (Weinberger - US), as the intervention
was focused on carers only. Somme 2012 concluded that more
eJective case management related both to better integration
between the health and social service organisations, and to the
intensity of the case management.
The findings of the authors of a review of community care
demonstrations in the US 25 years ago are still relevant today.
They concluded that "expanding public financing of community
services beyond what already exists is likely to increase costs.
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Small nursing home cost reductions are more than oJset by the
increased costs of providing services to those who would remain
at home even without the expanded services. However, expanded
community services appear to make people better oJ and not to
cause substantial reductions in family care-giving. Policymakers
should move beyond asking whether expanding community care
will reduce costs to addressing how much community care society
is willing to pay for, who should receive it, and how it can be
delivered eJiciently" (Kemper 1987).
A U T H O R S '   C O N C L U S I O N S
Implications for practice
For patients and carers
There were some data to indicate that case management was
eJective in ameliorating some outcomes at certain time points
relevant to people with dementia. However, the results were
uncertain at other time points. Case management may represent
a more patient-centred system of care. The data available suggest
that admissions to care homes and overall healthcare costs are
reduced. In addition, length of time to admission to long-term
care was reduced, but more evidence is needed. The data did
not indicate that case management improved cognition, functional
status or depression, and there were no data available on the
satisfaction of participants.
There were some data to suggest that case management may
contribute to reduced carer burden, but much of these data were
diJicult to interpret, given the variation in interventions, outcome
measures and reporting. One of the determinants of individual
carer burden will be the level of formal and informal support
available. However, the appropriate information to address these
issues of substitution and complementary information was not
always available in the studies. There was some indication that
carers were less depressed and less likely to be hospitalised and to
visit the emergency department in the longer term, and that service
costs were reduced at one and three years. There were minimal data
available on satisfaction with care, but the available data indicated
that those receiving case management were more satisfied. There
does not seem to be compelling evidence that case management
substantially aJects a carer's quality of life, carer well-being or
reduces carer distress.
For clinicians
The heterogeneity in the interventions, outcomes and participants
may explain these largely equivocal findings. The eJects of
case management in a 'comprehensive' form apply to only half
of the studies included in the review (Table 5). A number of
studies have evaluated a case management intervention on top
of other health system changes (such as promoting adherence to
recommended treatment protocols). Some conclusions, therefore,
apply to diJering variants of case management packages. One
of the trials which was part of a wider quality improvement
programme demonstrated that there were few diJerences in
provider knowledge or attitudes favourable to dementia care,
suggesting that this care model’s eJects on quality were primarily
mediated through other components of the case management
programme (Vickrey - California).
More attention needs to be given in future studies to demonstrating
the extent to which the case management intervention is delivered
as planned. Well-developed training and protocol manuals will
help with assuring the fidelity and replicability of the intervention.
In one trial case managers were found not to be working to
protocol (Jansen - Netherlands). The authors noted that improved
"adherence to key care processes may lead to better quality of care
and participant outcomes".
There are indications of benefits to increased involvement and
linkage with primary care in case management interventions for
people with dementia. Three out of the 13 studies were based
within primary care (Callahan - Indianapolis; Jansen - Netherlands;
Vickrey - California).
It is important that these interventions are targeted at the
right populations. Some interventions were more assertive in co-
ordination of care by case managers, which were targeted at people
who were more likely to benefit from the intervention. However,
at least two trials indicated that the intervention was not targeted
appropriately (Jansen - Netherlands; Newcomer - US). It was
noted in the latter study that the levels of burden and depression
among carers were generally below those that would indicate
clinical problems. It was suggested that to be more eJective, the
demonstration may have needed to target carers with clinically
identified levels of burden and depression or other risk factors (e.g.
low income, health crises, duration of care-giving, living separately
from the care recipient) who could have benefited more from the
demonstration interventions.
For funders and policy makers
Health care policy in the UK recommends the development of a
comprehensive system of case management similar to that for
people with long-term conditions using the Quality and Outcomes
Framework register data from primary care (NICE 2006). Primary
care and specialist services need to integrate care more eJectively
(Joint commissioning panel for mental health 2012) and case
managers are likely to be able to facilitate this. The newly-evolving
GP commissioning consortia will want to commission cost-eJective
models of care for people with dementia (Joint commissioning
panel for mental health 2012). Indeed, care co-ordination features
heavily in the recent guidance where commissioners are advised to
work with their local dementia partnership to agree and implement
a robust service model for care co-ordination (NICE 2013). A recent
report has indicated that case management would substantially
reduce health and social care costs but increase the costs of
unpaid care (Knapp 2014). Case management features as a clear
strategy for co-ordinating dementia care in France; the role of
the co-ordinators has been created on the basis of current case
management evidence (French Ministry of Health 2008).
This review shows that there is not yet a robust evidence base for
the eJectiveness of case management in meeting healthcare needs
or cost eJectiveness for patients or carers. Funders should support
research which investigates the eJectiveness of specific models
of case management for people with dementia. The one citation
in Studies awaiting classification may alter the conclusions of the
review once assessed.
Implications for research
A future update of this review, including results from ongoing
trials and those 'awaiting classification', may increase the precision
of the estimates of eJect sizes. Future systematic reviews and
meta-analyses could be performed to investigate the eJect of
Case management approaches to home support for people with dementia (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
36
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
particular models of case management compared with standard
care. This review would be strengthened by additional large-scale
high-quality studies where specific features and modalities (e.g.
telephone and face-to-face) of case management are investigated.
Further robust research is needed to determine whether case
management care is an eJective system for people with dementia
and their carers, in terms of clinical outcomes and cost.
Future trials need to be rigorous in design and delivery, with
subsequent reporting to include high-quality descriptions of all
aspects of methodology to enable appraisal and interpretation of
results. Detailed process evaluations are also required, to identify
components of this complex intervention and to facilitate the
interpretation of trial outcomes.
Case management is a complex intervention (Campbell 2000); we
recommend that a full description of care in the intervention and
control groups is provided. In future it will be important to classify
more closely the content of case management interventions and
their fidelity to the expected intervention (McGrew 1994). Future
studies will need to continue and increase this precision in
discriminating between community-based staJ doing some care
co-ordination activities and a specific role of case manager, and
also to delineate more carefully the content of the intervention
itself and its core components. Process evaluations would help to
identify the components of case management, understand how
it is delivered and how issues of sustainability and replicability
are addressed. Process evaluations are particularly important for
interpreting outcomes, and for understanding how an intervention
is implemented across multiple sites. Although seven of the 13
studies reported using standardised protocols, the use of well-
developed manuals and protocols should be more widespread,
since they can help to ensure the transparency, replicability
and integrity of this complex intervention.  This highlights the
need for greater consistency in process level and quality of care
indicators (which systematically describe how the interventions are
implemented). These could include: the number of people with a
care plan and how oVen it is monitored, reviewed and updated;
the number of times visited, followed up or telephoned by the
case manager; the number of phone calls or contacts that the case
manager makes on behalf of the person with dementia or the carer.
Future studies should consider including measures such as these
to help ascertain the active ingredients of case management by
relating these to their outcomes.
Only two of the studies reported data on the use of prescribed
medications, and there were not enough data to draw reliable
conclusions about whether or not certain prescribed medications
have an influence on the eJectiveness of case management
interventions. This could be considered in future studies. Following
CONSORT recommendations (CONSORT 2010a; CONSORT 2010b)
in the reporting of future studies would greatly assist synthesis of
data in reviews. The timing of participant admission to residential
or nursing homes was not reported in all studies; a number of
studies report cumulative data at the endpoint of the trial. More
trials should address this outcome at each follow-up point, which
would be fairly easy to collect and report in a CONSORT diagram.
We note that scale measurements (which may be both easier to
collect and less ambiguous) were more likely than binary data to
be reported in the papers for assessing clinical outcomes. More
trials should address admissions to nursing homes at each follow-
up point, admission to hospital and associated length of stay,
along with the length of time until institutionalisation (which was
only reported in one of the trials). Matters are complicated by the
use of many scales for the same outcomes, which makes meta-
analysis more diJicult. Heterogeneous measurements were used
to describe the same outcome, constituting a lost opportunity
for researchers. Any relevant studies in this area should aim to
provide data that are compatible with this review. There are few
cost-eJectiveness studies identified so far, and this gap should be
addressed, particularly in relation to clinically meaningful benefits
and the potential for cost savings with this intervention. More
attention should also be paid to patient and carer perspectives in
terms of measuring satisfaction, quality of life, well-being, social
support and carer burden.
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Characteristics of included studies [ordered by study ID]
 
Methods RCT
Follow-up: 12 months
Analysis: intention-to-treat.
Participants Setting: Health care co-ordinated with the Alzheimer's Association, Cleveland, Ohio, US.
Inclusion criteria: Selected dementia ICD-9 codes in the medical record followed by confirmation
from  by primary care physician; aged > 55 years; living in the community; living in the Cleveland Area
Alzheimer's Association service area
1. Family level (consists of participants, carers, or dyads [both carers and participants]) n = 210: 127 in-
tervention; 83 control.
2. Interviewed carer subsample n = 183: 112 intervention; 71 control.
3. Interviewed participant (PWD) sub-sample n = 121: 69 intervention; 52 control.
4. In 94 families both the carer and PWD (dyad) were interviewed.
Age: PWD mean = 76.4 (SD 8.58) carer mean = 63.9 (SD 13.92)
Gender: PWD 41% men; carer 28% men
Diagnostic criteria: Selected dementia ICD-9 codes in the medical record followed by confirmation by
primary care physician.
Diagnosis (medical records: Age-related cognitive decline 49.0%; Dementia/amnesiac disorder 22.4%;
Alzheimer’s Disease 13.3%; Dementia 9.5%; Dementia of the Alzheimer’s Type 3.8%; Vascular dementia,
uncomplicated 1.4%).
Blessed score – 9.77 (SD 9.34); Intervention – 10.98 (SD 9.58); Control – 8.18 (SD 8.89)
Number of co-morbidities 2.7(SD 1.96);
Interventions Intervention group:
n = 94
Telephone-based care consultation delivered within a partnership between a managed care health sys-
tem and an Alzheimer's Association.
Duration: 12 months
Intensity: follow-up biweekly, then reduced to monthly, then 3-monthly unless more visits needed.
2 part-time care consultants and 1 part-time care consultant assistant/volunteer per 100 families.
Bass - Ohio 
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Skill mix: Care consultation was delivered by 1 of the 3 Association staJ members, 2 of whom are mas-
ter's-prepared licensed social workers.
Case management tasks: assessment, care planning, implementation and monitoring of care plan.
Components: participant information and education, participant advocacy, provision of emotional
support, carer education. A standardised protocol was followed by care consultants.
Breadth of services spanned: Case manager co-ordinates/liaises with other outside services.
Control group:
n = 63
Usual managed care services. Use of Association services other than care consultation by both the in-
tervention and control groups is incorporated into the analysis.
(seeTable 2 for further details)
Outcomes Carer strain and depression
Carer satisfaction with types of services, quality of services.
Use of services:
Hospital admissions (number of nights)
Physician visits
Emergency department visits
Unable to use:
Participant's Depression (Centre for Epidemiological studies Depression, CES-D modified); means and
SDs not reported at T2
Cognition (Blessed test score) numbers in groups not reported clearly
Participant satisfaction with Kaiser services; means and SDs not reported at T2
Carergiver satisfaction with information not reported fully for control group
Use of services:
Case management visit (mean, SD of the proportion of participants who had case management visits
(yes = 1) were presented)
rather than the mean number of visits).
Direct care community services (includes personal care services, home health service, nursing home
care and respite service) (composite score 0 - 4; we did not extract composite scores, preferring number
in receipt of services)
Non-association information and support services (includes finding and arranging for services, legal as-
sistance, health information and emotional support or counselling) (composite score 0 - 4; we did not
extract composite scores, preferring number in receipt of services)
Attrition (data were not reported by group)
Notes Lost to follow-up: 14% (25/182) - follow-up rates in intervention and control groups not reported sepa-
rately.
Risk of bias
Bias Authors' judgement Support for judgement
Bass - Ohio  (Continued)
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Random sequence genera-
tion (selection bias)
High risk Participants and family carers were assigned to the intervention or control
group after completion of baseline telephone interviews (i.e. initial data col-
lection) by members of the research team. The research team was totally
separate from the persons providing the intervention, as well as health care
providers who identified eligible patients. Group assignment was ongoing over
a 2-year period of recruitment as participants consented to enrol in the study.
As names of consenting participants were received by the research team, the
consent process was completed, followed by baseline telephone interviews by
the research team. After baseline interviews, 2 participants were assigned to
the intervention group followed by one participant to the control group. Each
participant consisted of a patient and his/her family carer (dyad), except for a
small number of patients who did not have a family carer.
Allocation concealment
(selection bias)
High risk Although the health care organisation referring participants did not know the
sequence of assignment and were not notified of which group individuals were
assigned to, it is possible that they may have worked this out since it was so
regular.This information was only known to the research team, with assign-
ment based solely on the pre-established sequence (2 intervention-group par-
ticipants to one control-group participant).
Blinding (performance
bias and detection bias) 
Participants
High risk Participants could have volunteered to their physicians or nurses whether
they were assigned to the intervention or control group over the course of the
study.
Blinding (performance
bias and detection bias) 
Personnel
High risk Participants could have volunteered to their physicians or nurses whether
they were assigned to the intervention or control group over the course of the
study. If participants or family carers informed physicians/nurses of their par-
ticipation, it was not known by the research team or individuals delivering the
telephone intervention.
Blinding (performance
bias and detection bias) 
Outcome assessors
Low risk Data collectors were blinded to whether participants were assigned to the in-
tervention or control group.
Blinding (performance
bias and detection bias) 
Other
Low risk None
Incomplete outcome data
(attrition bias) 
All outcomes
High risk Some missing follow-up data for psychosocial outcomes, numbers allocated
to the groups and numbers lost to follow-up not clearly reported
Selective reporting (re-
porting bias)
High risk Selective outcome reporting may be present
Other bias Unclear risk Baseline assessment: no test to assess differences between groups is reported
Bass - Ohio  (Continued)
 
 
Methods Cluster-RCT
Follow-up: 6, 12 and 18 months
Analysis: Completers analysis was given at each time point
Participants Setting: Two large primary care practices within 2 US university-affiliated healthcare systems from Jan-
uary 2002 through August 2004.
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Diagnosis: Dementia (Alzheimer's Disease)
Inclusion criteria: Alzheimer's Disease according to DSM-IV
n = 153
Age: Mean: 77.5
Gender: 87 men, 66 women
80% of the intervention group received cholinesterase inhibitors. 55% of the augmented usual care
group also received cholinesterase inhibitors (P = 0.002).
MMSE mean (SD): Intervention group 18.6 (5.9); control group 17.5 (5.2)
Chronic disease score, mean (SD) Intervention 8.0 (3.9) Control 7.6 (4.0)
Interventions Intervention group:
n = 84
Collaborative care management
Duration: 12 months
Intensity: carers and participants were seen by the care manager in the primary care clinic bimonthly
initially and then contacts were lengthened to monthly for a period of 1 year. Mean number of contacts
with care manager was 14.4 (SD 8.9) over 12 months (range 0 - 51)
Skill mix: collaborative care management delivered by a team led by their primary care physician and a
geriatric nurse practitioner who served as the care manager.
Case management tasks: case finding, assessment, financial assessment, care planning, implementa-
tion and monitoring of care plan, arranging/allocation of services, review, case closure.
Components:
Participant information and education, emotional support, carer education, medication management,
education on communication skills; carer coping skills; legal and financial advice; participant exer-
cise guidelines with a guidebook and videotape; and a carer guide provided by the local chapter of the
Alzheimer’s Association.
Breadth of services spanned: Case manager co-ordinates/liaises with other outside services, within
multidisciplinary team and arranges and allocates services.
Control group:
n = 69
Augmented Usual care
(see Table 2 for further details)
Outcomes Numbers of admissions to hospital (number of participants, number of days)
Numbers of admission to nursing home
Length of hospital stay (mean days, SD)
Numbers died
Cognitive functioning (MMSE) (telephone version),
Neuropsychiatric symptoms (NPI) (carer and participant NPI)
Depression in dementia (Cornell Scale for Depression in Dementia)
Activities of daily living (ADL - AD)
Callahan - Indianapolis  (Continued)
Case management approaches to home support for people with dementia (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
50
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Carer mood (Patient Health Questionnaire-9)
Carer satisfaction : Primary care rated as very good or excellent (12/18 months)
Attrition
Cholinesterase inhibitor use
Health care use: cumulative physician or nurse visits (mean, SD)
Unable to use:
None
Notes Lost to follow-up: 25% (39/153)
Almost 3 years of recruitment. Did not reach expected sample size n = 240 - limits the power to detect
smaller differences in cognition, activities of daily living, or nursing home placement.
Supported by grant R01 HS10884 from the Agency for Healthcare Research and Quality.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Physicians were randomised in blocks of 2 stratified by teaching status (faculty
or resident) and the clinic site. A randomisation number table was used to as-
sign the first physician; an odd number meant physician was allocated to usual
care and even to intervention group. The second physician was then assigned
the opposite status. The process was repeated until all physicians were ran-
domised.
Allocation concealment
(selection bias)
Low risk Allocation was adequately concealed up until participant completed baseline
assessment. Physicians were not informed about their randomisation status
and control physicians did not have access to the intervention.
Blinding (performance
bias and detection bias) 
Participants
Unclear risk Participants and carers were blinded to the randomisation status of the physi-
cian up until counselling session, informed consent and baseline assessment
were completed. Then they were aware of receiving the intervention.
Blinding (performance
bias and detection bias) 
Personnel
Unclear risk Diagnostic team and geriatric nurse practitioner were blinded to the randomi-
sation status of the physician up until counselling session, informed consent
and baseline assessment were completed. Then they were aware of perform-
ing the intervention.
Blinding (performance
bias and detection bias) 
Outcome assessors
Low risk Telephone interviewers were blinded to participants' randomisation status,
and they were not allowed to query respondents about their interventions.
Blinding (performance
bias and detection bias) 
Other
Unclear risk Physician was blinded to the randomisation status, however, could have been
informed by the above participants
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Missing outcome data balanced in numbers across intervention and control
groups with similar reasons for missing data across groups.
Selective reporting (re-
porting bias)
High risk Data were not fully reported in the paper, although the authors did send us
data: standard deviations for F3 (18 mo) cumulative physician/nurse visits, F2
(12 mo) and F3 (18 mo) cumulative hospitalisation rates, F2 (12 mo) and F3 (18
mo) hospital days.
Callahan - Indianapolis  (Continued)
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Analysis not consistent with randomisation. No ICC was reported. Some selec-
tive reporting may be present.
Other bias Unclear risk Some baseline differences between groups: Black: 40/69 (58%) Augmented
usual care group ; 35/84 (42%) Intervention (P = 0.05). Women 66/69 (96%)
Augmented usual care group ; 70/84 (83%) Intervention (P = 0.02). However,
these differences were adjusted for in subsequent analyses.
Callahan - Indianapolis  (Continued)
 
 
Methods RCT
Follow-up: 1 week, 12 and 18 months
Analysis: intention-to-treat
Participants Setting: 2 largest dementia resource centres in Hong Kong
Diagnosis: Alzheimer's Disease
Inclusion criteria: family members caring for a relative with dementia at home. Eligibity criteria:
i) aged at least 18 years and could speak and read Chinese; ii) lived with a relative who was diagnosed
as having the Alzheimer’s type of dementia (mild or moderate illness stage) according to the criteria
of the DSM-IV, and they provided care for at least 4 hours per day; and iii) their relative suffered no co-
morbidity of other mental illness during the recruitment period
n = 92 dyads (participant and carer)
Carers' age: mean 45.1 (8.9) years
Participants' age: mean 67.8 (6.8) years
Gender: 52 men, 40 women
MMSE mean (SD) intervention: 17.5 (4.7); control 17.3 (3.9)
Duration of illness at recruitment: 2.1 years
60% of participants' duration of illness less than 2 years.
52% received cholinesterase inhibitors or N-methyl-D-aspartate antagonists (e.g. donepezil and me-
mantine)
Interventions Intervention group:
Each of the family participants was assigned one case manager, who conducted weekly home visits,
family health and educational needs assessment using the Educational Needs Questionnaire (Chien
2005), and education about dementia care. In collaboration with the carers, the case managers priori-
tised the problems and formulated an individualised education and support programme for effective
dementia care for each family. This preparatory phase lasted about 1 month. All family care sessions
consisted of education, sharing and discussion, psychological support and problem-solving, in accor-
dance with the common elements found effective in previous studies for carers. A protocol was specifi-
cally designed for this study, based on evidence from other family intervention studies in dementia.
Duration: 6 months (After 1 month’s needs assessment and preparation, the DFCP was conducted for
individual families, lasting about 5 months)
Intensity: 10 sessions held every other week for 2 hours. The family and the case manager met bi-week-
ly, for a total of 10 2-hour sessions
Chien - Hong Kong 2001 
Case management approaches to home support for people with dementia (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
52
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Skill mix: Each family was assigned 1 nurse case manager who worked with another nurse in the centre.
"The committee designed an information and psychological support system linking case managers and
dementia care services, health professionals and referrals."
Care management Tasks: Assessment, care planning, implementation and monitoring of care plan
Components: Participant information and education; carer education; provision of emotional/thera-
peutic support
Breadth of services spanned: Case manager co-ordinates/liaises with other outside services, within
multidisciplinary team
Control group: Routine care
The routine care group participants received the usual family services provided by the dementia re-
sources centres.
(seeTable 2 for further details)
Outcomes Length of institutionalisation to a residential home or hospital unit - average number of days per
month over the previous 6 months.
World Health Organization Quality of Life Measure (Brief HK version) (carers);
Social Support Questionnaire (SSQ6, 6 item);
MMSE
NPI Questionnaire (NPI, 12-item) (participants' symptoms, carers distress not reported);
Family Caregiving Burden Inventory (FCBI)
Attrition
Unable to use:
Utilisation of services - Family Support Services Index (FSSI)
Rate of institutionalisation:
Average number of residential placements or hospitalisations over the previous 6 months - we did not
extract, as we preferred to enter numbers admitted, or mean number of nights/days)
Notes Lost to follow-up: 98% of families completed the study. One family in the control group (loss of contact)
and 1 family in the intervention group (mortality) at 18 months assessment
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Method of randomisation was not mentioned, although it was stated that fam-
ilies were randomly selected from client list using computer-generated ran-
dom number list.
Allocation concealment
(selection bias)
Unclear risk Precise method of concealment not described.
Blinding (performance
bias and detection bias) 
Participants
Unclear risk Not mentioned in the paper.
Blinding (performance
bias and detection bias) 
Unclear risk Not mentioned in the paper.
Chien - Hong Kong 2001  (Continued)
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Personnel
Blinding (performance
bias and detection bias) 
Outcome assessors
Low risk A research assistant, who was blind to the participant assignment, adminis-
tered the pretest before randomisation (Time 1), and asked the participants
again to complete the outcome measures, including carers’ burden, quality of
life, social support, use of family services and client symptom severity scales,
for 3 post-tests at 1 week (Time 2), 12 months (Time 3) and 18 months (Time 4)
following the intervention.
Blinding (performance
bias and detection bias) 
Other
Low risk None.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Low attrition. Missing outcome data balanced in numbers across intervention
groups.
Selective reporting (re-
porting bias)
Low risk No apparent signs of selective outcome reporting.
Other bias Unclear risk Even though the intervention was given to only the experimental group, the
2 centres provided both groups with routine dementia care. Contamination
within each centre may have occurred.
Chien - Hong Kong 2001  (Continued)
 
 
Methods RCT.
Follow-up: 6 months.
Analysis: intention-to-treat.
Participants Setting: 2 dementia resource centres in Hong Kong
Diagnosis: Alzheimer's Disease
Inclusion criteria: family carers being 18 years or older and living with and caring for a relative with
Alzheimer's disease (AD). AD diagnosis based on the DSM-IV criteria
n = 88 dyads (participant and carer)
Carers' age: mean 43.6 (9.2) years
Participants' age: mean 67.8 (6.8) years
Gender: 50 men, 38 women
Duration of illness: mean 2.8 (1.5) years
80% of participants were at an early stage of dementia
55% received cholinesterase inhibitors (e.g. donepezil) or N-methyl-D-aspartate antagonists (e.g. me-
mantine)
63% received a low dosage of antipsychotic medication
MMSE mean (SD) Intervention 17.5 (4.7); control 17.3 (3.9)
Interventions Intervention group:
n = 44
Chien- Hong Kong 2008 
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Dementia care management programme - an educational and supportive group for carers. It consist-
ed of 5 phases—orientation to dementia care (1 session), educational workshop about dementia care
(3 sessions), family role and strength rebuilding (6 sessions), community support resources (1 session),
and review of programme and evaluation (1 session)
Duration: 6 months.
Intensity: 12 sessions that were held every other week and lasted 2 hours each
Skill mix: Each family was assigned 1 case manager who worked with another nurse in the centre. Case
managers received 32 hours of formal training by the researchers and co-ordinated all levels of family
care according to the results of a structured needs assessment
Care management Tasks: Assessment, care planning, implementation and monitoring of care plan
Components: carer education
Breadth of services spanned: Case manager co-ordinates/liaises with other outside services, within
multidisciplinary team
Control group:
n = 44
Standard care with 6 month educational sessions in order to blind the participants of the treatment
group allocation
(seeTable 2 for further details)
Outcomes Length of institutionalisation over past 6 months (residential placements or hospitalisations, duration
days per month) at 6 and 12 months
Length of institutionalisation in a residential home or hospital unit (length of hospital stay)
Carer quality of life (World Health Organization Quality of Life Scale)
Cognitive functioning (MMSE)
Neuropsychiatric symptoms (NPI) (participants’ symptoms)
Carer burden (the Chinese version of the Family Caregiving Burden Inventory)
Carer social support (6-item social support questionnaire SSQ6)
Attrition
Unable to use:
Use of services (Family support services index); we did not extract composite scores, preferring number
in receipt of services
Institutionalisation over past 6 months (residential placements or hospitalisations) (numbers of times -
we did not extract, preferring numbers admitted)
Notes Lost to follow-up: 95% of families completed the dementia care programme. One family in the control
group lost to follow-up at 12 months assessment
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Method of randomisation was not mentioned.
Chien- Hong Kong 2008  (Continued)
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Allocation concealment
(selection bias)
Unclear risk Not mentioned in the paper.
Blinding (performance
bias and detection bias) 
Participants
Unclear risk Carers were given 6 monthly education sessions on dementia care in the stan-
dard care group (control) to conceal the intervention of interest for family car-
ers. SInce the intervention also included assessment, care planning, imple-
menting and monitoring care plans, participants may not have been blind to
allocation.
Blinding (performance
bias and detection bias) 
Personnel
Unclear risk Not mentioned in the paper.
Blinding (performance
bias and detection bias) 
Outcome assessors
Low risk One researcher was blind to the group assignment who administered tests be-
fore randomisation and at 6 and 12 months.
Blinding (performance
bias and detection bias) 
Other
Low risk None.
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Number randomised not stated clearly. Attrition not reported clearly for each
group.
Selective reporting (re-
porting bias)
Low risk No apparent signs of selective outcome reporting; there were no missing data.
Other bias Unclear risk Even though the intervention was given to only the experimental group, the
2 centres provided both groups with routine dementia care. Contamination
within each centre may have occurred.
Chien- Hong Kong 2008  (Continued)
 
 
Methods RCT
Follow-up: 3 months, 6 months, 10 months, 14 months, 18 months
Analysis: Completers analysis was given at each time point
Participants Setting: Community home care. Participants were recruited from outpatient clinics as well as referred
by physicians at North Alberta, Canada
Diagnosis: Alzheimer's Disease (AD) based on the Nathional Institute of Neurological and Communitive
Disorders and Stroke
Inclusion criteria for the persons with dementia: Diagnosis of early stage Alzheimer's type dementia;
not at imminent risk of placement in long-term facility; living in the community, having a carer living
with them or in the same city without a serious illness
Inclusion criteria for carers: principal informal carers, no serious illness and living with the person with
dementia or in the city
n = 75 dyads (participant and carer)
Baseline MMSE mean (SD) intervention 22.7 (3.8) (range reported: 28 - 11); control group 22.8 ( 4.2)
(range reported: 29 - 13)
Chu - Canada 
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Age: Not given; 68% of participants were > 75 years old
Gender: numbers not reported, although "there were equal numbers of males and females"
65% treatment group and 81% control group lived with their primary carer
Interventions Intervention group:
n = 37
The Early Home Care Program provided case management, occupational therapy, physical therapy, so-
cial work, nursing, respiratory therapy, in-home respite, and out-of-home respite, homemaking, per-
sonal care assistance, volunteer service and psychiatric consultation.
Duration: 18 months
Intensity: The case manager made monthly contact by phone or home visit. The frequency of contacts
increased as needed.
Skill mix: Case managers (1 for part of the study, 2 for 1 year of study - a social worker and an occupa-
tional therapist) and professionals such as occupational therapist, nurse and social worker were in-
volved as appropriate
Care management tasks: Care planning, implementation/management of care plan, arranging/allocat-
ing services, monitoring the implementation of the care plan
Components: participant information and education, Participant advocacy, Legal/insurance/bene-
fits/financial assistance, Provision of emotional/therapeutic support, Counselling/therapy
Breadth of services spanned: Case manager co-ordinates/liaises with other outside services, within
multidisciplinary team, arranges and allocates services and manages care network
Control group:
n = 38
Participants were given an information package on community resources. As control group members
became eligible for the conventional home care programme, they were informed accordingly. Control
group participants who were admitted to the conventional home care programme maintained their
group status.
(seeTable 2 for further details)
Outcomes Participant well-being (using the Depression Scale-Short Form GDS Scale) (means and SDs at 3, 6, 10,
18 months)
Cognition (MMSE) (means and SDs at 3, 6, 10, 18 months);
Carer well-being (Burden Interview and CES-D Depression Scale) (means and SDs at 6, 10, 18 months)
Number using services (case management and in home support services such as respite personal care,
homemaking)
Number using services (direct care such as occupational therapy, physical therapy, social work, nursing
and respiratory therapy)
Attrition
Unable to use
Length of time participants remained in the community (not reported fully – just figure 1)
Activities of daily living (Alberta Assessment and Placement Instrument AAPI) (not reported)
Chu - Canada  (Continued)
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Neuropsychiatric Syptoms (Memory and Behaviour Checklist) - problem behaviours and carer reaction
(means and SDs at 3, 6, 10, 18 months) (change scores not reported)
Notes Lost to follow-up 27/75 (36%)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Participants were first stratified based on the carer's gender and then kinship
to the participants. Then, under each kinship category, the first participant
is assigned to 1 group and the second participant assigned to the alternate
group and so on.
Allocation concealment
(selection bias)
High risk No method was used to conceal the allocation sequence.
Blinding (performance
bias and detection bias) 
Participants
High risk No measure was used to blind study participants.
Blinding (performance
bias and detection bias) 
Personnel
High risk No measure was used to blind study personnel.
Blinding (performance
bias and detection bias) 
Outcome assessors
High risk No measure was used to blind outcome assessors.
Blinding (performance
bias and detection bias) 
Other
Unclear risk A possible performance bias. At the start of the study the pilot project co-ordi-
nator was also the only case manager involved. Then, further research funding
was made available to hire a 2nd case manager for a 12-month period. At the
end of the 12 months, it was back to 1 case manager, who was the project co-
ordinator.
Incomplete outcome data
(attrition bias) 
All outcomes
High risk 'As treated' analysis done (for some outcomes) with substantial departure of
the intervention received from that assigned at randomisation.
Selective reporting (re-
porting bias)
High risk Data were not fully reported in the paper, although the authors did send us
further data analysis. There are some data missing for total home care usage
outcomes (SDs for mean number of hours) and total numbers institutionalised
(SDs). Length of time participants remained in the community. Activities of
daily living (Alberta Assessment and Placement Instrument AAPI) (not report-
ed). AAPI was devised locally and assesses people with dementia for long-term
care needs - systematic assessment, not a validated tool.
Other bias Unclear risk A significant proportion of the control group received case management. As
control group members became eligible for the conventional home care pro-
gramme, they were informed accordingly. Control group participants who
were admitted to the conventional home care programme maintained their
group status.
Chu - Canada  (Continued)
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Follow-up: 3 and 6 months
Analysis: Completers analysis given at each time point
Participants Setting: Participants were recruited by contacting a self-help line or by key informants in Goa, on the
west coast of India
Diagnosis: dementia by DSM-IV criteria (specific type not mentioned)
Inclusion criteria: Mild and moderate dementia according to the Clinical Dementia Rating scale (CDR).
Excluded if severe co-morbid physical health conditions
n = 81
Age: mean 78.3 (8) years.
Gender: Men (PWD) = 53, Men (carers) = 10
Interventions Intervention group:
n = 41
The intervention was a flexible, stepped-care model primarily aimed at improving the awareness and
knowledge of carers regarding dementia, to provide emotional support to carers, to maximise their
care-giving resources and to improve care-giving skills.
Duration: minimum of 6 months
Intensity: The minimum frequency of visits was at least once a fortnight for 6 months. The maximum
was based on the needs as assessed by the HCA. Thus, the visits could be more frequent depending on
the need of that particular family
Skill mix: Intervention delivered by a community team composed of 2 full-time HCAs, 2 psychiatrists
and a lay counsellor. The minimum requirements for being a HCA were knowledge of the local lan-
guage, being literate, preferably passed higher secondary school, and motivated to be involved in the
community care of older people. They received intensive training for a week through role play and
interactive training methods. The HCA were trained in key skills, including listening and counselling
skills, bereavement counselling, stress management and health advice for common health problems.
The HCAs were supported and supervised by the 2 part-time specialists: 2 psychiatrists (1 supporting
each team) and 1 counsellor (supporting both teams)
Care management tasks: case finding; implementation and monitoring of care plan. The HCAs referred
people back to the psychiatrist, or advised the families about services
Components: medication management, counselling, carer education, legal advice
Breadth of services spanned: case manager works within multidisciplinary team; co-ordinates outside
services.
Control group:
n = 40
The control-arm dyads received only education and information regarding dementia, and were then
placed on a waiting list to receive the intervention after 6 months. They were free to utilise the existing
health services during this time.
(seeTable 2 for further details)
Outcomes Carer mental health using the Generla Health Questionnaire (GHQ)
Zarit Burden score (ZBI)
Behavioural and psychological symptoms using the NPI Questionnaire
Dias - Goa India  (Continued)
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Participant’s functional ability using Everyday Ability Scale for India (EASI)
Outcomes not used:
None
Notes Lost to follow-up 27% (22/81)
Mortality was high; 22% (18) died during the study
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation of dyads (participants with dementia and carers) was carried
out by an 'independent person', based on a simple random number tables.
Allocation concealment
(selection bias)
Unclear risk Methods of allocation to intervention or control sequence was not clarified.
Blinding (performance
bias and detection bias) 
Participants
High risk Participants were aware of the allocation status.
Blinding (performance
bias and detection bias) 
Personnel
Unclear risk The Home Care Advisors (HCA) team who delivered the intervention were
aware of intervention/control allocated status. No mention of other personnel
blinding.
Blinding (performance
bias and detection bias) 
Outcome assessors
High risk Blinding of outcome assessors was attempted by keeping allocation status in
a separate office from the outcome evaluation teams. Families were also in-
structed not to divulge information on the visits by the Home Care Advisor. In
order to evaluate the masking process, researchers were asked to guess the in-
tervention status. ⅔ of the assessors correctly guessed the allocation status.
Blinding (performance
bias and detection bias) 
Other
Low risk None.
Incomplete outcome data
(attrition bias) 
All outcomes
High risk Missing outcome data balanced in numbers across intervention groups with
similar reasons for missing data across groups.
Selective reporting (re-
porting bias)
Low risk All outcomes are reported equally for both groups.
Other bias Low risk Baseline assessment: At baseline groups were equivalent, except for the fact
that carers in the intervention group had higher GHQ scores. However, this dif-
ference was adjusted for in subsequent analyses.
Dias - Goa India  (Continued)
 
 
Methods RCT
Follow-up: 1 year and 2 years
Analysis: Competers analysis was reported at each time point (6, 12, 18 and 24 months)
Participants Setting: Participants were recruited from 5 municipalities in Finland
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Inclusion criteria:
Aged > 65, living at home, entitled to payment for community care, receiving primary support from an
informal carer; must not be suffering from any other severe diseases (e.g. stroke, cancer) that might
lead to institutionalisation in the near future
Exclusion criteria:
Patients were excluded if they and their carers were not able to participate in annual training courses
n = 100
Age: 79.5 mean
Gender: 47 men, 53 women
Diagnosis: Alzheimer’s disease (AD) intervention n (%) = 30 (57); control n (%) = 24 (51)
Vascular dementia, intervention n (%) =16 (30), control n (%) = 19 (40)
Other dementia n (%)= intervention 7 (13); cont n (%) = 4 (9)
MMSE score, mean (SD), intervention 14.4 (6.2), control 15.3 (5.5)
Severity of cognitive impairment (MMSE): (intervention) Mild 40%; Moderate 24%; Severe 36%; (con-
trol) Mild 38%; Moderate 38%; Severe 24%.
Interventions Intervention group
n = 53
2-year intervention programme of systematic, comprehensive support by a dementia family care co-
ordinator who had access to the physician and co-ordinated the care, services, and support of the fam-
ilies. She provided advocacy for participants and carers, comprehensive support for participants and
carers, continuous and systematic counselling, annual training courses for participants and carers, fol-
low-up calls, in-home visits, assistance with arrangements for social and healthcare services and 24-
hour-per-day availability by mobile telephone
Duration: 2 years
Intensity: The frequency of contacts varied from once a month to 5 times a day, depending on the situa-
tion of the participants and their carers
Skill mix: Intervention delivered by a care co-ordinator who had access to the physician. The co-ordi-
nator was a registered nurse with a public health background who received extensive training, support
and advice in dementia care from dementia specialists
Care management tasks: assessment, care planning, Implementation/management of care plan, ar-
ranging/allocating services
Components: provide participant information and education, participant advocacy, provision of emo-
tional/therapeutic support, counselling/therapy, carer education
Breadth of services spanned: case manager co-ordinates/liaises with other outside services, within
multidisciplinary team, arranges and allocates services and manages care network
Control group:
n = 47
The control group received the usual services provided for geriatric patients in community care by the
municipal social and healthcare system or the private sector
Outcomes Placement in long-term institutions (numbers admitted);
Death at home (numbers and % died);
Eloniemi-Sulkava 2001  (Continued)
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Carer burden at 12, 24 months (not clear which scale? Zarit burden scale? authors were contacted for
clarification);
Cognition at 12, 24 months (MMSE)
Outcomes not used:
Time to institutionalisation/maintenance of community residence (the period in community care) (haz-
ard ratios, P values, CI)
(probability of remaining in the community Kaplan Meier method was used to estimate probabilities of
survival without institutionalisation)
Notes Lost to follow-up:
At 12 months: intervention 10/53; control 12/47
At 24 month:intervention n = 26/53, control n = 22/47
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Randomisation to intervention or control using numbered sealed envelopes.
The final 14 participants were allocated to intervention groups at a rate of 2:1
as opposed to 1:1 like the earlier participants, therefore some degree of bias
present.
Allocation concealment
(selection bias)
Low risk StaJ allocating participants to treatment groups were blinded to allocations.
100 sealed non-transparent envelopes which contained 53 allocations to inter-
vention group and 47 allocations to control group.
Blinding (performance
bias and detection bias) 
Participants
High risk Participants knew which intervention they were receiving.
Blinding (performance
bias and detection bias) 
Personnel
Low risk StaJ who could refer participants for institutionalisation (primary outcomes)
were blinded to their treatment group.
Blinding (performance
bias and detection bias) 
Outcome assessors
Low risk The main outcome (placement in long-term institutional care) was assessed
blindly via a group of experts (usually a chief physician, head nurse, and social
worker) who were unaware of the allocation situation and generally unaware
that a patient was participating in the study.
Blinding (performance
bias and detection bias) 
Other
Low risk None.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Missing outcome data balanced in numbers across intervention groups with
similar reasons for missing data across groups.
Selective reporting (re-
porting bias)
Low risk No apparent selective reporting.
Other bias Low risk None.
Eloniemi-Sulkava 2001  (Continued)
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Methods RCT
Follow-up: 6 months, 12 months, 24 months
Participants Setting: couples were recruited from February 2004 and May 2004, by newspaper announcements and
from the Alzheimer's drug users register of the Social Insurance Institution of Finland
Inclusion criteria: A spouse was caring for his/her partner with dementia at home, living in Helsinki,
minimum score of 1 on the CDR, maximum score of 23 on the MMSE
n = 125
Age: 77.5 mean
Gender: 78 men, 47 women
Diagnosis: Participants had to have an aetiological diagnosis of dementia based on a specialist's exami-
nations, including a brain CT or MRI scans. (Alzheimer’s Disease 85%; Vascular Dementia 9%; Other 6%)
Severity of cognitive impairment: Mild 26%; Moderate 55%; Severe 19%
MMSE score, mean (SD) Intervention 13.4 (6.2); Control 14.2 (6.6)
Charlson comorbidity index: Control 2.4 (SD 1.8); Intervention 2.4 (SD 1.5)
Interventions Intervention group:
n = 63
Setting: primary care
The core elements of the intervention consisted of a family care co-ordinator’s (FCC) actions, a geriatri-
cian’s medical investigations and treatments, goal-oriented support group meetings for spouse carers,
and individual tailored services. The intervention was initiated by a home visit from the FCC.
Duration: maximum of 24 months but it varied because of the phased recruitment and the attrition of
the participants
Intensity: Tailored and individualised
Skill mix: Intervention delivered by the FCC who was a trained public health registered nurse with ad-
vanced practice education (altogether 3.5 years) and special education in dementia care (1 year).
Care management tasks: case finding/screening, assessment, care planning, implementation/manage-
ment of care plan, arranging/allocating services
Components: provide participant information and education, participant advocacy, pharmacy/medica-
tions review/management/prescribing, provision of emotional/therapeutic support
Breadth of services spanned: case manager co-ordinates/liaises with other outside services and co-or-
dinates/liaises with geriatrician, arranges and allocates services, does not manage care network
Control group:
n = 62
The control group received the usual services from the municipal social and healthcare system and/or
the private sector, depending on their own initiative.
(seeTable 2 for further details)
Outcomes Numbers and % of deaths of people with dementia;
Number and % of people institutionalised
Eloniemi-Sulkava 2009 
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Functional Ability (Barthel Index) (1 year)
BPSDs (NPI) (1 year)
Costs of municipal healthcare and social care services (excluding services used from intervention bud-
get)(total Euros per year)
Time to institutionalisation (hazard ratios, CI, P values)
Use and costs of services from intervention budget (total number used);
Unable to use (Service use data not used as we extracted number of participants who used service,
which was not reported):
Cumulative institutionalisation (Kaplan Meier curves log rank tests);
Use of municipal healthcare and social care services (number of used services) - not reported separate-
ly;
Use of healthcare services (primary care physicians' visits, specialist polyclinic visits, primary nurses’
visits, dentists’ visits, days in primary care hospitals, days in specialised care hospitals, respite care
days in institutions, days in long-term institutional care; number of used services, costs; number of
used services, costs - P values and SDs not reported);
Use of community care services (district nurses’ home visits, visits in ambulatory physiotherapy, par-
ticipation in group, physiotherapy, days in II World War veterans’ rehabilitation institutions, domestic
help home visits (common help for couples), meals on wheels (common help for couples), day care (vis-
its), bathing services; number of used services, costs - P values and SDs not reported);
Used intervention services [FCC (home visits, office visits, telephone calls to/from families, telephone
calls for arranging proper service), Geriatrician (home visits, office visits, telephone calls), Home phys-
iotherapy, (visits), rehabilitation in institutional care (days), home respite care, peer support group
meetings, (participations), group meetings for challenging care-giving situations, participations (18
carers participated in groups of 6 people for 5 group meetings), dementia information sessions (3 ses-
sions) (participations)]. Reported for intervention group only
Care-giver burden (Zarit burden scale) - change scores not reported
Not used (outcomes not prespecified in our review protocol)
Numbers of deaths of carers
Notes Lost to follow-up: 6 months (8%); 12 months (19%); 24 months (39%)
Participants were not evaluated after they had been institutionalised
Intervention group:
0 - 6 months: 2 died, 2 institutionalised; 6 - 12 months: 4 died, 2 institutionalised; 12 - 24 months: 5
died,7 institutionalised (total 11 died, 11 institutionalised)
Control Group:
0 - 6 months: 2 died; 4 institutionalised; 6 - 12 months: 3 died, 5 institutionalised; 12 - 24 months: 6 died,
7 institutionalised (total 11 died, 16 institutionalised)
The intervention costs included the salaries of the FCC and geriatrician (EUR 117,000), home-based
physiotherapy for spouses with dementia (EUR 72,593), and rehabilitation periods in dementia care
units (EUR 67,106), costs of peer support groups (EUR 47,531), group meetings for challenging care-giv-
ing situations (EUR 3,000), tutoring of the FCC and the geriatrician (EUR 10,000), home respite care (EUR
7383), office rents (EUR 5000), miscellaneous (e.g. transportation of the FCC and the geriatrician, hip
protectors, nutrition supplements: EUR 1391), and dementia information sessions (EUR 750). These ex-
penses account for EUR 2923/intervention family per year. Intervention costs (EUR 331,754)
Eloniemi-Sulkava 2009  (Continued)
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This study was conducted in the Central Union for the Welfare of the Aged and as a part of the Geriatric
Rehabilitation project Research grants were received from the Finnish Slot Machine Association
The authors were independent of the funding organisations
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk The couples were randomly assigned by block randomisation (block size 10)
into intervention and control groups.
Allocation concealment
(selection bias)
Low risk Once 10 couples fulfilled randomisation criteria, the study nurse phoned the
randomisation centre staJ who had not met the couples or seen the clinical
records.
Blinding (performance
bias and detection bias) 
Participants
High risk Participants were not blinded to the allocated intervention.
Blinding (performance
bias and detection bias) 
Personnel
Low risk The use of health and social services were retrieved from central registers and
therefore, they were blinded to participants. However, the study nurses (case
managers) were not blinded to RCT-allocation - it was impossible to keep up
since the participants talked so openly about their experiences of the study.
Blinding (performance
bias and detection bias) 
Outcome assessors
Low risk The intervening nurse was different from the assessors nurses and did not par-
ticipate in the assessments.
Blinding (performance
bias and detection bias) 
Other
Low risk None
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Missing outcome data balanced in numbers across intervention groups with
similar reasons for missing data across groups.
Selective reporting (re-
porting bias)
Unclear risk The length of time until participants were institutionalised at 12 months was
reported. However this was only presented as a figure so could not be used.
The authors note that the difference between groups at 18 months was signifi-
cant.
Other bias Low risk None
Eloniemi-Sulkava 2009  (Continued)
 
 
Methods RCT (Waiting list controls received a delayed intervention package at 16 weeks)
Follow-up: 4 and 8 months
Analysis: Completers analysis was used
Participants Setting: Participants were recruited from inner city area of North London from local day centres, GPs,
hospital discharges, and some of them self-referred following reports in local newspapers
Diagnosis: dementia based on DSM-III criteria (specific type not mentioned). MMSE not reported
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Inclusion criteria: Participants had to be aged > 65, had to have fulfilled DSM-III-R criteria for demen-
tia, living with a carer, not in current contact with psychiatric services, behavioural problems present in
PWD
n = 40 dyads (participants and carers)
Age: 81 mean
Gender: 24 men, 16 women
Interventions Intervention group:
n = 22
The intervention group received an individualised care package for the carer and the person with de-
mentia, which considered medication (for managing verbal and/or physical aggression, night distur-
bance, restlessness and sexual disinhibition); psychological techniques (charts recording precipitants
of aggression, involving of participants in pleasant activities, distraction techniques, etc) and social
measures (referral to day centre, respite for carers, application for benefits)
Duration: 4 months
Intensity: During the intervention period, each participant and carer received a mean of 12 visits (6 - 19)
lasting an average of 58 minutes (31 - 87)
Skill mix: Interventions were planned by a multidisciplinary team (consultant psychiatrist of old age,
clinical psychologist, and where possible a community psychiatric nurse, psychiatric socIal worker and
occupational therapist) and were implemented in the participant's home by a psychiatrist
Care management tasks: assessment, care planning, implementation/management of care plan, ar-
ranging/allocating services, case closure (discharged back to their GP)
Components: provide participant information and education, pharmacy/medications review/manage-
ment/prescribing, provision of emotional/therapeutic support, carer education
Breadth of services spanned: case manager co-ordinates/liaises with other outside services, within
multidisciplinary team; arranges and allocates services
Control group:
n = 18
Waiting list controls received a delayed intervention package at 16 weeks
Outcomes General Health Questionnaire (carers)
Attrition
Outcomes not used:
Behavioural symptoms of person with dementia assessed (Present Behavioural Examination; PBE);
change in carer mental health (GHQ/GMS (ICD-10) (mean change or mean end points, SDs not reported
- number that significantly improved was reported but this was not defined)
Notes Lost to follow-up: 18% (7/40)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random permuted block system.
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Allocation concealment
(selection bias)
Unclear risk Not mentioned in the paper.
Blinding (performance
bias and detection bias) 
Participants
High risk Participants were not blinded to the allocated intervention.
Blinding (performance
bias and detection bias) 
Personnel
Unclear risk Not mentioned in the paper.
Blinding (performance
bias and detection bias) 
Outcome assessors
Low risk Outcome assessors were blinded.
Blinding (performance
bias and detection bias) 
Other
Low risk None.
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk There was an imbalance in number and reasons for missing data across the
groups: 7 people were lost to the study, 2 from group 1 (1 moved away and an-
other withdrew consent) and 5 from group 2 (4 died and 1 entered residential
care).
Selective reporting (re-
porting bias)
High risk Phase 2 data missing for GHQ. Phase 1 and Phase 2 data missing means and
SDs for PBE. Some outcomes were not adequately reported and so selective
outcome reporting could be present.
Other bias Unclear risk No baseline data reported.
Hinchli=e - UK  (Continued)
 
 
Methods RCT
Follow-up:6 and 12 months
Analysis: Intention-to-treat
Participants Setting: Participants were recruited from 6303 older general practice patients in West-Freisland, the
Netherlands. Primary care physicians screened dementia symptoms and performed a cognitive assess-
ment
Diagnosis: dementia (specific type not mentioned).
Inclusion criteria: persons with MMSE < 24 or a risk of dementia of at least 50% (7 Minutes Screen test);
aged 65 years or older, with a carer available
n = 99 dyads (participants and carers)
Age: 81.5 mean, 73% of participants were 75 years+
Gender: 35 men, 64 women
MMSE mean (SD): intervention group 22.0 (4.2); control group 22.7 (3.8)
Chronic diseases (% ≥ 1): intervention group 72%; control group 60%
Randomisation took place at participant level among 55 GPs and a diabetes care centre.
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Interventions Intervention group:
n = 54
Case management delivered by district nurses who had a co-ordinating function consisting of assess-
ment, giving advice and information, planning, co-ordination, organising collaboration and monitoring
of care. The case managers provided practical, informational and socio-emotional support
Standard Activities: The case managers started the intervention with a home visit in which they admin-
istered an assessment of general functioning of the participant and potential protocols for problem ar-
eas.
Used the Resident Assessment Instrument Home Care (RAI-HC) which assesses the general functioning
of the participant and provides protocols for the management of 30 potential and actual problem ar-
eas.
Tailor-made activities: referral of participants and carers to other healthcare professionals, organisa-
tion of family meetings.
Duration: 12 months
Intensity: the 3 case managers spent a mean time of 10.8 hours a year per participant-carer dyad on the
case management intervention.
Skill mix: Intervention was delivered by a case manager (district nurse) who was trained in working
with a computerised protocol and in organising family meetings. They also received 2 seminars on how
to deal with participants with dementia and their informal carers. They met monthly to discuss innova-
tions and geriatric cases while supervised by a staJ member of their home care organisation.
Care management tasks: assessment, care planning, implementation/management of care plan, ar-
ranging/allocating services, monitoring the implementation of the care plan
Components: provide participant information and education, carer education, provision of emotion-
al/therapeutic support
Breadth of services spanned: case manager co-ordinates/liaises with other outside services, arranges
and allocates services.
Control group:
n = 45
In the usual care group the participants could receive care depending on their own initiative.
(seeTable 2 for further details)
Outcomes Participant's quality of life - Dementia Quality of Life (DQOL) (overall score entered)
Carergiver's quality of life using SF-36 (mental health component entered)
Carer’s psychological well-being (CES-D)
Carer’s burden (SSPIC)
Number institutionalised (1 year)
Number died (6 months, 1 year)
Mean number of days in hospital per month (6, 12 months - from authors)
Attrition (6 months, 1 year)
Outcomes not used (Service use data not used, as we extracted number of participants who used ser-
vice):
Jansen - Netherlands  (Continued)
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Carer’s sense of competence (SCQ) (Primary outcome measure) (not prespecified in review protocol)
Use of primary care (mean number of consults, median)
Home care (hours a week, median)
Outpatient geriatric/psychiatric team/diagnostic service (number of consults, median)
Day care (mean number of days, median)
Medical specialist (mean number of consults, median)
Physiotherapist (mean number of consults, median)
Psychologist (mean number of consults, median)
Social Worker (mean number of consults, median)
Notes Lost to follow-up: 12% (12/99) at 6 months
Total lost to follow-up 18% (18/99) at 12 months
The study was supported by grants from The Netherlands Organisation for Health Research and Devel-
opment (ZonMw), The Hague, the Netherlands (grant No. 2200.0114)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation was carried out by an independent person using random num-
ber tables.
Allocation concealment
(selection bias)
Unclear risk Not mentioned in the paper.
Blinding (performance
bias and detection bias) 
Participants
High risk Participants were aware of their intervention/control status. Participants knew
that 2 different interventions were studied and they were informed about
group assignment.
Blinding (performance
bias and detection bias) 
Personnel
High risk GPs might have known about participants in the intervention group because
nurses might have contacted them about those patients. This might have en-
couraged GPs to give more attention to people with dementia and carers in
the usual care group.
Blinding (performance
bias and detection bias) 
Outcome assessors
Low risk Interviewers were blind to group allocation.
Blinding (performance
bias and detection bias) 
Other
Low risk Researchers were blinded until they finished analysing data. Primary care
practitioners and interviewers were blinded to group assignment unless par-
ticipants revealed their allocation.
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk There was attrition at follow-up and some imbalance in number of missing da-
ta across the groups at 6 months.
Selective reporting (re-
porting bias)
Low risk No apparent selective reporting.
Other bias Low risk Some differences between the groups at baseline: Carers in the intervention
group had less social support. Participants in the intervention group had been
Jansen - Netherlands  (Continued)
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longer with cognitive symptoms. Potential confounding due to baseline differ-
ences was checked by adding these variables as covariate in the analyses. No
confounding due to baseline differences appeared.
Jansen - Netherlands  (Continued)
 
 
Methods RCT
Follow-up:4 and 12 months
Analysis: Intention-to-treat
Participants Setting: recruited from psychogeriatric outpatient and memory clinics of Prince of Wales Hospital, a
teaching hospital in Hong Kong.
Diagnosis: dementia (specific type not mentioned)
Inclusion criteria: Community-dwelling people aged 65 years old or above, diagnosed to have mild de-
mentia, with Chinese MMSE (Chiu 1998) scored 15+, and/or a Clinical Dementia Rating of 1 (Hughes
1982).
Exclusion criteria included: (1) no family carer (defined as a family member who visited the person at
least once a month); (2) refused home visits by case manager, (3) participants with significant concomi-
tant diseases with more than 1 hospital admission in the previous 12 months. The last criterion was in-
troduced in order to obtain a more homogeneous sample of people with dementia with relatively sta-
ble physical condition.
n = 102 dyads (participants and carers);
Age mean (SD): Intervention: 78.6 (6.4), Control: 78.2 (5.4)
Women: Intervention 35 (59%), Control: 24 (56%)
Dementia-related drug; Intervention: 18 (31%), Control: 14 (33%)
Antipsychotics: Intervention: 9 (15%), Control: 3 (7%)
Antidepressants: Intervention 14 (24%), Control 12 (28%)
MMSE mean (SD): Intervention: 17.6 (5.2), Control: 18.0 (5.1)
CSDD mean (IQR): Intervention: 3.0 (1.0, 6.0), Control: 4.0 (1.0, 7.0)
NPI mean (IQR): Intervention 14.0 (5.0, 29.5), Control: 17.0 (6.0, 35.0)
PWI-ID mean (SD): Intervention 69.6 (20.0), Control 72.2 (18.6)
Carers: Intervention n = 59 Control n = 43
Women: Intervention: 45 (76%), Control: 30 (70%)
Spouse: Intervention: 15 (25%), Control: 15 (35%)
ZBI mean (SD): Intervention: 33.2 (17.8), Control: 32.3 (15.8)
PWI-A mean (SD): Intervention: 63.6 (15.1), Control: 61.2 (18.5)
GHQ mean (SD): Intevention: 13.1 (5.4), 14.2 (6.6)
Interventions Intervention group
n = 59
A case management model for people with mild dementia, whereby resources within the family and
in the community were mobilised and optimally used. Community-dwelling psychiatric and geriatrics
outpatients with mild dementia were randomised to receive case management by a trained occupa-
tional therapist for 4 months.
The participants were assigned to a case manager (CM) who was a trained occupational therapist. The
intervention period lasted for 4 months. During the intervention period, regular home visits were car-
ried out. The CM offered interventions in the following areas:
1. Assessment and advice
2. Home-based programme on cognitive stimulation
Lam - Hong Kong 
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3. Case management
Duration: 4 months
Intensity: low minimum requirements for carer visits (1 visit per month)/CM accessible by a telephone
hotline during working hours Monday to Saturday
Skill mix: Intervention was delivered by a case manager (a community-based occupational therapist)
who liaised closely with psychogeriatricians or geriatricians in the memory/outpatient clinics. The
CM liaised closely with the psychogeriatricians or geriatricians in the clinics. An early review could be
arranged if necessary
Case management tasks: assessment, care planning, implementation and monitoring of care plan, ar-
ranging/allocation of services, monitoring the implementation of the care plan, review, case closure
Components: participant and carer education/advice (see above), medication reviews (followed up at 3
monthly intervals in the psychogeriatric or memory clinics)
Breadth of services spanned: Case manager co-ordinates/liaises with other outside services, within
multidisciplinary team and arranges and allocates care/services but does not manages care network
Control group
n = 43
One home visit for home safety was performed by the same occupational therapist with the control
participants at the beginning of the trial, but the participants did not have access to case management.
Both groups were followed up at 3-monthly intervals in the psychogeriatric or memory clinics.
(seeTable 2 for further details)
Outcomes Zarit Carer burden interview (ZBI) (Zarit 1986) (primary)
General Health Questionnaire (GHQ) (Goldberg 1997) (carer depression) (primary)
Personal Well-Being Index for adults (carer quality of life) (primary)
Chinese Mini Mental State Examination (CMMSE) (Chiu 1998)
Cornell Scale for Depression in Dementia (CSDD) (Alexopoulos 1988)
Neuropsychiatric Inventory (NPI)
Personal Well-Being Index-Intellectual Disability (PWI-ID) (Cummins 2005a; Cummins 2005) (primary)
Admission to nursing homes at 12 months
Use of social care support (paid helpers, day care, home help and respite care)
Attrition
Outcomes not used:
none
Notes Loss to follow-up: 3% at 4 months; 10% at 12 months
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation was carried out by an independent research assistant using
random number tables.
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Allocation concealment
(selection bias)
Low risk Another research assistant who administered the assessments both to persons
with dementia and to their carers in both CM and control groups was blinded
to the randomised allocation.
Blinding (performance
bias and detection bias) 
Participants
High risk Participants were not blinded to the allocated intervention.
Blinding (performance
bias and detection bias) 
Personnel
Unclear risk Not mentioned in the paper.
Blinding (performance
bias and detection bias) 
Outcome assessors
Low risk Another research assistant who administered the assessments both to persons
with dementia and their carers in both CM and control groups was blinded to
the randomised allocation.
Blinding (performance
bias and detection bias) 
Other
Low risk None.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Low attrition. Missing outcome data balanced in numbers across intervention
groups.102 participants entered the trial, 10 participants dropped out (7 died,
2 CVA, 1 unaccounted for).
Selective reporting (re-
porting bias)
Low risk None.
Other bias Low risk None.
Lam - Hong Kong  (Continued)
 
 
Methods RCT
Follow-up: 6, 12, 18, 24, 36 months
Analysis: Intention-to-treat
Participants Setting: Participants were enrolled voluntarily from Illinois, Tennessee, Oregon, New York, Ohio, Flori-
da, Minessota, and West Virginia in the USA (1988 - 1994)
Diagnosis: dementia (specific type not mentioned)
MMSE mean (SD): Intervention 14.2 (8.7); Control 14.6 (8.6)
Inclusion criteria: Physician-certified diagnosis of dementia, be enrolled in (or eligible for) both parts A
and B of Medicare, and resident in the study sites areas.
n = 8095
Age mean (SD): Intervention: 78.5 (7.8), Control: 78.7 (8.0)
Gender: % women: Intervention: 39.4, Control: 42.5
Interventions Intervention group:
n = 4151
Two case management models were implemented. Model A (low reimbursement - high caseload) sites
operated with a target case manager-to-client ratio of 1:100 and had a monthly community service re-
Newcomer - US 
Case management approaches to home support for people with dementia (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
72
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
imbursement limit or cap from USD 290 through USD 489 per month per participant. Model B (high re-
imbursement - low caseload) sites had a target case manager-to-client ratio of 1:30 and a slightly high-
er reimbursement limit of from USD 430 through USD 699 per month per participant
Duration: not clear - demonstration operational December 1989 - November 1994
Intensity: Model A sites had a 1:100 case manager to participant ratio, whereas Model B sites had a 1:30
ratio
Skill mix: Each site agency implemented the demonstration in somewhat different ways. For example,
the Illinois programme employed nurses as case managers, whereas other sites employed social work-
ers, mental health professionals, and gerontology specialists.
Care management tasks: assessment, care planning, implementation/management of care plan, ar-
ranging/allocating services, case budget management/budget holding; monitoring the implementation
of the care plan. Case management was largely oriented to assessment, client monitoring, care plan-
ning, and situational problem-solving
Components: provide patient/carer information and education; provision of emotional/therapeutic
support, counselling, carer education
Breadth of services spanned: case manager co-ordinates/liaises with other outside services, within
multidisciplinary team, arranges and allocates care/services and manages care network. One element
ignored by this demonstration was the co-ordination of case manager and primary care physician ac-
tivities. This was not an explicit focus in any site, nor was it an expectation of the demonstration
Control group:
n = 3944
Participants in the control group continued to receive their usual care (not described further).
(seeTable 2 for further details)
Outcomes Carer's burden (Zarit Burden Scale),
Carer’s depression (Geriatric Depression Scale),
Home entry rates (number entering nursing homes in first six months),
Mortality (died during first 6 months and died during second 6 months of period)
Use of home care services: chore care use, companion care use, personal care use, any home care use
during year; hours during year. Home care variable is created by combining chore, companion, and per-
sonal care into a single measure (% used; mean and SD hours during year).
Day care use (% used; mean and SD day care days during the year)
Assisted living housing use (% used; mean and SD day care days during the year)
Annual mean (SD) number of hospital admissions for care-givers (Illinois site - Shelton 2001)
Annual mean length of hospital stay for care-givers (Illinois site - Shelton 2001)
Annual mean (SD) number of emergency department visits (Illinois site - Shelton 2001)
Medicare expenditures (in US dollars)
Outcomes not used
Home entry rates (number entering nursing homes not presented for each group for each time peri-
od; number of home placement in second 6 months - not entered because cumulative figures for 12
months not reported)
Notes n = 5209 for Services' outcomes
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n = 5304 for Carer's outcomes
Carers lost to follow-up (carer burden and depression measures): 6 months (17%), 12 months (38%), 18
months (49%), 24 months (46%), 36 months (64%)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random number-generating algorithm was used to assign cases into the treat-
ment and control groups.
Allocation concealment
(selection bias)
Low risk The demonstration sites were responsible for recruiting applicants to the
demonstration. After screening and qualifying the applicants, their names
were given to the programme evaluators, for random assignment into the
treatment or control groups. The sites were notified of those selected into the
treatment group.
Blinding (performance
bias and detection bias) 
Participants
High risk Participants were not blinded to the allocated intervention.
Blinding (performance
bias and detection bias) 
Personnel
Unclear risk Not mentioned in the paper.
Blinding (performance
bias and detection bias) 
Outcome assessors
Unclear risk Not mentioned in the paper.
Blinding (performance
bias and detection bias) 
Other
Low risk None.
Incomplete outcome data
(attrition bias) 
All outcomes
High risk Missing data high in both groups, although balanced in numbers across
groups.
Selective reporting (re-
porting bias)
High risk The 3 papers have different sample sizes, therefore selective reporting is a pos-
sibility.
Other bias Unclear risk Control group cases might be exposed to comparable benefits, such as case
management and community care benefits if they were participating in state
Medicaid programmes. For this reason, the demonstration programmes were
encouraged not to seek or accept applications from those receiving Medic-
aid. They complied with this request, but researchers had no ability to prevent
the applicants from entering Medicaid programmes later. In total 7.5% of the
treatment group and 7.7% of the controls were Medicaid programme recipi-
ents for some portion of the study observation period. Statistical controls were
used to adjust for the potential effect of Medicaid participation. Most of the
Medicaid participation occurred after the case entered a nursing home, which
was a censoring outcome. The direction of bias for those entering Medicaid
while still in the community would be to reduce case management and com-
munity service treatment differences relative to the controls.
Newcomer - US  (Continued)
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Methods Cluster-RCT
Follow-up: 12, 18 months
Analysis: intention-to-treat
Participants Setting: Participants were recruited from 18 primary care clinics within 3 healthcare organisations and
3 community agencies providing services for persons with dementia and their carers in the San Diego,
California metropolitan area. Private group practice, academic group practice, and health maintenance
organisation practice types were represented by the 3 health care organisations. Participants were
identified by querying health care organisation administrative databases for occurrence during the pre-
vious year of a dementia diagnosis code
Inclusion criteria: People with dementia, aged 65+, with an informal carer
n = 408 dyads (participant and carer)
Age: 80.1 mean
Gender: 184 men 224 women
Diagnosis: Intervention group: AD 176 (76.9%), VAD 16 (6.9%), other 37 (16.2%); Control group: AD 128
(75.7%), VAD 15 (8.9%), other 26 (15.4%)
Severity of cognitive impairment: Blessed score (SD): Intervention: 5.7 (3.4), Control: 6.3 (4.2)
Charlson co-morbidity index (SD): Intervention 2.7 (1.8), Control 2.7 (1.8)
Baseline cholinesterase inhibitor use: Intervention 128 (54%), Control 93 (55%)
Interventions Intervention group:
n = 238
Intervention components were based on the chronic care model and emphasised linkages with com-
munity resources and multi-agency co-ordination. Key components included dementia care managers,
formal procedures for communication within and between organisations and agencies, included ad-
herence to 23 dementia guideline recommendations, Internet-based care management, collaborative
care planning with carers, carer self-management support, ongoing follow-up, and provider education.
Participant carer dyads in the intervention arm were assigned a care manager, who was trained in the
use of Internet-based care management software. The care managers performed a structured home
assessment, identified problems, initiated care plan actions, and sent a summary to the primary care
physician and other designated providers. Care managers provided ongoing follow-up as needed, with
in-home reassessments every 6 months
Duration: 18 months or until case closed or no longer enrolled in programme
Intensity: 77% of the dyads received an initial visit from a care manager and 55% had a formal reassess-
ment. The median number of assessment and reassessment visits was 2. There were an average of 15
follow-up telephone calls from a care manager per dyad.
Skill mix: Care managers were mainly social workers who received formal training and used an Inter-
net-based care management software system for care planning and co-ordination
Care management tasks: case finding/screening, assessment, care planning, implementation/manage-
ment of care plan
Components: carer education and co-ordination between organisations and agencies
The care managers were responsible for co-ordinating care and making referrals. The care managers
(primarily social workers) used an Internet-based care management software system for care planning
and co-ordination. Referrals were made using the software package and follow-up assessments were
carried out usually by telephone
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Breadth of services spanned: case manager co-ordinates/liaises with other outside services and within
team, arranges and allocates services and manages care network
Control group:
n = 170
Participants, carers and providers in the usual care group were not offered study interventions. Control
group received care as usual, continuing to receive care from their usual providers. They were not of-
fered any of the specialised dementia care management developed as the study intervention
Outcomes The ICC > 0.03 of the outcomes reduced the sample size by a factor of 1.57
Participant’s quality of life (Health Unilities Index Mark 3)
Carer’s quality of life (EuroQol-5D)
Carer’s social support
Cholinesterase inhibitor use (at 12 or 18 months)
Service use at 18 months: number received: in home, volunteer, or paid respite care services; services
from a professional home health aide; services from a paid professional carer; adult day care, services
or information from local Alzheimer's Association, services or information from Caregiver Resource
Centre, services or information from meals on wheels
Number participated in carer support group
Institutionalised/nursing home stays: mean number of days per month (we inflated monthly means by
18 months)
Hospital admissions/inpatient utilisation: number of nights per month (we inflated monthly means by
18 months).
Hospital admissions: (number with any stays in 18 months)
Emergency department visits: mean number of days per month (we inflated monthly means by 18
months)
Emergency department: (number with visits in 18 months)
Informal care-giving: hours per month: (aid unskilled, unpaid unskilled)
Healthcare in the home per month: (home nurse visits, home health aide visits)
Use of one or more community services, respite care, home health aid, professional carer services,
adult day care, carer’s support group
Unable to use (not reported in useable format):
Cognitive status (MMSE or other formal test) n/% reported (mean/SD not reported)
Participant's behaviour (CDBS) (mean/SD not reported)
Not used (not prespecified in our review protocol)
Participant’s health care
Carer’s confidence in care-giving
Carer’s mastery
Carer receiving the needed help with behavioural problem (satisfaction)
Adherence to 23 dementia guideline recommendations at follow-up (primary outcome)
Vickrey - California  (Continued)
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Carer's knowledge about dementia
Primary care provider knowledge, attitudes and perceptions of quality of care
Notes Lost to follow-up: 12 months 11% (45/408); 18 months 29% (118/408) (cumulative)
12-month follow-up n = 47 (Intervention: 33; Control: 14)
Intervention = 15 withdrew, 3 people with dementia died, 5 switched, 10 non-response
Control = 4 withdrew, 1 person with dementia died, 1 switched, 8 non-response
18-month follow-up n = 118 (Intervention: 72; Control: 46)
Intervention = 19 withdrew, 34 people with dementia died, 5 switched, 14 non-response
Control = 6 withdrew, 20 people with dementia died, 6 switched, 14 non-response
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation of clinics using a computerised random-number generator.
Allocation concealment
(selection bias)
Low risk This was a cluster-randomised trial, with the clinic as the unit of randomisa-
tion. There were a fixed number of clinics involved in the study and these were
paired by volume. The study statistician conducted the randomisation of each
pair of clinics into intervention and usual care arms, using a method described
in the publication of the main study findings. No clinics or study participants
were specifically notified that they were in an intervention or usual care arm.
Adjusted multiple regression analysis was used to overcome the complex clus-
ter design.
Blinding (performance
bias and detection bias) 
Participants
Low risk Participants were unaware of clinic randomisation status until baseline as-
sessment and were not reminded of randomisation status at follow-up, al-
though study participants in the intervention arm were contacted by the care
manager and offered the programme being tested, and intervention clinic
physicians were offered physician education programmes.
Blinding (performance
bias and detection bias) 
Personnel
Low risk No study personnel (at the sites at which this intervention was carried out or
centrally at UCLA) were specifically notified about intervention/usual care sta-
tus of any study participants, except for care managers at the sites and an un-
blinded research assistant at UCLA who informed care managers about new
participants.
Blinding (performance
bias and detection bias) 
Outcome assessors
Unclear risk Eight nurse abstractors completed a 3-day training and were not informed of
participant randomisation status or study hypotheses and received no inter-
vention description (perhaps unclear risk: "medical record abstractors could
have discerned aspects of the study intervention, and we did not assess the ex-
tent to which abstractors were blinded to intervention status")
Blinding (performance
bias and detection bias) 
Other
Low risk None.
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk There was an imbalance in number and reasons for missing data across the
groups.
Vickrey - California  (Continued)
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Selective reporting (re-
porting bias)
Low risk No apparent selective reporting.
Other bias Low risk None.
Vickrey - California  (Continued)
AD: Alzheimer's Disease
ADL-AD: Activities of Daily Living - Alzheimer's Disease
BPSD: behavioural and psychological symptoms of dementia
CDBS: California Dementia Behaviour Scale
CDR: Clinical Dementia Rating
CSDD: Cornell Scale for Depression in Dementia
CT: computed tomography
DFCP: Dementia Family Care Programme
DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders Edition III, revised
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders Edition IV
GHQ: General Health Questionnaire
ICC: intraclass correlation coeJicient
ICD9: International Classification of Diseases 9th edition
IQR: Inter quartile range
MMSE: Mini Mental State Examination
MRI: magnetic resonance imaging
NPI: Neuropsychiatric Inventory
PBE: Present Behavioural Examination
PWD: person with dementia
RCT: randomised controlled trial
SD: standard deviation
VAD: vascular Alzheimer's Disease
ZBI: Zarit carer Burden Interview
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Aliberti - Las Vegas Not an RCT.
Baldwin - UK The intervention was not delivered in the community.
Bellantonio - Connecticut Did not meet criteria for case management intervention.
Callahan-Indianapolis Both groups receiving case management (collaborative care) - intervention receiving home-based
occupational therapy.
Engedal - Oslo Did not meet criteria for case management intervention.
Fabris - Italy Hospital-based control group.
Farran - US Did not meet criteria for case management intervention.
Gerdner - US Psychoeducational Intervention which did not meet criteria for case management.
Gitlin - US1 Did not meet criteria for case management intervention.
Gitlin - US2 Did not meet criteria for case management intervention.
Gonyea - US Did not meet criteria for case management intervention.
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Study Reason for exclusion
Goodman - US Did not meet criteria for case management intervention.
Gormley - UK Did not meet criteria for case management intervention.
GraJ - The Netherlands Did not meet criteria for case management intervention.
Gutterman - US Did not meet criteria for case management intervention.
Hepburn - US Did not meet criteria for case management intervention.
Hébert - Canada Psycho-educational Intervention which did not meet criteria for case management.
Kwak - Georgia The study focused only upon carers of people with dementia.
Lu - China The intervention is delivered in the hospital and in the community.
Lukas - Ulm Did not meet criteria for case management intervention.
Mittelman - New York Did not meet criteria for case management intervention.
Montgomery - US Did not meet criteria for case management intervention.
Mostardt - Germany Not an RCT: quasi experiment/observational study with two matched groups
O'Connor - Cambridge UK Did not meet criteria for case management intervention.
Onor - Italy Did not meet criteria for case management intervention.
Schoenmakers-Belgium The study focused only upon carers of people with dementia.
Stenvall - Sweden Did not meet criteria for case management intervention - individual care planning not case man-
agement at home. Subgroup analysis.
Valimaki - Finland Did not meet criteria for case management intervention.
Van denDungen-Netherlands Did not meet criteria for case management intervention.
Vernooij-DassenNetherland Did not meet criteria for case management intervention.
Weinberger - US Study focused only upon carers of people with dementia.
Wilcock - UK RCT proposal for psycho-educational intervention. Did not meet criteria for case management in-
tervention.
Wisniewski - US Did not meet criteria for case management intervention.
Wolfs - The Netherlands Did not meet criteria for case management intervention.
 
Characteristics of studies awaiting assessment [ordered by study ID]
 
Methods 18-month RCT
Samus 2014 
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Objectives: To assess whether a dementia care coordination intervention delays time to transition
from home and reduces unmet needs in elders with memory disorders.
Participants 303 community-living elders from 28 postal code areas of Baltimore, MD. 
Participants: Age 70+ years, with a cognitive disorder, community-living, English-speaking, and
having a study partner available.
Interventions Setting: Intervention: 18-month care co-ordination intervention to systematically identify and ad-
dress dementia-related care needs through individualised care planning; referral and linkage to
services; provision of dementia education and skill-building strategies; and care monitoring by an
interdisciplinary team.
Outcomes Primary outcomes were time to transfer from home and total percent of unmet care needs at 18
months.
Notes Results: Intervention participants had a significant delay in time to all-cause transition from home
and the adjusted hazard of leaving the home was decreased by 37% (Hazard ratio: 0.63, 95% Con-
fidence Interval: 0.42e0.94) compared with control participants. Although there was no signifi-
cant group difference in reduction of total percent of unmet needs from baseline to 18 months, the
intervention group had significant reductions in the proportion of unmet needs in safety and le-
gal/advance care domains relative to controls. Intervention participants had a significant improve-
ment in self-reported quality of life (QOL) relative to control participants. No
group differences were found in proxy-rated QOL, neuropsychiatric symptoms, or depression. 
Conclusions: A home-based dementia care co-ordination intervention delivered by non-clinical
community workers trained and overseen by geriatric clinicians led to delays in transition from
home, reduced unmet needs, and improved self-reported QOL.
Samus 2014  (Continued)
 
Characteristics of ongoing studies [ordered by study ID]
 
Trial name or title CARE-DEM trial
Methods This study will develop and evaluate the feasibility of collaborative care for people with dementia
in primary care. It will create a training programme for primary care staJ to enable them to under-
take case management with patients with dementia and their families (Work package 1). The fea-
sibility of implementing the training programme will be tested in a pilot rehearsal trial (Work pack-
age 2), which will also allow effect sizes to be estimated for a definitive main trial. Qualitative meth-
ods will be used to study the development process and implementation in the field, as well as to in-
form refinement of the training programme and introduction of the case management methods in-
to routine practice.
If the intervention appears to be effective, the researchers will seek further funding for Work pack-
age 3, a definitive main trial which will address the key research question:
Primary objective: To evaluate the clinical and cost effectiveness of usual care augmented by col-
laborative care, compared to usual care, at reducing behavioural and psychological disorders in
people with dementia in primary care.
Secondary objectives of this study:
1) To develop and pilot the feasibility of a UK model of collaborative care for dementia, led by a pri-
mary-care based case manager using evidence based care pathways (Work packages 1 & 2).
2) To provide a detailed description and analysis of the case management intervention, including
a description of how it works in practice, and a toolkit for its replication should the intervention
prove effective (Work package 2 & Qualitative study).
3) To explore the acceptability and value of a collaborative care model in dementia, delivered by a
case manager, to people with dementia, their family carers and other dementia care professionals
and services (Qualitative study).
Ili=e - UK 
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Secondary objectives of the follow-on study (Work package 3)
4) To conduct a cost-utility analysis of usual care augmented by collaborative care management,
compared to usual care, on NHS resource utilisation by people with dementia and their family car-
ers. The outcome in this analysis would be change in quality-adjusted life years (QALYs) derived
from the DEMQOL (using an algorithm currently being developed in a study by Banerjee, Brazier,
Knapp and others, funded by the HTA) (Work package 3, definitive trial).
Participants Not known
Interventions Not known
Outcomes Not known
Starting date March 2011
Contact information Professor Stephen IliJe, Professor of Primary Care for Older People, Centre for Ageing Population
Studies, University College London
Steve IliJe/Louise Robinson (co PIs), Bond J, Chew-Graham C, Katona C, Knapp M.
Notes Publication expected September 2014
Ili=e - UK  (Continued)
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Case management versus usual care (primary outcomes)
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Institutionalised (number of partici-
pants admitted to residential or nursing
homes) (as reported at each time point)
9   Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 At 6 months 6 5741 Odds Ratio (M-H, Fixed, 95% CI) 0.82 [0.69, 0.98]
1.2 At 10 - 12 months 9 5990 Odds Ratio (M-H, Fixed, 95% CI) 0.95 [0.83, 1.08]
1.3 At 18 months 4 363 Odds Ratio (M-H, Fixed, 95% CI) 0.25 [0.10, 0.61]
1.4 At 24 months 2 201 Odds Ratio (M-H, Fixed, 95% CI) 1.03 [0.52, 2.03]
2 Institutionalised (nursing home stays,
mean number of days per month)
2   Mean Difference (IV, Fixed, 95%
CI)
Subtotals only
2.1 At 6 months 1 88 Mean Difference (IV, Fixed, 95%
CI)
-5.80 [-7.93, -3.67]
2.2 At 12 months 1 88 Mean Difference (IV, Fixed, 95%
CI)
-7.70 [-9.38, -6.02]
2.3 At 18 months 1 267 Mean Difference (IV, Fixed, 95%
CI)
0.17 [-0.92, 1.26]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
3 Time to institutionalisation 1   Hazard Ratio (Fixed, 95% CI) Subtotals only
3.1 At 12 months 1   Hazard Ratio (Fixed, 95% CI) 0.66 [0.38, 1.14]
4 Hospital admission (mean number of
nights/
3   Mean Difference (IV, Random,
95% CI)
Subtotals only
4.1 at 6 months 3 341 Mean Difference (IV, Random,
95% CI)
0.63 [0.40, 0.86]
5 Hospital admissions: (number of par-
ticipants admitted to hospital)
6 1637 Odds Ratio (M-H, Fixed, 95% CI) 0.85 [0.67, 1.09]
5.1 Admitted to hospital at 6 months 4 439 Odds Ratio (M-H, Fixed, 95% CI) 1.06 [0.61, 1.84]
5.2 Admitted to hospital at 12 months 5 585 Odds Ratio (M-H, Fixed, 95% CI) 0.87 [0.59, 1.30]
5.3 Admitted to hospital at 18 months 5 613 Odds Ratio (M-H, Fixed, 95% CI) 0.76 [0.53, 1.10]
6 Mortality (number of deaths, partici-
pants) (as reported at each time point)
11   Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
6.1 At 4 - 6 months 8 5864 Odds Ratio (M-H, Fixed, 95% CI) 0.86 [0.64, 1.16]
6.2 At 12 months 8 6112 Odds Ratio (M-H, Fixed, 95% CI) 1.00 [0.83, 1.20]
6.3 At 18 - 24 months 5 513 Odds Ratio (M-H, Fixed, 95% CI) 1.00 [0.52, 1.92]
6.4 At 36 months 1 5209 Odds Ratio (M-H, Fixed, 95% CI) 1.03 [0.92, 1.15]
7 Quality of life (participants) 3   Mean Difference (IV, Fixed, 95%
CI)
Subtotals only
7.1 At 4 months 1 99 Mean Difference (IV, Fixed, 95%
CI)
-3.74 [-12.42, 4.94]
7.2 At 6 months 1 58 Mean Difference (IV, Fixed, 95%
CI)
0.26 [-0.45, 0.97]
7.3 At 12 months 3 511 Mean Difference (IV, Fixed, 95%
CI)
0.03 [-0.06, 0.12]
7.4 At 18 months 1 225 Mean Difference (IV, Fixed, 95%
CI)
0.06 [-0.05, 0.17]
8 Quality of life (carers) 5   Std. Mean Difference (IV, Fixed,
95% CI)
Subtotals only
8.1 at 4 months 1 99 Std. Mean Difference (IV, Fixed,
95% CI)
-0.25 [-0.66, 0.15]
8.2 At 6 months 1 88 Std. Mean Difference (IV, Fixed,
95% CI)
0.33 [-0.09, 0.75]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
8.3 At 12 months 5 681 Std. Mean Difference (IV, Fixed,
95% CI)
0.21 [0.06, 0.37]
8.4 At 18 months 2 373 Std. Mean Difference (IV, Fixed,
95% CI)
0.25 [0.04, 0.46]
9 Caregiver burden 8   Std. Mean Difference (IV, Fixed,
95% CI)
Subtotals only
9.1 At 3 - 4 months 3 228 Std. Mean Difference (IV, Fixed,
95% CI)
-0.06 [-0.33, 0.20]
9.2 At 6 months 4 4601 Std. Mean Difference (IV, Fixed,
95% CI)
-0.07 [-0.12, -0.01]
9.3 At 10 - 12 months 7 3772 Std. Mean Difference (IV, Fixed,
95% CI)
-0.05 [-0.12, 0.01]
9.4 At 18 months 3 2860 Std. Mean Difference (IV, Fixed,
95% CI)
-0.08 [-0.16, -0.01]
9.5 At 24 months 2 2931 Std. Mean Difference (IV, Fixed,
95% CI)
-0.03 [-0.11, 0.04]
9.6 At 36 months 1 1906 Std. Mean Difference (IV, Fixed,
95% CI)
-0.04 [-0.13, 0.05]
 
 
Analysis 1.1.   Comparison 1 Case management versus usual care (primary outcomes), Outcome 1 Institutionalised
(number of participants admitted to residential or nursing homes) (as reported at each time point).
Study or subgroup Case man-
agement
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
1.1.1 At 6 months  
Callahan - Indianapolis 3/84 1/69 0.36% 2.52[0.26,24.77]
Chien - Hong Kong 2001 7/46 7/46 2.02% 1[0.32,3.12]
Chien- Hong Kong 2008 5/44 10/44 3.02% 0.44[0.14,1.4]
Chu - Canada 1/37 1/37 0.33% 1[0.06,16.61]
Eloniemi-Sulkava 2009 2/63 4/62 1.33% 0.48[0.08,2.7]
Newcomer - US 264/2682 294/2527 92.94% 0.83[0.7,0.99]
Subtotal (95% CI) 2956 2785 100% 0.82[0.69,0.98]
Total events: 282 (Case management), 317 (Control)  
Heterogeneity: Tau2=0; Chi2=2.58, df=5(P=0.76); I2=0%  
Test for overall effect: Z=2.25(P=0.02)  
   
1.1.2 At 10 - 12 months  
Callahan - Indianapolis 4/72 1/62 0.21% 3.59[0.39,32.99]
Chien - Hong Kong 2001 2/45 9/44 1.84% 0.18[0.04,0.89]
Chien- Hong Kong 2008 3/44 9/44 1.77% 0.28[0.07,1.13]
Favours case management 2000.005 100.1 1 Favours control
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Study or subgroup Case man-
agement
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chu - Canada 2/36 6/36 1.2% 0.29[0.06,1.57]
Eloniemi-Sulkava 2001 4/53 9/47 1.86% 0.34[0.1,1.21]
Eloniemi-Sulkava 2009 2/59 5/56 1.05% 0.36[0.07,1.93]
Jansen - Netherlands 2/43 1/38 0.21% 1.8[0.16,20.73]
Lam - Hong Kong 3/59 1/43 0.23% 2.25[0.23,22.4]
Newcomer - US 563/2682 533/2527 91.62% 0.99[0.87,1.14]
Subtotal (95% CI) 3093 2897 100% 0.95[0.83,1.08]
Total events: 585 (Case management), 574 (Control)  
Heterogeneity: Tau2=0; Chi2=15.4, df=8(P=0.05); I2=48.05%  
Test for overall effect: Z=0.79(P=0.43)  
   
1.1.3 At 18 months  
Callahan - Indianapolis 0/65 3/62 16.36% 0.13[0.01,2.56]
Chien - Hong Kong 2001 3/44 9/43 39.06% 0.28[0.07,1.1]
Chien- Hong Kong 2008 2/42 7/43 30.33% 0.26[0.05,1.32]
Chu - Canada 1/34 3/30 14.24% 0.27[0.03,2.77]
Subtotal (95% CI) 185 178 100% 0.25[0.1,0.61]
Total events: 6 (Case management), 22 (Control)  
Heterogeneity: Tau2=0; Chi2=0.21, df=3(P=0.98); I2=0%  
Test for overall effect: Z=3.02(P=0)  
   
1.1.4 At 24 months  
Eloniemi-Sulkava 2001 17/53 14/47 61.25% 1.11[0.48,2.61]
Eloniemi-Sulkava 2009 7/53 7/48 38.75% 0.89[0.29,2.76]
Subtotal (95% CI) 106 95 100% 1.03[0.52,2.03]
Total events: 24 (Case management), 21 (Control)  
Heterogeneity: Tau2=0; Chi2=0.09, df=1(P=0.76); I2=0%  
Test for overall effect: Z=0.08(P=0.94)  
Test for subgroup differences: Chi2=9.61, df=1 (P=0.02), I2=68.8%  
Favours case management 2000.005 100.1 1 Favours control
 
 
Analysis 1.2.   Comparison 1 Case management versus usual care (primary outcomes),
Outcome 2 Institutionalised (nursing home stays, mean number of days per month).
Study or subgroup Case management Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
1.2.1 At 6 months  
Chien- Hong Kong 2008 44 11.1 (5.1) 44 16.9 (5.1) 100% -5.8[-7.93,-3.67]
Subtotal *** 44   44   100% -5.8[-7.93,-3.67]
Heterogeneity: Not applicable  
Test for overall effect: Z=5.33(P<0.0001)  
   
1.2.2 At 12 months  
Chien- Hong Kong 2008 44 9.4 (2.3) 44 17.1 (5.2) 100% -7.7[-9.38,-6.02]
Subtotal *** 44   44   100% -7.7[-9.38,-6.02]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=8.98(P<0.0001)  
   
Favours case management 105-10 -5 0 Favours control
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Study or subgroup Case management Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
1.2.3 At 18 months  
Vickrey - California 153 1.2 (4.7) 114 1 (4.3) 100% 0.17[-0.92,1.26]
Subtotal *** 153   114   100% 0.17[-0.92,1.26]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.31(P=0.76)  
Test for subgroup differences: Chi2=68.93, df=1 (P<0.0001), I2=97.1%  
Favours case management 105-10 -5 0 Favours control
 
 
Analysis 1.3.   Comparison 1 Case management versus usual care
(primary outcomes), Outcome 3 Time to institutionalisation.
Study or subgroup Case man-
agement
Control log[Hazard
Ratio]
Hazard Ratio Weight Hazard Ratio
  N N (SE) IV, Fixed, 95% CI   IV, Fixed, 95% CI
1.3.1 At 12 months  
Eloniemi-Sulkava 2009 0 0 -0.4 (0.278) 100% 0.66[0.38,1.14]
Subtotal (95% CI)       100% 0.66[0.38,1.14]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.49(P=0.14)  
Favours case management 1000.01 100.1 1 Favours control
 
 
Analysis 1.4.   Comparison 1 Case management versus usual care (primary
outcomes), Outcome 4 Hospital admission (mean number of nights/.
Study or subgroup Favours case
management
Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
1.4.1 at 6 months  
Eloniemi-Sulkava 2009 62 7.7 (3.4) 62 6.5 (2.6) 4.45% 1.25[0.18,2.32]
Jansen - Netherlands 42 1.3 (0.7) 41 0.6 (0.4) 42.47% 0.72[0.47,0.97]
Callahan - Indianapolis 72 1.1 (0.7) 62 0.6 (0.4) 53.08% 0.5[0.3,0.7]
Subtotal *** 176   165   100% 0.63[0.4,0.86]
Heterogeneity: Tau2=0.02; Chi2=3.31, df=2(P=0.19); I2=39.62%  
Test for overall effect: Z=5.32(P<0.0001)  
Favours case management 52.5-5 -2.5 0 Favours control
 
 
Analysis 1.5.   Comparison 1 Case management versus usual care (primary outcomes),
Outcome 5 Hospital admissions: (number of participants admitted to hospital).
Study or subgroup Case man-
agement
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
1.5.1 Admitted to hospital at 6 months  
Callahan - Indianapolis 11/72 7/62 4.49% 1.42[0.51,3.91]
Chien - Hong Kong 2001 3/46 4/46 2.63% 0.73[0.15,3.47]
Favours case management 1000.01 100.1 1 Favours control
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Study or subgroup Case man-
agement
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chien- Hong Kong 2008 4/44 6/44 3.84% 0.63[0.17,2.42]
Eloniemi-Sulkava 2009 13/63 11/62 6.2% 1.21[0.49,2.94]
Subtotal (95% CI) 225 214 17.16% 1.06[0.61,1.84]
Total events: 31 (Case management), 28 (Control)  
Heterogeneity: Tau2=0; Chi2=1.18, df=3(P=0.76); I2=0%  
Test for overall effect: Z=0.21(P=0.84)  
   
1.5.2 Admitted to hospital at 12 months  
Bass - Ohio 17/94 16/63 11.06% 0.65[0.3,1.41]
Callahan - Indianapolis 19/64 13/62 6.54% 1.59[0.71,3.59]
Chien - Hong Kong 2001 4/45 7/44 4.54% 0.52[0.14,1.9]
Chien- Hong Kong 2008 3/44 6/44 3.94% 0.46[0.11,1.98]
Eloniemi-Sulkava 2009 23/63 23/62 10.37% 0.98[0.47,2.02]
Subtotal (95% CI) 310 275 36.45% 0.87[0.59,1.3]
Total events: 66 (Case management), 65 (Control)  
Heterogeneity: Tau2=0; Chi2=4.1, df=4(P=0.39); I2=2.5%  
Test for overall effect: Z=0.66(P=0.51)  
   
1.5.3 Admitted to hospital at 18 months  
Callahan - Indianapolis 25/65 17/49 8.4% 1.18[0.54,2.55]
Chien - Hong Kong 2001 2/44 5/43 3.4% 0.36[0.07,1.98]
Chien- Hong Kong 2008 1/42 9/43 6.12% 0.09[0.01,0.76]
Eloniemi-Sulkava 2009 25/63 30/62 12.85% 0.7[0.35,1.43]
Vickrey - California 36/116 28/86 15.62% 0.93[0.51,1.7]
Subtotal (95% CI) 330 283 46.39% 0.76[0.53,1.1]
Total events: 89 (Case management), 89 (Control)  
Heterogeneity: Tau2=0; Chi2=6.28, df=4(P=0.18); I2=36.33%  
Test for overall effect: Z=1.47(P=0.14)  
   
Total (95% CI) 865 772 100% 0.85[0.67,1.09]
Total events: 186 (Case management), 182 (Control)  
Heterogeneity: Tau2=0; Chi2=12.15, df=13(P=0.52); I2=0%  
Test for overall effect: Z=1.29(P=0.2)  
Test for subgroup differences: Chi2=0.99, df=1 (P=0.61), I2=0%  
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Analysis 1.6.   Comparison 1 Case management versus usual care (primary outcomes),
Outcome 6 Mortality (number of deaths, participants) (as reported at each time point).
Study or subgroup Case man-
agement
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
1.6.1 At 4 - 6 months  
Callahan - Indianapolis 4/72 1/62 1.08% 3.59[0.39,32.99]
Chu - Canada 1/37 0/37 0.51% 3.08[0.12,78.14]
Dias - Goa India 6/41 12/40 11.02% 0.4[0.13,1.2]
Eloniemi-Sulkava 2009 2/63 2/62 2.08% 0.98[0.13,7.21]
Hinchliffe - UK 0/22 4/18 5.13% 0.07[0,1.43]
Jansen - Netherlands 2/54 2/45 2.23% 0.83[0.11,6.12]
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Study or subgroup Case man-
agement
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lam - Hong Kong 2/59 1/43 1.19% 1.47[0.13,16.8]
Newcomer - US 70/2682 72/2527 76.76% 0.91[0.65,1.28]
Subtotal (95% CI) 3030 2834 100% 0.86[0.64,1.16]
Total events: 87 (Case management), 94 (Control)  
Heterogeneity: Tau2=0; Chi2=7.04, df=7(P=0.43); I2=0.51%  
Test for overall effect: Z=1(P=0.32)  
   
1.6.2 At 12 months  
Callahan - Indianapolis 3/64 2/62 0.86% 1.48[0.24,9.15]
Chu - Canada 2/37 0/37 0.21% 5.28[0.24,113.87]
Eloniemi-Sulkava 2001 6/53 3/47 1.26% 1.87[0.44,7.95]
Eloniemi-Sulkava 2009 4/63 3/62 1.26% 1.33[0.29,6.22]
Jansen - Netherlands 4/54 3/45 1.35% 1.12[0.24,5.29]
Lam - Hong Kong 6/59 4/43 1.86% 1.1[0.29,4.18]
Newcomer - US 225/2682 220/2527 92.68% 0.96[0.79,1.17]
Vickrey - California 2/161 1/116 0.51% 1.45[0.13,16.14]
Subtotal (95% CI) 3173 2939 100% 1[0.83,1.2]
Total events: 252 (Case management), 236 (Control)  
Heterogeneity: Tau2=0; Chi2=2.46, df=7(P=0.93); I2=0%  
Test for overall effect: Z=0.03(P=0.98)  
   
1.6.3 At 18 - 24 months  
Callahan - Indianapolis 1/65 4/62 22.44% 0.23[0.02,2.09]
Chien - Hong Kong 2001 1/46 0/46 2.69% 3.07[0.12,77.24]
Chu - Canada 4/33 1/36 4.68% 4.83[0.51,45.62]
Eloniemi-Sulkava 2001 9/53 8/47 39.19% 1[0.35,2.84]
Eloniemi-Sulkava 2009 5/63 6/62 31% 0.8[0.23,2.79]
Subtotal (95% CI) 260 253 100% 1[0.52,1.92]
Total events: 20 (Case management), 19 (Control)  
Heterogeneity: Tau2=0; Chi2=4.19, df=4(P=0.38); I2=4.46%  
Test for overall effect: Z=0(P=1)  
   
1.6.4 At 36 months  
Newcomer - US 941/2682 872/2527 100% 1.03[0.92,1.15]
Subtotal (95% CI) 2682 2527 100% 1.03[0.92,1.15]
Total events: 941 (Case management), 872 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.44(P=0.66)  
Test for subgroup differences: Chi2=1.18, df=1 (P=0.76), I2=0%  
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Analysis 1.7.   Comparison 1 Case management versus usual care
(primary outcomes), Outcome 7 Quality of life (participants).
Study or subgroup Case management Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
1.7.1 At 4 months  
Lam - Hong Kong 57 -3.4 (22.9) 42 0.4 (20.9) 100% -3.74[-12.42,4.94]
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Study or subgroup Case management Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Subtotal *** 57   42   100% -3.74[-12.42,4.94]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=0.84(P=0.4)  
   
1.7.2 At 6 months  
Jansen - Netherlands 30 0.1 (1.4) 28 -0.2 (1.4) 100% 0.26[-0.45,0.97]
Subtotal *** 30   28   100% 0.26[-0.45,0.97]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.72(P=0.47)  
   
1.7.3 At 12 months  
Jansen - Netherlands 30 0.1 (1.4) 28 -0.2 (1.4) 1.63% 0.26[-0.45,0.97]
Lam - Hong Kong 53 -5.5 (24.8) 39 -2.5 (18.9) 0.01% -2.99[-11.93,5.95]
Vickrey - California 205 -0.1 (0.4) 156 -0.1 (0.4) 98.36% 0.03[-0.06,0.12]
Subtotal *** 288   223   100% 0.03[-0.06,0.12]
Heterogeneity: Tau2=0; Chi2=0.83, df=2(P=0.66); I2=0%  
Test for overall effect: Z=0.72(P=0.47)  
   
1.7.4 At 18 months  
Vickrey - California 129 -0.1 (0.4) 96 -0.1 (0.4) 100% 0.06[-0.05,0.17]
Subtotal *** 129   96   100% 0.06[-0.05,0.17]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.04(P=0.3)  
Test for subgroup differences: Chi2=1.21, df=1 (P=0.75), I2=0%  
Favours control 105-10 -5 0 Favours case management
 
 
Analysis 1.8.   Comparison 1 Case management versus usual
care (primary outcomes), Outcome 8 Quality of life (carers).
Study or subgroup Case management Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
1.8.1 at 4 months  
Lam - Hong Kong 57 -1.8 (11.5) 42 1.2 (11.8) 100% -0.25[-0.66,0.15]
Subtotal *** 57   42   100% -0.25[-0.66,0.15]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.25(P=0.21)  
   
1.8.2 At 6 months  
Chien- Hong Kong 2008 44 10.2 (22.6) 44 2.7 (22.8) 100% 0.33[-0.09,0.75]
Subtotal *** 44   44   100% 0.33[-0.09,0.75]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.52(P=0.13)  
   
1.8.3 At 12 months  
Chien - Hong Kong 2001 46 15.6 (20.4) 46 -1.9 (23.8) 12.95% 0.78[0.36,1.21]
Chien- Hong Kong 2008 44 16.5 (21.9) 44 -1.9 (23.4) 12.33% 0.8[0.37,1.24]
Jansen - Netherlands 43 -2.9 (13.4) 37 -0.5 (15) 12.04% -0.17[-0.61,0.27]
Lam - Hong Kong 53 1.9 (16.4) 39 0.2 (11.6) 13.63% 0.12[-0.29,0.53]
Vickrey - California 187 0 (0.2) 142 -0 (0.3) 49.05% 0.04[-0.18,0.25]
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Study or subgroup Case management Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Subtotal *** 373   308   100% 0.21[0.06,0.37]
Heterogeneity: Tau2=0; Chi2=19.57, df=4(P=0); I2=79.56%  
Test for overall effect: Z=2.75(P=0.01)  
   
1.8.4 At 18 months  
Chien - Hong Kong 2001 46 17.9 (19.2) 46 -2.6 (20.6) 22.75% 1.02[0.58,1.46]
Vickrey - California 161 -0 (0.4) 120 -0 (0.4) 77.25% 0.02[-0.21,0.26]
Subtotal *** 207   166   100% 0.25[0.04,0.46]
Heterogeneity: Tau2=0; Chi2=15.54, df=1(P<0.0001); I2=93.56%  
Test for overall effect: Z=2.36(P=0.02)  
Test for subgroup differences: Chi2=5.57, df=1 (P=0.13), I2=46.13%  
Favours control 42-4 -2 0 Favours case management
 
 
Analysis 1.9.   Comparison 1 Case management versus usual care (primary outcomes), Outcome 9 Caregiver burden.
Study or subgroup Favours case
management
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
1.9.1 At 3 - 4 months  
Chu - Canada 32 -0.2 (20.2) 31 1.3 (23.8) 27.97% -0.07[-0.56,0.43]
Dias - Goa India 34 -5.3 (19.8) 32 -0.2 (21.5) 29.07% -0.24[-0.73,0.24]
Lam - Hong Kong 57 -1.1 (13) 42 -1.9 (14.4) 42.96% 0.06[-0.34,0.46]
Subtotal *** 123   105   100% -0.06[-0.33,0.2]
Heterogeneity: Tau2=0; Chi2=0.91, df=2(P=0.64); I2=0%  
Test for overall effect: Z=0.48(P=0.63)  
   
1.9.2 At 6 months  
Chien- Hong Kong 2008 44 -11.4 (21.7) 44 -4.8 (21.8) 1.89% -0.3[-0.72,0.12]
Chu - Canada 22 -3.9 (18.6) 26 7.3 (25.2) 1.01% -0.49[-1.07,0.09]
Dias - Goa India 33 -5.8 (19.8) 26 -0.3 (20.8) 1.26% -0.27[-0.78,0.25]
Newcomer - US 2268 0.1 (10.6) 2138 0.6 (7.6) 95.85% -0.05[-0.11,0.01]
Subtotal *** 2367   2234   100% -0.07[-0.12,-0.01]
Heterogeneity: Tau2=0; Chi2=4.04, df=3(P=0.26); I2=25.82%  
Test for overall effect: Z=2.22(P=0.03)  
   
1.9.3 At 10 - 12 months  
Chien - Hong Kong 2001 46 -19.9 (20) 46 -1.6 (20.9) 2.23% -0.89[-1.32,-0.46]
Chien- Hong Kong 2008 44 -19.8 (20.4) 44 -1.9 (27.6) 2.19% -0.73[-1.16,-0.3]
Chu - Canada 22 -0.9 (21.6) 20 3.8 (24.1) 1.11% -0.2[-0.81,0.41]
Eloniemi-Sulkava 2001 43 5 (3.1) 35 3.6 (2.9) 2% 0.46[0.01,0.91]
Jansen - Netherlands 43 0.1 (4.2) 38 -0 (3.6) 2.15% 0.03[-0.4,0.47]
Lam - Hong Kong 53 -2.7 (15.2) 39 -1 (11.6) 2.39% -0.12[-0.53,0.3]
Newcomer - US 1702 -0.2 (10.7) 1597 0.1 (11.2) 87.92% -0.03[-0.1,0.04]
Subtotal *** 1953   1819   100% -0.05[-0.12,0.01]
Heterogeneity: Tau2=0; Chi2=29.92, df=6(P<0.0001); I2=79.95%  
Test for overall effect: Z=1.68(P=0.09)  
   
1.9.4 At 18 months  
Chien - Hong Kong 2001 46 -22.5 (18) 46 -2.8 (18.9) 2.83% -1.06[-1.5,-0.62]
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Study or subgroup Favours case
management
Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Chu - Canada 27 0.9 (16.8) 21 3.3 (17.1) 1.66% -0.14[-0.71,0.43]
Newcomer - US 1437 -0.6 (10.8) 1283 0 (11.2) 95.51% -0.05[-0.13,0.02]
Subtotal *** 1510   1350   100% -0.08[-0.16,-0.01]
Heterogeneity: Tau2=0; Chi2=19.69, df=2(P<0.0001); I2=89.84%  
Test for overall effect: Z=2.24(P=0.02)  
   
1.9.5 At 24 months  
Eloniemi-Sulkava 2001 24 4.8 (3.3) 25 4.2 (3.5) 1.67% 0.17[-0.39,0.73]
Newcomer - US 1528 -0.5 (10.8) 1354 -0.1 (11.2) 98.33% -0.04[-0.11,0.04]
Subtotal *** 1552   1379   100% -0.03[-0.11,0.04]
Heterogeneity: Tau2=0; Chi2=0.53, df=1(P=0.47); I2=0%  
Test for overall effect: Z=0.89(P=0.38)  
   
1.9.6 At 36 months  
Newcomer - US 986 -0.6 (11.1) 920 -0.1 (11.3) 100% -0.04[-0.13,0.05]
Subtotal *** 986   920   100% -0.04[-0.13,0.05]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.98(P=0.33)  
Test for subgroup differences: Chi2=1.11, df=1 (P=0.95), I2=0%  
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Comparison 2.   Case management versus usual care (secondary outcomes)
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Cognition measures (participants) 6   Std. Mean Difference (IV, Fixed,
95% CI)
Subtotals only
1.1 At 3 - 4 months 2 154 Std. Mean Difference (IV, Fixed,
95% CI)
-0.21 [-0.53, 0.11]
1.2 At 6 months 3 267 Std. Mean Difference (IV, Fixed,
95% CI)
0.03 [-0.21, 0.27]
1.3 At 10 - 12 months 6 518 Std. Mean Difference (IV, Fixed,
95% CI)
0.00 [-0.17, 0.18]
1.4 At 18 months 3 256 Std. Mean Difference (IV, Fixed,
95% CI)
-0.02 [-0.27, 0.22]
1.5 At 24 months 1 49 Std. Mean Difference (IV, Fixed,
95% CI)
0.07 [-0.49, 0.63]
2 Behavioural measures (participants) 6   Std. Mean Difference (IV, Fixed,
95% CI)
Subtotals only
2.1 3 - 4 months 2 165 Std. Mean Difference (IV, Fixed,
95% CI)
-0.13 [-0.44, 0.18]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
2.2 6 months 4 368 Std. Mean Difference (IV, Fixed,
95% CI)
-0.20 [-0.41, 0.01]
2.3 10 - 12 months 5 479 Std. Mean Difference (IV, Fixed,
95% CI)
-0.38 [-0.56, -0.19]
2.4 18 months 2 206 Std. Mean Difference (IV, Fixed,
95% CI)
-0.35 [-0.63, -0.07]
3 Depression/mood measures (partici-
pants)
3   Std. Mean Difference (IV, Fixed,
95% CI)
Subtotals only
3.1 At 3 - 4 months 2 164 Std. Mean Difference (IV, Fixed,
95% CI)
0.12 [-0.19, 0.43]
3.2 At 6 months 2 185 Std. Mean Difference (IV, Fixed,
95% CI)
0.08 [-0.21, 0.37]
3.3 At 10 - 12 months 3 259 Std. Mean Difference (IV, Fixed,
95% CI)
-0.07 [-0.32, 0.17]
3.4 At 18 months 2 159 Std. Mean Difference (IV, Fixed,
95% CI)
-0.02 [-0.33, 0.29]
4 Function measures (participants) 3   Std. Mean Difference (IV, Fixed,
95% CI)
Subtotals only
4.1 At 3 months 1 66 Std. Mean Difference (IV, Fixed,
95% CI)
-0.20 [-0.68, 0.29]
4.2 At 6 months 3 318 Std. Mean Difference (IV, Fixed,
95% CI)
-0.03 [-0.25, 0.19]
4.3 at 12 months 2 251 Std. Mean Difference (IV, Fixed,
95% CI)
0.04 [-0.21, 0.29]
4.4 At 18 months 1 114 Std. Mean Difference (IV, Fixed,
95% CI)
-0.09 [-0.46, 0.28]
5 Carer distress (behavioural) mea-
sures (NPI-distress/reaction RMBPC)
2   Mean Difference (IV, Fixed, 95% CI) Subtotals only
5.1 At 3 months 1 66 Mean Difference (IV, Fixed, 95% CI) -2.5 [-6.87, 1.87]
5.2 At 6 months 2 193 Mean Difference (IV, Fixed, 95% CI) -0.20 [-3.23, 2.82]
5.3 At 10 -12 months 1 126 Mean Difference (IV, Fixed, 95% CI) -1.9 [-4.00, 2.20]
5.4 At 18 months 1 114 Mean Difference (IV, Fixed, 95% CI) -0.5 [-3.24, 2.24]
6 Mood/depression measures (carers) 5   Std. Mean Difference (IV, Fixed,
95% CI)
Subtotals only
Case management approaches to home support for people with dementia (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
91
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
6.1 At 6 months 4 4675 Std. Mean Difference (IV, Fixed,
95% CI)
-0.04 [-0.10, 0.02]
6.2 At 10 - 12 months 5 3705 Std. Mean Difference (IV, Fixed,
95% CI)
-0.04 [-0.11, 0.02]
6.3 At 18 months 3 2888 Std. Mean Difference (IV, Fixed,
95% CI)
-0.08 [-0.16, -0.01]
6.4 At 24 months 1 2887 Std. Mean Difference (IV, Fixed,
95% CI)
-0.06 [-0.14, 0.01]
6.5 At 36 months 1 1910 Std. Mean Difference (IV, Fixed,
95% CI)
-0.07 [-0.16, 0.02]
7 Carer well-being - GHQ (changes
from baseline)
3   Mean Difference (IV, Random, 95%
CI)
Subtotals only
7.1 At 3 - 4 months 3 203 Mean Difference (IV, Random, 95%
CI)
-2.53 [-5.20, 0.13]
7.2 At 6 months 1 65 Mean Difference (IV, Random, 95%
CI)
-2.2 [-4.14, -0.26]
7.3 At 12 months 1 92 Mean Difference (IV, Random, 95%
CI)
-1.90 [-4.11, 0.31]
8 Social support measures 3   Std. Mean Difference (IV, Fixed,
95% CI)
Subtotals only
8.1 At 6 months 1 88 Std. Mean Difference (IV, Fixed,
95% CI)
0.18 [-0.24, 0.60]
8.2 At 12 months 3 541 Std. Mean Difference (IV, Fixed,
95% CI)
0.17 [-0.00, 0.34]
8.3 At 18 months changes from base-
line
2 382 Std. Mean Difference (IV, Fixed,
95% CI)
0.13 [-0.07, 0.33]
9 Satisfaction with health plan (carers)
changes from baseline
1 314 Mean Difference (IV, Fixed, 95% CI) 0.03 [-0.13, 0.20]
9.1 Satisfaction with types of service at
12 months
1 157 Mean Difference (IV, Fixed, 95% CI) 0.02 [-0.26, 0.30]
9.2 Satisfaction with quality of services
at 12 months
1 157 Mean Difference (IV, Fixed, 95% CI) 0.04 [-0.17, 0.25]
10 Satisfaction with care (carers) 1 306 Odds Ratio (M-H, Fixed, 95% CI) 2.24 [1.37, 3.67]
10.1 Primary care rated as very good or
excellent (12 months)
1 153 Odds Ratio (M-H, Fixed, 95% CI) 3.85 [1.82, 8.11]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
10.2 Primary care rated as very good or
excellent (18 months)
1 153 Odds Ratio (M-H, Fixed, 95% CI) 1.43 [0.73, 2.80]
11 Leaving the study early (patients)
unwilling or unable to provide infor-
mation (including died/ institution-
alised)
12   Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
11.1 At 3 - 4 months 3 223 Odds Ratio (M-H, Fixed, 95% CI) 0.66 [0.28, 1.56]
11.2 At 6 months 5 5728 Odds Ratio (M-H, Fixed, 95% CI) 0.99 [0.86, 1.14]
11.3 At 12 months 7 6232 Odds Ratio (M-H, Fixed, 95% CI) 0.98 [0.88, 1.09]
11.4 At 18 months 6 6034 Odds Ratio (M-H, Fixed, 95% CI) 0.88 [0.79, 0.98]
11.5 At 24 months 3 5505 Odds Ratio (M-H, Fixed, 95% CI) 0.87 [0.78, 0.97]
11.6 At 36 months 1 5304 Odds Ratio (M-H, Fixed, 95% CI) 0.98 [0.88, 1.10]
 
 
Analysis 2.1.   Comparison 2 Case management versus usual care
(secondary outcomes), Outcome 1 Cognition measures (participants).
Study or subgroup Case management Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
2.1.1 At 3 - 4 months  
Chu - Canada 31 -0.8 (5.6) 24 -0.1 (6) 36.03% -0.11[-0.65,0.42]
Lam - Hong Kong 57 -0.5 (3.4) 42 0.4 (3) 63.97% -0.26[-0.66,0.14]
Subtotal *** 88   66   100% -0.21[-0.53,0.11]
Heterogeneity: Tau2=0; Chi2=0.19, df=1(P=0.66); I2=0%  
Test for overall effect: Z=1.27(P=0.2)  
   
2.1.2 At 6 months  
Callahan - Indianapolis 72 -1 (12.1) 62 -1.1 (9.8) 50.12% 0.01[-0.33,0.35]
Chien- Hong Kong 2008 44 1.1 (6.2) 44 1.2 (5.7) 33.1% -0.02[-0.43,0.4]
Chu - Canada 24 -1 (5.6) 21 -2 (6) 16.78% 0.17[-0.42,0.76]
Subtotal *** 140   127   100% 0.03[-0.21,0.27]
Heterogeneity: Tau2=0; Chi2=0.28, df=2(P=0.87); I2=0%  
Test for overall effect: Z=0.22(P=0.82)  
   
2.1.3 At 10 - 12 months  
Callahan - Indianapolis 64 -1.2 (12.2) 62 -2.5 (18.3) 24.52% 0.08[-0.27,0.43]
Chien - Hong Kong 2001 46 2.3 (7.7) 46 1.8 (6.3) 17.91% 0.07[-0.34,0.48]
Chien- Hong Kong 2008 44 1.5 (7.5) 44 1.8 (6.2) 17.14% -0.04[-0.46,0.37]
Chu - Canada 24 -2.4 (6.1) 18 -3.9 (7.3) 7.96% 0.22[-0.39,0.84]
Eloniemi-Sulkava 2001 43 12.6 (6.1) 35 13.6 (5.7) 14.98% -0.17[-0.61,0.28]
Lam - Hong Kong 53 1.5 (4.2) 39 1.8 (3.4) 17.49% -0.08[-0.49,0.33]
Subtotal *** 274   244   100% 0[-0.17,0.18]
Control 10.5-1 -0.5 0 Case/care
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Study or subgroup Case management Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Heterogeneity: Tau2=0; Chi2=1.56, df=5(P=0.91); I2=0%  
Test for overall effect: Z=0.05(P=0.96)  
   
2.1.4 At 18 months  
Callahan - Indianapolis 65 -1.9 (12.6) 49 -1.8 (11.3) 44.17% -0.01[-0.38,0.36]
Chien - Hong Kong 2001 46 0.8 (6.2) 46 1 (5.3) 36.36% -0.03[-0.44,0.37]
Chu - Canada 28 -4 (6.2) 22 -3.8 (7.9) 19.47% -0.04[-0.6,0.52]
Subtotal *** 139   117   100% -0.02[-0.27,0.22]
Heterogeneity: Tau2=0; Chi2=0.01, df=2(P=0.99); I2=0%  
Test for overall effect: Z=0.19(P=0.85)  
   
2.1.5 At 24 months  
Eloniemi-Sulkava 2001 24 13.5 (6.9) 25 13 (6.3) 100% 0.07[-0.49,0.63]
Subtotal *** 24   25   100% 0.07[-0.49,0.63]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.26(P=0.79)  
Test for subgroup differences: Chi2=1.66, df=1 (P=0.8), I2=0%  
Control 10.5-1 -0.5 0 Case/care
 
 
Analysis 2.2.   Comparison 2 Case management versus usual care
(secondary outcomes), Outcome 2 Behavioural measures (participants).
Study or subgroup Case managment Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
2.2.1 3 - 4 months  
Dias - Goa India 34 -4.8 (8.1) 32 -2.3 (9.8) 40.3% -0.27[-0.76,0.21]
Lam - Hong Kong 57 8.8 (14.2) 42 9.3 (14.2) 59.7% -0.03[-0.43,0.36]
Subtotal *** 91   74   100% -0.13[-0.44,0.18]
Heterogeneity: Tau2=0; Chi2=0.56, df=1(P=0.45); I2=0%  
Test for overall effect: Z=0.84(P=0.4)  
   
2.2.2 6 months  
Callahan - Indianapolis 72 -1.1 (20) 62 -2.3 (26.8) 37.5% 0.05[-0.29,0.39]
Chien- Hong Kong 2008 44 -13.1 (13.7) 44 0.8 (13.6) 21.86% -1.01[-1.45,-0.56]
Dias - Goa India 33 -4.2 (7.9) 26 -2.1 (10.5) 16.26% -0.23[-0.74,0.29]
Jansen - Netherlands 45 5.5 (5.6) 42 4.6 (5.6) 24.38% 0.16[-0.26,0.58]
Subtotal *** 194   174   100% -0.2[-0.41,0.01]
Heterogeneity: Tau2=0; Chi2=17.6, df=3(P=0); I2=82.96%  
Test for overall effect: Z=1.88(P=0.06)  
   
2.2.3 10 - 12 months  
Callahan - Indianapolis 64 -2.5 (17.6) 62 2.7 (28.7) 27.4% -0.22[-0.57,0.13]
Chien - Hong Kong 2001 46 -5.5 (15.4) 46 1 (15.3) 19.68% -0.42[-0.83,-0.01]
Chien- Hong Kong 2008 44 -17.9 (13.7) 44 0.6 (15.4) 15.94% -1.26[-1.72,-0.8]
Jansen - Netherlands 43 6.6 (6.8) 38 5.5 (4.8) 17.58% 0.18[-0.25,0.62]
Lam - Hong Kong 53 4.6 (17.2) 39 10.2 (15.4) 19.39% -0.33[-0.75,0.08]
Subtotal *** 250   229   100% -0.38[-0.56,-0.19]
Heterogeneity: Tau2=0; Chi2=21.39, df=4(P=0); I2=81.3%  
Test for overall effect: Z=4.02(P<0.0001)  
Favours case management 21-2 -1 0 Favours control
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Study or subgroup Case managment Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
   
2.2.4 18 months  
Callahan - Indianapolis 65 -2.1 (16.4) 49 2.8 (24.2) 55.4% -0.24[-0.61,0.13]
Chien - Hong Kong 2001 46 -5.3 (13.1) 46 1.5 (14.9) 44.6% -0.48[-0.9,-0.07]
Subtotal *** 111   95   100% -0.35[-0.63,-0.07]
Heterogeneity: Tau2=0; Chi2=0.71, df=1(P=0.4); I2=0%  
Test for overall effect: Z=2.47(P=0.01)  
Test for subgroup differences: Chi2=2.75, df=1 (P=0.43), I2=0%  
Favours case management 21-2 -1 0 Favours control
 
 
Analysis 2.3.   Comparison 2 Case management versus usual care (secondary
outcomes), Outcome 3 Depression/mood measures (participants).
Study or subgroup case/care Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
2.3.1 At 3 - 4 months  
Chu - Canada 33 -0.4 (2.9) 32 0.2 (3.9) 40.39% -0.18[-0.67,0.31]
Lam - Hong Kong 57 2.5 (5) 42 1 (3.4) 59.61% 0.32[-0.08,0.72]
Subtotal *** 90   74   100% 0.12[-0.19,0.43]
Heterogeneity: Tau2=0; Chi2=2.42, df=1(P=0.12); I2=58.7%  
Test for overall effect: Z=0.75(P=0.45)  
   
2.3.2 At 6 months  
Callahan - Indianapolis 72 -0.1 (2.8) 62 -0.2 (8) 72.49% 0.02[-0.32,0.36]
Chu - Canada 25 -0.1 (2.9) 26 -0.9 (3.3) 27.51% 0.25[-0.31,0.8]
Subtotal *** 97   88   100% 0.08[-0.21,0.37]
Heterogeneity: Tau2=0; Chi2=0.48, df=1(P=0.49); I2=0%  
Test for overall effect: Z=0.54(P=0.59)  
   
2.3.3 At 10 - 12 months  
Callahan - Indianapolis 64 -0.9 (6.3) 62 0.4 (8.3) 49.02% -0.18[-0.53,0.17]
Chu - Canada 22 0.1 (3.5) 19 -0.4 (3.9) 15.88% 0.16[-0.46,0.77]
Lam - Hong Kong 53 0.9 (6.5) 39 1.1 (3.6) 35.11% -0.03[-0.44,0.39]
Subtotal *** 139   120   100% -0.07[-0.32,0.17]
Heterogeneity: Tau2=0; Chi2=0.92, df=2(P=0.63); I2=0%  
Test for overall effect: Z=0.56(P=0.57)  
   
2.3.4 At 18 months  
Callahan - Indianapolis 65 -0.2 (6.3) 49 0 (7.4) 71.54% -0.03[-0.4,0.34]
Chu - Canada 20 -0.3 (3.2) 25 -0.3 (4) 28.46% 0[-0.59,0.59]
Subtotal *** 85   74   100% -0.02[-0.33,0.29]
Heterogeneity: Tau2=0; Chi2=0.01, df=1(P=0.93); I2=0%  
Test for overall effect: Z=0.13(P=0.9)  
Test for subgroup differences: Chi2=1.14, df=1 (P=0.77), I2=0%  
Favours case management 21-2 -1 0 Favours control
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Analysis 2.4.   Comparison 2 Case management versus usual care
(secondary outcomes), Outcome 4 Function measures (participants).
Study or subgroup Case management Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
2.4.1 At 3 months  
Dias - Goa India 34 0.1 (3.6) 32 0.8 (3.4) 100% -0.2[-0.68,0.29]
Subtotal *** 34   32   100% -0.2[-0.68,0.29]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.8(P=0.43)  
   
2.4.2 At 6 months  
Callahan - Indianapolis 72 1.3 (18.1) 62 2.3 (22.5) 42.11% -0.05[-0.39,0.29]
Dias - Goa India 33 0.2 (3.5) 26 0.4 (3.5) 18.38% -0.06[-0.57,0.46]
Eloniemi-Sulkava 2009 63 67.4 (22.5) 62 66.3 (141.1) 39.51% 0.01[-0.34,0.36]
Subtotal *** 168   150   100% -0.03[-0.25,0.19]
Heterogeneity: Tau2=0; Chi2=0.07, df=2(P=0.96); I2=0%  
Test for overall effect: Z=0.24(P=0.81)  
   
2.4.3 at 12 months  
Callahan - Indianapolis 64 2 (23.7) 62 4.7 (23.3) 50.27% -0.11[-0.46,0.24]
Eloniemi-Sulkava 2009 63 62.4 (26.2) 62 57.2 (27.6) 49.73% 0.19[-0.16,0.54]
Subtotal *** 127   124   100% 0.04[-0.21,0.29]
Heterogeneity: Tau2=0; Chi2=1.47, df=1(P=0.23); I2=31.85%  
Test for overall effect: Z=0.3(P=0.76)  
   
2.4.4 At 18 months  
Callahan - Indianapolis 65 4.9 (25.6) 49 7.2 (23.1) 100% -0.09[-0.46,0.28]
Subtotal *** 65   49   100% -0.09[-0.46,0.28]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.49(P=0.62)  
Test for subgroup differences: Chi2=0.86, df=1 (P=0.84), I2=0%  
Favours control 10.5-1 -0.5 0 Favours case management
 
 
Analysis 2.5.   Comparison 2 Case management versus usual care (secondary outcomes),
Outcome 5 Carer distress (behavioural) measures (NPI-distress/reaction RMBPC).
Study or subgroup Case management Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
2.5.1 At 3 months  
Dias - Goa India 34 -4.8 (8.1) 32 -2.3 (9.8) 100% -2.5[-6.87,1.87]
Subtotal *** 34   32   100% -2.5[-6.87,1.87]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.12(P=0.26)  
   
2.5.2 At 6 months  
Callahan - Indianapolis 72 0.2 (8.1) 62 -0.8 (13.6) 61.14% 1[-2.86,4.86]
Dias - Goa India 33 -4.2 (7.9) 26 -2.1 (10.5) 38.86% -2.1[-6.95,2.75]
Subtotal *** 105   88   100% -0.2[-3.23,2.82]
Heterogeneity: Tau2=0; Chi2=0.96, df=1(P=0.33); I2=0%  
Test for overall effect: Z=0.13(P=0.89)  
   
Favours case management 2010-20 -10 0 Favours control
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Study or subgroup Case management Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
2.5.3 At 10 -12 months  
Callahan - Indianapolis 64 -0.7 (8.4) 62 1.2 (14.2) 100% -1.9[-6,2.2]
Subtotal *** 64   62   100% -1.9[-6,2.2]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.91(P=0.36)  
   
2.5.4 At 18 months  
Callahan - Indianapolis 65 0.4 (7.1) 49 0.9 (7.6) 100% -0.5[-3.24,2.24]
Subtotal *** 65   49   100% -0.5[-3.24,2.24]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.36(P=0.72)  
Test for subgroup differences: Chi2=1.03, df=1 (P=0.79), I2=0%  
Favours case management 2010-20 -10 0 Favours control
 
 
Analysis 2.6.   Comparison 2 Case management versus usual care
(secondary outcomes), Outcome 6 Mood/depression measures (carers).
Study or subgroup Case management Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
2.6.1 At 6 months  
Callahan - Indianapolis 72 -0.2 (7.2) 62 -0.1 (7.6) 2.86% -0.01[-0.35,0.33]
Chu - Canada 21 8 (8.6) 26 11.1 (10.3) 0.98% -0.32[-0.9,0.26]
Jansen - Netherlands 45 11.8 (7.5) 41 9.7 (8.1) 1.82% 0.27[-0.16,0.69]
Newcomer - US 2269 0.1 (4.7) 2139 0.3 (4.8) 94.34% -0.05[-0.11,0.01]
Subtotal *** 2407   2268   100% -0.04[-0.1,0.02]
Heterogeneity: Tau2=0; Chi2=2.95, df=3(P=0.4); I2=0%  
Test for overall effect: Z=1.44(P=0.15)  
   
2.6.2 At 10 - 12 months  
Bass - Ohio 94 0 (0.6) 63 0.1 (0.7) 4.07% -0.18[-0.5,0.14]
Callahan - Indianapolis 64 -0.7 (6.4) 62 0.2 (7.9) 3.4% -0.12[-0.47,0.23]
Chu - Canada 20 11.8 (11.1) 20 10.9 (10.2) 1.08% 0.08[-0.54,0.7]
Jansen - Netherlands 43 11.2 (6.8) 37 11.5 (8.1) 2.15% -0.04[-0.48,0.4]
Newcomer - US 1705 0 (4.7) 1597 0.2 (4.9) 89.29% -0.04[-0.1,0.03]
Subtotal *** 1926   1779   100% -0.04[-0.11,0.02]
Heterogeneity: Tau2=0; Chi2=1.09, df=4(P=0.9); I2=0%  
Test for overall effect: Z=1.3(P=0.19)  
   
2.6.3 At 18 months  
Callahan - Indianapolis 65 -0.7 (6.8) 49 0.8 (7.7) 3.87% -0.21[-0.58,0.17]
Chu - Canada 26 8.8 (6.6) 21 9.1 (8.6) 1.62% -0.04[-0.61,0.54]
Newcomer - US 1439 -0.1 (4.8) 1288 0.3 (5) 94.52% -0.08[-0.15,-0]
Subtotal *** 1530   1358   100% -0.08[-0.16,-0.01]
Heterogeneity: Tau2=0; Chi2=0.46, df=2(P=0.8); I2=0%  
Test for overall effect: Z=2.24(P=0.03)  
   
2.6.4 At 24 months  
Newcomer - US 1531 -0.2 (5.2) 1356 0.2 (5) 100% -0.06[-0.14,0.01]
Subtotal *** 1531   1356   100% -0.06[-0.14,0.01]
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Study or subgroup Case management Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Heterogeneity: Not applicable  
Test for overall effect: Z=1.73(P=0.08)  
   
2.6.5 At 36 months  
Newcomer - US 988 -0 (4.8) 922 0.3 (4.9) 100% -0.07[-0.16,0.02]
Subtotal *** 988   922   100% -0.07[-0.16,0.02]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.44(P=0.15)  
Test for subgroup differences: Chi2=1.03, df=1 (P=0.91), I2=0%  
Favours case management 10.5-1 -0.5 0 Favours control
 
 
Analysis 2.7.   Comparison 2 Case management versus usual care (secondary
outcomes), Outcome 7 Carer well-being - GHQ (changes from baseline).
Study or subgroup case management control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Random, 95% CI   Random, 95% CI
2.7.1 At 3 - 4 months  
Dias - Goa India 34 -0.9 (5.1) 37 0.4 (4) 35.55% -1.3[-3.46,0.86]
Hinchliffe - UK 20 -6.8 (3.3) 13 -0.9 (5) 28.63% -5.9[-8.98,-2.82]
Lam - Hong Kong 57 -0.8 (5) 42 0.3 (5.6) 35.82% -1.06[-3.18,1.06]
Subtotal *** 111   92   100% -2.53[-5.2,0.13]
Heterogeneity: Tau2=3.99; Chi2=7.3, df=2(P=0.03); I2=72.62%  
Test for overall effect: Z=1.86(P=0.06)  
   
2.7.2 At 6 months  
Dias - Goa India 34 -1.4 (3.6) 31 0.8 (4.3) 100% -2.2[-4.14,-0.26]
Subtotal *** 34   31   100% -2.2[-4.14,-0.26]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.23(P=0.03)  
   
2.7.3 At 12 months  
Lam - Hong Kong 53 -1.9 (6.3) 39 0 (4.5) 100% -1.9[-4.11,0.31]
Subtotal *** 53   39   100% -1.9[-4.11,0.31]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.68(P=0.09)  
Test for subgroup differences: Chi2=0.13, df=1 (P=0.94), I2=0%  
Favours case management 105-10 -5 0 Favours control
 
 
Analysis 2.8.   Comparison 2 Case management versus usual care
(secondary outcomes), Outcome 8 Social support measures.
Study or subgroup Case managment Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
2.8.1 At 6 months  
Chien- Hong Kong 2008 44 1.2 (3.6) 44 0.6 (3.1) 100% 0.18[-0.24,0.6]
Subtotal *** 44   44   100% 0.18[-0.24,0.6]
Heterogeneity: Not applicable  
Favours control 10.5-1 -0.5 0 Favours case management
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Study or subgroup Case managment Control Std. Mean Difference Weight Std. Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Test for overall effect: Z=0.83(P=0.41)  
   
2.8.2 At 12 months  
Chien - Hong Kong 2001 46 1.4 (2.8) 46 -0.1 (2.4) 16.74% 0.58[0.16,0.99]
Chien- Hong Kong 2008 44 1.4 (2.8) 44 -0.1 (2.4) 16.01% 0.58[0.15,1]
Vickrey - California 205 4.7 (40.3) 156 6 (38.1) 67.26% -0.03[-0.24,0.18]
Subtotal *** 295   246   100% 0.17[-0,0.34]
Heterogeneity: Tau2=0; Chi2=10.8, df=2(P=0); I2=81.48%  
Test for overall effect: Z=1.92(P=0.06)  
   
2.8.3 At 18 months changes from baseline  
Chien - Hong Kong 2001 46 1.2 (1.7) 46 0.3 (2.1) 23.96% 0.47[0.05,0.88]
Vickrey - California 166 2 (40.2) 124 1.1 (41.6) 76.04% 0.02[-0.21,0.25]
Subtotal *** 212   170   100% 0.13[-0.07,0.33]
Heterogeneity: Tau2=0; Chi2=3.36, df=1(P=0.07); I2=70.25%  
Test for overall effect: Z=1.24(P=0.21)  
Test for subgroup differences: Chi2=0.09, df=1 (P=0.95), I2=0%  
Favours control 10.5-1 -0.5 0 Favours case management
 
 
Analysis 2.9.   Comparison 2 Case management versus usual care (secondary
outcomes), Outcome 9 Satisfaction with health plan (carers) changes from baseline.
Study or subgroup Case management Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
2.9.1 Satisfaction with types of service at 12 months  
Bass - Ohio 94 0.1 (0.9) 63 0.1 (0.9) 36.01% 0.02[-0.26,0.3]
Subtotal *** 94   63   36.01% 0.02[-0.26,0.3]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.14(P=0.89)  
   
2.9.2 Satisfaction with quality of services at 12 months  
Bass - Ohio 94 0 (0.6) 63 -0 (0.7) 63.99% 0.04[-0.17,0.25]
Subtotal *** 94   63   63.99% 0.04[-0.17,0.25]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.38(P=0.7)  
   
Total *** 188   126   100% 0.03[-0.13,0.2]
Heterogeneity: Tau2=0; Chi2=0.01, df=1(P=0.91); I2=0%  
Test for overall effect: Z=0.39(P=0.7)  
Test for subgroup differences: Chi2=0.01, df=1 (P=0.91), I2=0%  
Favours control 0.50.25-0.5 -0.25 0 Favours case management
 
 
Case management approaches to home support for people with dementia (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
99
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Analysis 2.10.   Comparison 2 Case management versus usual care
(secondary outcomes), Outcome 10 Satisfaction with care (carers).
Study or subgroup Case man-
agement
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
2.10.1 Primary care rated as very good or excellent (12 months)  
Callahan - Indianapolis 70/84 39/69 33.68% 3.85[1.82,8.11]
Subtotal (95% CI) 84 69 33.68% 3.85[1.82,8.11]
Total events: 70 (Case management), 39 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=3.54(P=0)  
   
2.10.2 Primary care rated as very good or excellent (18 months)  
Callahan - Indianapolis 59/84 43/69 66.32% 1.43[0.73,2.8]
Subtotal (95% CI) 84 69 66.32% 1.43[0.73,2.8]
Total events: 59 (Case management), 43 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.03(P=0.3)  
   
Total (95% CI) 168 138 100% 2.24[1.37,3.67]
Total events: 129 (Case management), 82 (Control)  
Heterogeneity: Tau2=0; Chi2=3.73, df=1(P=0.05); I2=73.21%  
Test for overall effect: Z=3.22(P=0)  
Test for subgroup differences: Chi2=3.73, df=1 (P=0.05), I2=73.21%  
Favours control 1000.01 100.1 1 Favours case management
 
 
Analysis 2.11.   Comparison 2 Case management versus usual care (secondary outcomes), Outcome 11 Leaving
the study early (patients) unwilling or unable to provide information (including died/ institutionalised).
Study or subgroup Case man-
agement
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
2.11.1 At 3 - 4 months  
Dias - Goa India 7/41 8/40 52.33% 0.82[0.27,2.53]
Hinchliffe - UK 2/22 5/18 38.96% 0.26[0.04,1.55]
Lam - Hong Kong 2/59 1/43 8.71% 1.47[0.13,16.8]
Subtotal (95% CI) 122 101 100% 0.66[0.28,1.56]
Total events: 11 (Case management), 14 (Control)  
Heterogeneity: Tau2=0; Chi2=1.62, df=2(P=0.45); I2=0%  
Test for overall effect: Z=0.95(P=0.34)  
   
2.11.2 At 6 months  
Callahan - Indianapolis 2/72 0/62 0.13% 4.43[0.21,94.1]
Dias - Goa India 2/34 7/32 1.74% 0.22[0.04,1.17]
Eloniemi-Sulkava 2009 4/63 6/62 1.45% 0.63[0.17,2.36]
Jansen - Netherlands 9/54 3/45 0.7% 2.8[0.71,11.05]
Newcomer - US 460/2728 438/2576 95.98% 0.99[0.86,1.14]
Subtotal (95% CI) 2951 2777 100% 0.99[0.86,1.14]
Total events: 477 (Case management), 454 (Control)  
Heterogeneity: Tau2=0; Chi2=6.68, df=4(P=0.15); I2=40.11%  
Test for overall effect: Z=0.16(P=0.87)  
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Study or subgroup Case man-
agement
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
   
2.11.3 At 12 months  
Callahan - Indianapolis 1/64 1/62 0.15% 0.97[0.06,15.83]
Eloniemi-Sulkava 2001 10/53 12/47 1.52% 0.68[0.26,1.75]
Eloniemi-Sulkava 2009 6/59 8/56 1.09% 0.68[0.22,2.1]
Jansen - Netherlands 2/45 4/42 0.58% 0.44[0.08,2.55]
Lam - Hong Kong 10/53 14/39 1.93% 0.42[0.16,1.07]
Newcomer - US 1026/2728 979/2576 92.66% 0.98[0.88,1.1]
Vickrey - California 33/238 14/170 2.07% 1.79[0.93,3.47]
Subtotal (95% CI) 3240 2992 100% 0.98[0.88,1.09]
Total events: 1088 (Case management), 1032 (Control)  
Heterogeneity: Tau2=0; Chi2=8.15, df=6(P=0.23); I2=26.39%  
Test for overall effect: Z=0.41(P=0.68)  
   
2.11.4 At 18 months  
Callahan - Indianapolis 20/65 19/49 1.97% 0.7[0.32,1.53]
Chien - Hong Kong 2001 1/46 1/46 0.13% 1[0.06,16.48]
Chien- Hong Kong 2008 2/44 1/44 0.13% 2.05[0.18,23.44]
Chu - Canada 10/37 17/38 1.61% 0.46[0.17,1.2]
Newcomer - US 1289/2728 1293/2576 92.29% 0.89[0.8,0.99]
Vickrey - California 39/205 32/156 3.87% 0.91[0.54,1.53]
Subtotal (95% CI) 3125 2909 100% 0.88[0.79,0.98]
Total events: 1361 (Case management), 1363 (Control)  
Heterogeneity: Tau2=0; Chi2=2.6, df=5(P=0.76); I2=0%  
Test for overall effect: Z=2.4(P=0.02)  
   
2.11.5 At 24 months  
Eloniemi-Sulkava 2001 26/53 22/47 1.64% 1.09[0.5,2.4]
Eloniemi-Sulkava 2009 12/53 13/48 1.45% 0.79[0.32,1.95]
Newcomer - US 1200/2728 1222/2576 96.91% 0.87[0.78,0.97]
Subtotal (95% CI) 2834 2671 100% 0.87[0.78,0.97]
Total events: 1238 (Case management), 1257 (Control)  
Heterogeneity: Tau2=0; Chi2=0.37, df=2(P=0.83); I2=0%  
Test for overall effect: Z=2.51(P=0.01)  
   
2.11.6 At 36 months  
Newcomer - US 1742/2728 1656/2576 100% 0.98[0.88,1.1]
Subtotal (95% CI) 2728 2576 100% 0.98[0.88,1.1]
Total events: 1742 (Case management), 1656 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.33(P=0.74)  
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Comparison 3.   Case management versus usual care (secondary outcomes: service use/cost )
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Use of community-based services
(number of participants/ carers)
4   Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Home care at 3 - 4 months 2 174 Odds Ratio (M-H, Fixed, 95% CI) 2.67 [0.79, 8.95]
1.2 Home care at 12 months 3 5376 Odds Ratio (M-H, Fixed, 95% CI) 2.28 [2.03, 2.56]
1.3 Home care at 18 months 1 74 Odds Ratio (M-H, Fixed, 95% CI) 5.63 [2.07, 15.29]
1.4 Day care at 4 months 1 99 Odds Ratio (M-H, Fixed, 95% CI) 4.51 [1.89, 10.77]
1.5 Day care at 12 months 2 5301 Odds Ratio (M-H, Fixed, 95% CI) 2.23 [1.98, 2.52]
1.6 Day care at 18 months 1 353 Odds Ratio (M-H, Fixed, 95% CI) 1.80 [0.92, 3.51]
1.7 Respite care at 4 months 1 99 Odds Ratio (M-H, Fixed, 95% CI) 2.26 [0.09, 56.78]
1.8 Respite care at 12 months 2 5301 Odds Ratio (M-H, Fixed, 95% CI) 2.24 [1.98, 2.53]
1.9 Domestic paid helpers at 4
months
1 99 Odds Ratio (M-H, Fixed, 95% CI) 5.4 [1.97, 14.81]
1.10 Domestic paid helpers at 12
months
1 92 Odds Ratio (M-H, Fixed, 95% CI) 3.0 [1.12, 8.04]
1.11 Personal care use at 12 months 2 5284 Odds Ratio (M-H, Fixed, 95% CI) 1.57 [1.40, 1.75]
1.12 Services from a professional
home health aide at 18 months
1 353 Odds Ratio (M-H, Fixed, 95% CI) 1.81 [1.05, 3.13]
1.13 Services from a paid professional
caregiver at 18 months
1 353 Odds Ratio (M-H, Fixed, 95% CI) 1.48 [0.85, 2.59]
1.14 In-home, volunteer, or paid
respite care services at 18 months
1 353 Odds Ratio (M-H, Fixed, 95% CI) 1.54 [0.98, 2.41]
1.15 Assisted living housing use at 12
months
1 5209 Odds Ratio (M-H, Fixed, 95% CI) 0.70 [0.56, 0.87]
1.16 Services or information from
local Alzheimers Association at 18
months
1 360 Odds Ratio (M-H, Fixed, 95% CI) 2.40 [1.56, 3.69]
1.17 Services or information from
care givers resource centre at 18
months
1 360 Odds Ratio (M-H, Fixed, 95% CI) 2.88 [1.77, 4.69]
1.18 Services or information on meals
on wheels at 18 months
1 360 Odds Ratio (M-H, Fixed, 95% CI) 0.97 [0.53, 1.77]
1.19 Participation in a caregiver sup-
port group at 18 months
1 356 Odds Ratio (M-H, Fixed, 95% CI) 1.64 [1.00, 2.68]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
2 Health service use by participants
(number of participants)
2   Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
2.1 Emergency department visits at
18 months
1 296 Odds Ratio (M-H, Fixed, 95% CI) 1.18 [0.74, 1.87]
2.2 Direct care (occupational ther-
apy, physical therapy, social work,
nursing and respiratory therapy (at
18 months))
1 75 Odds Ratio (M-H, Fixed, 95% CI) 1.31 [0.51, 3.35]
3 Health service use by participants
(continuous outcomes)
4   Mean Difference (IV, Fixed, 95% CI) Subtotals only
3.1 Emergency department visits at
12 months
1 157 Mean Difference (IV, Fixed, 95% CI) -0.17 [-0.63, 0.29]
3.2 Emergency department visits at
18 months
1 296 Mean Difference (IV, Fixed, 95% CI) 0.18 [-0.11, 0.47]
3.3 Physician visits (per month) at 6
months
1 296 Mean Difference (IV, Fixed, 95% CI) 0.08 [-1.28, 1.44]
3.4 Physician visits at 12 months 3 353 Mean Difference (IV, Fixed, 95% CI) 0.21 [-0.62, 1.04]
3.5 Physician and nurse visits at 18
months
1 113 Mean Difference (IV, Fixed, 95% CI) 5.4 [0.51, 10.29]
3.6 Outpatients geriatric/psychi-
atric team/diagnostic service over 12
months (number of consultations)
1 70 Mean Difference (IV, Fixed, 95% CI) 0.3 [-1.61, 2.21]
3.7 Medical specialist over 12 months
(number of consultations)
1 70 Mean Difference (IV, Fixed, 95% CI) -0.60 [-6.35, 5.15]
3.8 Physiotherapist over 12 months
(number of consultations)
1 70 Mean Difference (IV, Fixed, 95% CI) 0.0 [-28.18, 28.18]
3.9 Social worker over 12 months
(number of consultations)
1 70 Mean Difference (IV, Fixed, 95% CI) 0.02 [-0.52, 0.56]
4 Cost of service (participants) 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
4.1 Total health and social care costs
(1000 Euros; excluding intervention)
at 12 months
1 125 Mean Difference (IV, Fixed, 95% CI) -7.99 [-16.86, 0.89]
5 Healthcare and care-giving costs
(USD or EUR))
2   Mean Difference (Fixed, 95% CI) Subtotals only
5.1 Payer perspective, including nurs-
ing home cost at 18 months (USD)
1   Mean Difference (Fixed, 95% CI) -260.0 [-1177.99,
657.99]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
5.2 Payer perspective,excluding nurs-
ing home at 18 months (USD)
1   Mean Difference (Fixed, 95% CI) -272.0 [-1153.49,
609.49]
5.3 Societal perspective cost at 18
months (USD)
1   Mean Difference (Fixed, 95% CI) -365.0 [-1290.30,
560.30]
5.4 Total health and social care costs
at 12 months (1000 Euros; excluding
intervention)
1   Mean Difference (Fixed, 95% CI) -7.99 [-16.86, 0.88]
6 Health services costs (participants)
(Medicare expenditures) (community
services usage) in USD or EUR
2   Mean Difference (IV, Fixed, 95% CI) Subtotals only
6.1 At year 1 2 5276 Mean Difference (IV, Fixed, 95% CI) -8.13 [-17.00, 0.75]
6.2 At year 2 1 3665 Mean Difference (IV, Fixed, 95% CI) -654.0 [-1462.80,
154.80]
6.3 At year 3 1 2255 Mean Difference (IV, Fixed, 95% CI) -779.0 [-1976.72,
418.72]
6.4 Over 3 years 1 5170 Mean Difference (IV, Fixed, 95% CI) -705.0 [-1170.31,
-239.69]
7 Health service use by carers (di-
chotomous outcomes)
1   Odds Ratio (M-H, Fixed, 95% CI) Subtotals only
7.1 Hospitalised during 3 years (num-
ber of carers)
1 412 Odds Ratio (M-H, Fixed, 95% CI) 0.51 [0.33, 0.81]
7.2 Emergency department visits dur-
ing 3 years (number of carers)
1 412 Odds Ratio (M-H, Fixed, 95% CI) 0.58 [0.38, 0.89]
8 Health service use by carers (contin-
uous outcomes)
2   Mean Difference (IV, Fixed, 95% CI) Subtotals only
8.1 Annual hospital length of stay 1 412 Mean Difference (IV, Fixed, 95% CI) 0.90 [-0.23, 2.03]
8.2 Number of admissions over 12
months
1 412 Mean Difference (IV, Fixed, 95% CI) 0.15 [-0.20, 0.50]
8.3 Primary care physician over 12
months (number of consultations)
1 69 Mean Difference (IV, Fixed, 95% CI) 0.0 [-5.26, 5.26]
8.4 Outpatients geriatric/psychiatric
team over 12 months (number of con-
sultations)
1 69 Mean Difference (IV, Fixed, 95% CI) -0.77 [-5.33, 3.79]
8.5 Medical specialist over 12 months
(number of consultations)
1 69 Mean Difference (IV, Fixed, 95% CI) 0.10 [-5.93, 6.13]
8.6 Physiotherapist over 12 months
(number of consultations)
1 69 Mean Difference (IV, Fixed, 95% CI) 1.70 [-13.06, 16.46]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
9 Informal caregiver time (hours) 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
9.1 Paid unskilled at 6 months 1 296 Mean Difference (IV, Fixed, 95% CI) -5.10 [-789.73,
779.53]
9.2 Unpaid unskilled at 6 months 1 296 Mean Difference (IV, Fixed, 95% CI) 30.70 [-388.03,
449.43]
10 Medicare expenditures; communi-
ty services usage in Dollars
1   Mean Difference (Fixed, 95% CI) Subtotals only
10.1 At year 1 1   Mean Difference (Fixed, 95% CI) -229.0 [-489.48,
31.48]
10.2 At year 2 1   Mean Difference (Fixed, 95% CI) 17.0 [-943.97, 977.97]
10.3 At year 3 1   Mean Difference (Fixed, 95% CI) -325.0 [-770.89,
120.89]
10.4 Over 3 years 1   Mean Difference (Fixed, 95% CI) -167.0 [-946.28,
612.28]
11 Cost of services (carers) 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
11.1 Medicare Part A expenditure in
comparison to control
1 412 Mean Difference (IV, Fixed, 95% CI) -681.0 [-1382.40,
20.40]
 
 
Analysis 3.1.   Comparison 3 Case management versus usual care (secondary outcomes: service
use/cost ), Outcome 1 Use of community-based services (number of participants/ carers).
Study or subgroup Case man-
agement
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
3.1.1 Home care at 3 - 4 months  
Chu - Canada 6/37 0/38 11.3% 15.89[0.86,293.05]
Lam - Hong Kong 4/57 3/42 88.7% 0.98[0.21,4.64]
Subtotal (95% CI) 94 80 100% 2.67[0.79,8.95]
Total events: 10 (Case management), 3 (Control)  
Heterogeneity: Tau2=0; Chi2=3.03, df=1(P=0.08); I2=67.02%  
Test for overall effect: Z=1.59(P=0.11)  
   
3.1.2 Home care at 12 months  
Chu - Canada 20/37 9/38 1.08% 3.79[1.41,10.19]
Lam - Hong Kong 3/53 3/39 0.86% 0.72[0.14,3.77]
Newcomer - US 2006/2682 1430/2527 98.06% 2.28[2.02,2.56]
Subtotal (95% CI) 2772 2604 100% 2.28[2.03,2.56]
Total events: 2029 (Case management), 1442 (Control)  
Heterogeneity: Tau2=0; Chi2=2.88, df=2(P=0.24); I2=30.47%  
Test for overall effect: Z=13.89(P<0.0001)  
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Study or subgroup Case man-
agement
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
   
3.1.3 Home care at 18 months  
Chu - Canada 25/37 10/37 100% 5.63[2.07,15.29]
Subtotal (95% CI) 37 37 100% 5.63[2.07,15.29]
Total events: 25 (Case management), 10 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=3.38(P=0)  
   
3.1.4 Day care at 4 months  
Lam - Hong Kong 44/57 18/42 100% 4.51[1.89,10.77]
Subtotal (95% CI) 57 42 100% 4.51[1.89,10.77]
Total events: 44 (Case management), 18 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=3.4(P=0)  
   
3.1.5 Day care at 12 months  
Lam - Hong Kong 37/53 14/39 1.39% 4.13[1.72,9.94]
Newcomer - US 995/2682 533/2527 98.61% 2.21[1.95,2.5]
Subtotal (95% CI) 2735 2566 100% 2.23[1.98,2.52]
Total events: 1032 (Case management), 547 (Control)  
Heterogeneity: Tau2=0; Chi2=1.92, df=1(P=0.17); I2=47.83%  
Test for overall effect: Z=12.87(P<0.0001)  
   
3.1.6 Day care at 18 months  
Vickrey - California 31/201 14/152 100% 1.8[0.92,3.51]
Subtotal (95% CI) 201 152 100% 1.8[0.92,3.51]
Total events: 31 (Case management), 14 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.72(P=0.09)  
   
3.1.7 Respite care at 4 months  
Lam - Hong Kong 1/57 0/42 100% 2.26[0.09,56.78]
Subtotal (95% CI) 57 42 100% 2.26[0.09,56.78]
Total events: 1 (Case management), 0 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.49(P=0.62)  
   
3.1.8 Respite care at 12 months  
Lam - Hong Kong 3/53 0/39 0.15% 5.48[0.27,109.13]
Newcomer - US 1014/2682 541/2527 99.85% 2.23[1.97,2.52]
Subtotal (95% CI) 2735 2566 100% 2.24[1.98,2.53]
Total events: 1017 (Case management), 541 (Control)  
Heterogeneity: Tau2=0; Chi2=0.35, df=1(P=0.56); I2=0%  
Test for overall effect: Z=12.84(P<0.0001)  
   
3.1.9 Domestic paid helpers at 4 months  
Lam - Hong Kong 27/57 6/42 100% 5.4[1.97,14.81]
Subtotal (95% CI) 57 42 100% 5.4[1.97,14.81]
Total events: 27 (Case management), 6 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=3.28(P=0)  
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Study or subgroup Case man-
agement
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
   
3.1.10 Domestic paid helpers at 12 months  
Lam - Hong Kong 21/53 7/39 100% 3[1.12,8.04]
Subtotal (95% CI) 53 39 100% 3[1.12,8.04]
Total events: 21 (Case management), 7 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.18(P=0.03)  
   
3.1.11 Personal care use at 12 months  
Chu - Canada 20/37 9/38 0.82% 3.79[1.41,10.19]
Newcomer - US 1191/2682 859/2527 99.18% 1.55[1.39,1.74]
Subtotal (95% CI) 2719 2565 100% 1.57[1.4,1.75]
Total events: 1211 (Case management), 868 (Control)  
Heterogeneity: Tau2=0; Chi2=3.1, df=1(P=0.08); I2=67.73%  
Test for overall effect: Z=7.93(P<0.0001)  
   
3.1.12 Services from a professional home health aide at 18 months  
Vickrey - California 49/201 23/152 100% 1.81[1.05,3.13]
Subtotal (95% CI) 201 152 100% 1.81[1.05,3.13]
Total events: 49 (Case management), 23 (Control)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=2.12(P=0.03)  
   
3.1.13 Services from a paid professional caregiver at 18 months  
Vickrey - California 42/201 23/152 100% 1.48[0.85,2.59]
Subtotal (95% CI) 201 152 100% 1.48[0.85,2.59]
Total events: 42 (Case management), 23 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.38(P=0.17)  
   
3.1.14 In-home, volunteer, or paid respite care services at 18 months  
Vickrey - California 79/201 45/152 100% 1.54[0.98,2.41]
Subtotal (95% CI) 201 152 100% 1.54[0.98,2.41]
Total events: 79 (Case management), 45 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.89(P=0.06)  
   
3.1.15 Assisted living housing use at 12 months  
Newcomer - US 148/2682 195/2527 100% 0.7[0.56,0.87]
Subtotal (95% CI) 2682 2527 100% 0.7[0.56,0.87]
Total events: 148 (Case management), 195 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=3.18(P=0)  
   
3.1.16 Services or information from local Alzheimers Association at 18
months
 
Vickrey - California 117/204 56/156 100% 2.4[1.56,3.69]
Subtotal (95% CI) 204 156 100% 2.4[1.56,3.69]
Total events: 117 (Case management), 56 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=4(P<0.0001)  
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Study or subgroup Case man-
agement
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
   
3.1.17 Services or information from care givers resource centre at 18
months
 
Vickrey - California 83/204 30/156 100% 2.88[1.77,4.69]
Subtotal (95% CI) 204 156 100% 2.88[1.77,4.69]
Total events: 83 (Case management), 30 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=4.26(P<0.0001)  
   
3.1.18 Services or information on meals on wheels at 18 months  
Vickrey - California 28/204 22/156 100% 0.97[0.53,1.77]
Subtotal (95% CI) 204 156 100% 0.97[0.53,1.77]
Total events: 28 (Case management), 22 (Control)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=0.1(P=0.92)  
   
3.1.19 Participation in a caregiver support group at 18 months  
Vickrey - California 62/204 32/152 100% 1.64[1,2.68]
Subtotal (95% CI) 204 152 100% 1.64[1,2.68]
Total events: 62 (Case management), 32 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.97(P=0.05)  
Test for subgroup differences: Chi2=137.34, df=1 (P<0.0001), I2=86.89%  
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Analysis 3.2.   Comparison 3 Case management versus usual care (secondary outcomes:
service use/cost ), Outcome 2 Health service use by participants (number of participants).
Study or subgroup Case man-
agement
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
3.2.1 Emergency department visits at 18 months  
Vickrey - California 96/170 66/126 100% 1.18[0.74,1.87]
Subtotal (95% CI) 170 126 100% 1.18[0.74,1.87]
Total events: 96 (Case management), 66 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.7(P=0.48)  
   
3.2.2 Direct care (occupational therapy, physical therapy, social work,
nursing and respiratory therapy (at 18 months))
 
Chu - Canada 15/37 13/38 100% 1.31[0.51,3.35]
Subtotal (95% CI) 37 38 100% 1.31[0.51,3.35]
Total events: 15 (Case management), 13 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.57(P=0.57)  
Test for subgroup differences: Chi2=0.04, df=1 (P=0.84), I2=0%  
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Analysis 3.3.   Comparison 3 Case management versus usual care (secondary outcomes:
service use/cost ), Outcome 3 Health service use by participants (continuous outcomes).
Study or subgroup Favours case
management
Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
3.3.1 Emergency department visits at 12 months  
Bass - Ohio 94 0.1 (1.4) 63 0.3 (1.5) 100% -0.17[-0.63,0.29]
Subtotal *** 94   63   100% -0.17[-0.63,0.29]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.72(P=0.47)  
   
3.3.2 Emergency department visits at 18 months  
Vickrey - California 170 1.4 (1.4) 126 1.3 (1.1) 100% 0.18[-0.11,0.47]
Subtotal *** 170   126   100% 0.18[-0.11,0.47]
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=1.21(P=0.23)  
   
3.3.3 Physician visits (per month) at 6 months  
Vickrey - California 170 0.6 (6.7) 126 0.5 (5.3) 100% 0.08[-1.28,1.44]
Subtotal *** 170   126   100% 0.08[-1.28,1.44]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.12(P=0.91)  
   
3.3.4 Physician visits at 12 months  
Bass - Ohio 94 2.9 (2.8) 63 2.9 (2.6) 94.17% 0[-0.86,0.86]
Callahan - Indianapolis 64 9.3 (13.4) 62 5.6 (5.1) 5.59% 3.7[0.18,7.22]
Jansen - Netherlands 37 8.3 (42.9) 33 6.6 (29.7) 0.24% 1.7[-15.43,18.83]
Subtotal *** 195   158   100% 0.21[-0.62,1.04]
Heterogeneity: Tau2=0; Chi2=4.04, df=2(P=0.13); I2=50.45%  
Test for overall effect: Z=0.5(P=0.62)  
   
3.3.5 Physician and nurse visits at 18 months  
Callahan - Indianapolis 64 12.9 (18.5) 49 7.5 (6.6) 100% 5.4[0.51,10.29]
Subtotal *** 64   49   100% 5.4[0.51,10.29]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.16(P=0.03)  
   
3.3.6 Outpatients geriatric/psychiatric team/diagnostic service over 12 months
(number of consultations)
 
Jansen - Netherlands 37 0.5 (4.5) 33 0.2 (3.7) 100% 0.3[-1.61,2.21]
Subtotal *** 37   33   100% 0.3[-1.61,2.21]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.31(P=0.76)  
   
3.3.7 Medical specialist over 12 months (number of consultations)  
Jansen - Netherlands 37 2.7 (14.1) 33 3.3 (10.4) 100% -0.6[-6.35,5.15]
Subtotal *** 37   33   100% -0.6[-6.35,5.15]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.2(P=0.84)  
   
3.3.8 Physiotherapist over 12 months (number of consultations)  
Jansen - Netherlands 37 6.2 (38.5) 33 6.2 (74.1) 100% 0[-28.18,28.18]
Subtotal *** 37   33   100% 0[-28.18,28.18]
Heterogeneity: Not applicable  
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Study or subgroup Favours case
management
Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
Test for overall effect: Not applicable  
   
3.3.9 Social worker over 12 months (number of consultations)  
Jansen - Netherlands 37 0.1 (1.5) 33 0 (0.7) 100% 0.02[-0.52,0.56]
Subtotal *** 37   33   100% 0.02[-0.52,0.56]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.07(P=0.94)  
Test for subgroup differences: Chi2=6.36, df=1 (P=0.61), I2=0%  
Favours case management 2010-20 -10 0 Favours control
 
 
Analysis 3.4.   Comparison 3 Case management versus usual care (secondary
outcomes: service use/cost ), Outcome 4 Cost of service (participants).
Study or subgroup Favours case
management
Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
3.4.1 Total health and social care costs (1000 Euros; excluding intervention) at
12 months
 
Eloniemi-Sulkava 2009 63 15.6 (17.9) 62 23.6 (31) 100% -7.99[-16.86,0.89]
Subtotal *** 63   62   100% -7.99[-16.86,0.89]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.76(P=0.08)  
Favours case management 2010-20 -10 0 Favours control
 
 
Analysis 3.5.   Comparison 3 Case management versus usual care (secondary outcomes:
service use/cost ), Outcome 5 Healthcare and care-giving costs (USD or EUR)).
Study or subgroup Favours
case man-
agement
Control Mean Dif-
ference
Mean Difference Weight Mean Difference
  N N (SE) IV, Fixed, 95% CI   IV, Fixed, 95% CI
3.5.1 Payer perspective, including nursing home cost at 18 months (USD)  
Vickrey - California 0 0 -260 (468.37) 100% -260[-1177.99,657.99]
Subtotal (95% CI)       100% -260[-1177.99,657.99]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.56(P=0.58)  
   
3.5.2 Payer perspective,excluding nursing home at 18 months (USD)  
Vickrey - California 0 0 -272 (449.75) 100% -272[-1153.49,609.49]
Subtotal (95% CI)       100% -272[-1153.49,609.49]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.6(P=0.55)  
   
3.5.3 Societal perspective cost at 18 months (USD)  
Vickrey - California 0 0 -365 (472.1) 100% -365[-1290.3,560.3]
Subtotal (95% CI)       100% -365[-1290.3,560.3]
Heterogeneity: Not applicable  
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Study or subgroup Favours
case man-
agement
Control Mean Dif-
ference
Mean Difference Weight Mean Difference
  N N (SE) IV, Fixed, 95% CI   IV, Fixed, 95% CI
Test for overall effect: Z=0.77(P=0.44)  
   
3.5.4 Total health and social care costs at 12 months (1000 Euros; excluding in-
tervention)
 
Eloniemi-Sulkava 2009 0 0 -8 (4.526) 100% -7.99[-16.86,0.88]
Subtotal (95% CI)       100% -7.99[-16.86,0.88]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.77(P=0.08)  
Test for subgroup differences: Chi2=1.21, df=1 (P=0.75), I2=0%  
Favours case management 1000500-1000 -500 0 Favours control
 
 
Analysis 3.6.   Comparison 3 Case management versus usual care (secondary outcomes: service use/cost ),
Outcome 6 Health services costs (participants) (Medicare expenditures) (community services usage) in USD or EUR.
Study or subgroup Favours case/care Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
3.6.1 At year 1  
Eloniemi-Sulkava 2009 63 15.6 (17.9) 62 23.6 (31) 99.98% -7.99[-16.86,0.89]
Newcomer - US 2641 7169
(11751)
2510 7898
(11316)
0.02% -729[-1358.95,-99.05]
Subtotal *** 2704   2572   100% -8.13[-17,0.75]
Heterogeneity: Tau2=0; Chi2=5.03, df=1(P=0.02); I2=80.13%  
Test for overall effect: Z=1.79(P=0.07)  
   
3.6.2 At year 2  
Newcomer - US 1870 7378
(11812)
1795 8032
(13105)
100% -654[-1462.8,154.8]
Subtotal *** 1870   1795   100% -654[-1462.8,154.8]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.58(P=0.11)  
   
3.6.3 At year 3  
Newcomer - US 1184 8526
(14127)
1071 9305
(14813)
100% -779[-1976.72,418.72]
Subtotal *** 1184   1071   100% -779[-1976.72,418.72]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.27(P=0.2)  
   
3.6.4 Over 3 years  
Newcomer - US 2652 7555 (8486) 2518 8260 (8576) 100% -705[-1170.31,-239.69]
Subtotal *** 2652   2518   100% -705[-1170.31,-239.69]
Heterogeneity: Not applicable  
Test for overall effect: Z=2.97(P=0)  
Test for subgroup differences: Chi2=12.65, df=1 (P=0.01), I2=76.29%  
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Case management approaches to home support for people with dementia (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
111
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Analysis 3.7.   Comparison 3 Case management versus usual care (secondary outcomes:
service use/cost ), Outcome 7 Health service use by carers (dichotomous outcomes).
Study or subgroup Case man-
agement
Control Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
3.7.1 Hospitalised during 3 years (number of carers)  
Newcomer - US 39/210 62/202 100% 0.51[0.33,0.81]
Subtotal (95% CI) 210 202 100% 0.51[0.33,0.81]
Total events: 39 (Case management), 62 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.84(P=0)  
   
3.7.2 Emergency department visits during 3 years (number of carers)  
Newcomer - US 51/210 72/202 100% 0.58[0.38,0.89]
Subtotal (95% CI) 210 202 100% 0.58[0.38,0.89]
Total events: 51 (Case management), 72 (Control)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.51(P=0.01)  
Test for subgroup differences: Chi2=0.13, df=1 (P=0.71), I2=0%  
Favours case management 1000.01 100.1 1 Favours control
 
 
Analysis 3.8.   Comparison 3 Case management versus usual care (secondary outcomes:
service use/cost ), Outcome 8 Health service use by carers (continuous outcomes).
Study or subgroup Case management Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
3.8.1 Annual hospital length of stay  
Newcomer - US 210 7.7 (5) 202 6.8 (6.6) 100% 0.9[-0.23,2.03]
Subtotal *** 210   202   100% 0.9[-0.23,2.03]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.56(P=0.12)  
   
3.8.2 Number of admissions over 12 months  
Newcomer - US 210 1.6 (2.1) 202 1.4 (1.5) 100% 0.15[-0.2,0.5]
Subtotal *** 210   202   100% 0.15[-0.2,0.5]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.84(P=0.4)  
   
3.8.3 Primary care physician over 12 months (number of consultations)  
Jansen - Netherlands 36 3.9 (4.5) 33 3.9 (14.8) 100% 0[-5.26,5.26]
Subtotal *** 36   33   100% 0[-5.26,5.26]
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
   
3.8.4 Outpatients geriatric/psychiatric team over 12 months (number of con-
sultations)
 
Jansen - Netherlands 36 0 (0.7) 33 0.8 (13.3) 100% -0.77[-5.33,3.79]
Subtotal *** 36   33   100% -0.77[-5.33,3.79]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.33(P=0.74)  
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Study or subgroup Case management Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
3.8.5 Medical specialist over 12 months (number of consultations)  
Jansen - Netherlands 36 1.8 (17.4) 33 1.7 (5.9) 100% 0.1[-5.93,6.13]
Subtotal *** 36   33   100% 0.1[-5.93,6.13]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.03(P=0.97)  
   
3.8.6 Physiotherapist over 12 months (number of consultations)  
Jansen - Netherlands 36 3.9 (41.5) 33 2.2 (17.1) 100% 1.7[-13.06,16.46]
Subtotal *** 36   33   100% 1.7[-13.06,16.46]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.23(P=0.82)  
Test for subgroup differences: Chi2=1.77, df=1 (P=0.88), I2=0%  
Favours case management 10050-100 -50 0 Favours control
 
 
Analysis 3.9.   Comparison 3 Case management versus usual care (secondary
outcomes: service use/cost ), Outcome 9 Informal caregiver time (hours).
Study or subgroup Favours case
management
Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
3.9.1 Paid unskilled at 6 months  
Vickrey - California 170 100.9
(511.9)
126 106 (4472) 100% -5.1[-789.73,779.53]
Subtotal *** 170   126   100% -5.1[-789.73,779.53]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.01(P=0.99)  
   
3.9.2 Unpaid unskilled at 6 months  
Vickrey - California 170 1811.8
(1778.9)
126 1781.1
(1845.4)
100% 30.7[-388.03,449.43]
Subtotal *** 170   126   100% 30.7[-388.03,449.43]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.14(P=0.89)  
Test for subgroup differences: Chi2=0.01, df=1 (P=0.94), I2=0%  
Favours case management 1000500-1000 -500 0 Favours control
 
 
Analysis 3.10.   Comparison 3 Case management versus usual care (secondary outcomes:
service use/cost ), Outcome 10 Medicare expenditures; community services usage in Dollars.
Study or subgroup Case man-
agement
Control Mean Dif-
ference
Mean Difference Weight Mean Difference
  N N (SE) IV, Fixed, 95% CI   IV, Fixed, 95% CI
3.10.1 At year 1  
Newcomer - US 5151 0 -229 (132.9) 100% -229[-489.48,31.48]
Subtotal (95% CI)       100% -229[-489.48,31.48]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.72(P=0.08)  
   
Favours case management 1000500-1000 -500 0 Favours control
Case management approaches to home support for people with dementia (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
113
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Study or subgroup Case man-
agement
Control Mean Dif-
ference
Mean Difference Weight Mean Difference
  N N (SE) IV, Fixed, 95% CI   IV, Fixed, 95% CI
3.10.2 At year 2  
Newcomer - US 0 0 17 (490.3) 100% 17[-943.97,977.97]
Subtotal (95% CI)       100% 17[-943.97,977.97]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.03(P=0.97)  
   
3.10.3 At year 3  
Newcomer - US 0 0 -325 (227.5) 100% -325[-770.89,120.89]
Subtotal (95% CI)       100% -325[-770.89,120.89]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.43(P=0.15)  
   
3.10.4 Over 3 years  
Newcomer - US 0 0 -167 (397.6) 100% -167[-946.28,612.28]
Subtotal (95% CI)       100% -167[-946.28,612.28]
Heterogeneity: Not applicable  
Test for overall effect: Z=0.42(P=0.67)  
Test for subgroup differences: Chi2=0.45, df=1 (P=0.93), I2=0%  
Favours case management 1000500-1000 -500 0 Favours control
 
 
Analysis 3.11.   Comparison 3 Case management versus usual care (secondary
outcomes: service use/cost ), Outcome 11 Cost of services (carers).
Study or subgroup Case management Control Mean Difference Weight Mean Difference
  N Mean(SD) N Mean(SD) Fixed, 95% CI   Fixed, 95% CI
3.11.1 Medicare Part A expenditure in comparison to control  
Newcomer - US 210 1123 (2910) 202 1804 (4210) 100% -681[-1382.4,20.4]
Subtotal *** 210   202   100% -681[-1382.4,20.4]
Heterogeneity: Not applicable  
Test for overall effect: Z=1.9(P=0.06)  
Favours case management 1000500-1000 -500 0 Favours control
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Reduce carer depression/strain/burden or improved carer mental health/quality of life ✓   ✓ ✓ ✓ ✓   ✓ ✓ ✓ ✓ ✓ ✓
Delay institutionalisation /prolong period of community care     ✓ ✓ ✓   ✓ ✓          
Increase early use of home care and other community services       ✓ ✓             ✓ ✓
Reduce number of neuropsychiatric symptoms/behavioural problems   ✓       ✓   ✓ ✓        
Improved quality of care of person with dementia   ✓           ✓   ✓     ✓
Improve quality of life of person with dementia                   ✓      
Initiate long-term planning early related to issues such as housing, finance, legal matters and care-giving support
and respite care
        ✓               ✓
Decrease service utilisation ✓                     ✓  
Improved carer sense of competence               ✓          
Increase carer satisfaction ✓                        
Table 1.   Goals of case management interventions 
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  Intervention Control group
Group A)  Studies where the case manager encourages self management of care/empowers carerto arrange own care where possible a
Bass - Ohio
 
Telephone-based coaching programme based on the Chronic Care Model. Care con-
sultants conducted a structured initial assessment and developed strategies for
using personal, family, and community resources.  They developed a care plan as-
signing participants, family members, or Association staJ/volunteers to work on
tasks within a time frame for task completion and reassessment. Tasks often in-
clude using other Association services, e.g. education, training programmes, sup-
port groups, a respite reimbursement programme, and a nationwide programme to
return wanderers safely home. Regular follow-ups (initially biweekly, then 1-month
and 3-month intervals) to monitor progress/add to care plan.
Participants and carers
were able to contact the
Association indepen-
dently and use any of its
services other than care
consultation. All Associ-
ation services were free
of charge.
Chien- Hong Kong
2008
 
Programme provided case management, occupational therapy, physical therapy,
social work, nursing, respiratory therapy, in-home respite, and out-of-home respite,
homemaking, personal care assistance, volunteer service and psychiatric consulta-
tion. The objectives of the programme were to assist the participants and family to:
1) initiate long-term planning early related to issues such as housing, finance, legal
matters and care-giving support; 2) increase early use of home care/other commu-
nity services; 3) improve coping strategies; 4) improve care-giving strategies. Goal:
to prepare participants and families for the crises during course of the disease.
6-month educational
sessions. Both groups
were provided with rou-
tine dementia care,
such as pharmacother-
apy and social and
recreational activities
for the participants and
written educational ma-
terials about dementia
care for the carers.
Chien - Hong Kong
2001
Case manager weekly home visits with family participants to conduct family health
and educational needs assessment and provide education about dementia care,
formulate an individualised education and support programme for effective demen-
tia care for each family. Seven major themes of family supportive care programmes
were used along with the results of a needs assessment: (1) information about the
participant’s condition, prognosis, and current treatment and care; (2) development
of social relationships with relatives and friends, extended social support network;
(3) sharing and adaptation of the emotional impact of care-giving; (4) learning about
self care and motivation; (5) interpersonal relationships between family members
and participant; (6) establishing support from community groups and healthcare re-
sources; and (7) improvement of home care and finance skills.
Services provided by
dementia resources
centres: (1) medical
consultation, advice
to family on condition,
treatment plan and ef-
fects of medications
(weekly visiting psychi-
atrist); (2) advice/re-
ferrals for financial
aid/social welfare ser-
vices (social worker);
(3) monthly education
talks in dementia care
(registered psychiatric
nurse); and (4) weekly
social and recreational
activities (staJ at cen-
tre).
Dias - Goa India
 
Flexible, stepped-care model primarily aimed at improving the awareness and
knowledge of carers regarding dementia, to provide emotional support to carers, to
maximise their care-giving resources and to improve care-giving skills.The health-
care advisor (acted as case manager) provided: basic education about dementia
and common behaviour problems/management, support to the carer, referral to
psychiatrists/family doctor when behaviour problems are severe/warrant medica-
tion intervention, networking of families to enable the formation of support groups,
advice regarding existing government schemes for elders.
After receiving only ed-
ucation and informa-
tion regarding demen-
tia, dyads were placed
on a waiting list to re-
ceive the intervention
after 6 months. Free
to utilise the existing
health services during
this time.
Group B) Studies where the case manager ensures appropriate delivery of services (short-term)
Table 2.   Intervention and control description 
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Hinchliffe - UK
 
The intervention group received an individualised care package for the carer and
the person with dementia, which considered medication (for managing verbal and/
or physical aggression, night disturbance, restlessness and sexual disinhibition);
psychological techniques (charts recording precipitants of aggressions, involving of
participants in pleasant activities, distraction techniques, etc) and social measures
(referral to day centre, respite for carers, application for benefits).
Waiting list controls re-
ceived a delayed inter-
vention package at 16
weeks
 
Lam - Hong Kong
 
Case management by a trained occupational therapist for 4 months. The CM offered
interventions in the following areas: 1) Assessment and advice: CM evaluated the ac-
tivities of daily living and neuropsychiatric symptoms of the demented person, and
carer distress in care duties. CM also advised carers and demented participants on
the following areas: safe performance in basic self-care activities with environmen-
tal modification to promote safe home living, behavioural management, and com-
munication techniques.
2) Home-based programme on cognitive stimulation: Participants with family car-
ers received training on home-based cognitive stimulation strategies which includ-
ed reading newspapers together, reminiscence by old-time photos (Lin 2003; Rentz
1995), and continued engagement in usual household tasks and leisure activities.
The cognitive stimulating programme was reinforced by home visits and telephone
calls as appropriate for 16 weeks. Afterward, family carers were encouraged to con-
tinue with the activities
3) Case management; CM provided support to carers and participants, home visits
initially, and later by telephone calls, and follow-up at hospital clinic visits. CM en-
couraged the participants to be registered with local social centres so that the fam-
ily could tap into the locally available social services. CM liaised with the staJ in the
social centres involved, to ensure smooth integration of the participants into the ac-
tivity schedule.
One home visit for
home safety by the
same occupational
therapist as interven-
tion group at the begin-
ning of the trial (no ac-
cess to case manage-
ment). Both groups fol-
lowed up at 3-month-
ly intervals in the psy-
chogeriatric or memory
clinics.
Group C) Studies where the case manager ensures appropriate delivery of services (longer-term)
Callahan - Indi-
anapolis
 
Collaborative care management: comprehensive screening and diagnosis pro-
gramme, care-giver education and support, 1-year care management led by nurse
practitioner working with carer and primary care physician. Access to primary care
clinic-specific care physician, enrolment in Alzheimer’s Association safe return pro-
gramme, dementia medication if appropriate. At each contact, care manager as-
sessed current problems using a symptom checklist. Based on current problems,
the care manager could activate standardised protocols for behavioural problems.
Protocols emphasised non-drug management. Approx 12 hours contact (50% face-
to-face) per year. Nurse care managers met with an interdisciplinary support team
weekly to review new and/or difficult participants. Participant’s progress was mon-
itored with a web-based longitudinal tracking system. Care manager served as an
ombudsman for participant’s other chronic conditions (navigating the health sys-
tem). Care manager provided regular updates and care suggestions to primary care
physicians. Participants and carers were provided with written educational materi-
als and face-to-face counselling by a geriatric nurse practitioner.
Augmented Usual care:
participants and car-
ers were provided with
written educational ma-
terials and face-to-face
counselling by a geri-
atric nurse practition-
er. Meeting between 40
and 90 minutes at pri-
mary care clinic. Writ-
ten materials describ-
ing local community re-
sources provided. Con-
trol primary care physi-
cians received written
notification of the par-
ticipant’s diagnosis
from the diagnostic as-
sessment. Referral to
community resources.
Chu - Canada The Early Home Care Program provided case management, occupational therapy,
physical therapy, social work, nursing, respiratory therapy, in-home respite, and
out-of-home respite, homemaking, personal care assistance, volunteer service and
psychiatric consultation. The objectives of the programme were to assist the par-
ticipants and family to: 1) initiate long-term planning early related to issues such as
housing, finance, legal matters and care-giving support; 2) increase the early use of
home care and other community services; 3) improve the coping strategies related
Participants were giv-
en an information pack-
age on community re-
sources.
Table 2.   Intervention and control description  (Continued)
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to psychosocial issues which often hinder long-term planning and service utilisa-
tion; and 4) improve care-giving strategies related to functional and behavioural dif-
ficulties of the individuals with AD. The goal was to prepare participants and fami-
lies for the crises that occur along the course of the disease
Eloniemi-Sulkava
2001 
Two-year intervention programme of systematic, comprehensive support by a de-
mentia family care co-ordinator who had access to the physician and co-ordinat-
ed the care, services, and support of the families. She provided advocacy for partic-
ipants and carers, comprehensive support for participants and carers, continuous
and systematic counselling, annual training courses for participants and carers, fol-
low-up calls, in-home visits, assistance with arrangements for social and healthcare
services and 24-hour-per-day availability by mobile telephone.
Participants received
the usual services pro-
vided for geriatric pa-
tients in community
care by the municipal
social and healthcare
system or the private
sector.
Eloniemi-Sulkava
2009
The core elements of the intervention consisted of a family care co-ordinator’s (FCC)
actions, a geriatrician’s medical investigations and treatments, goal-oriented sup-
port group meetings for spouse carers, and individual tailored services. The inter-
vention was initiated by a home visit from the FCC. Initial support plan. The visit was
followed by the geriatrician’s appointments and comprehensive geriatric assess-
ments and treatment for the participants with dementia and if requested also for
the carers. The intervention couples continued their own physician’s visits either in
primary care system or in private sector. The carers participated in 5 goal-oriented
peer support group meetings during the first follow-up year (7 - 10 participants in
7 groups). Three 2-hour dementia information sessions were arranged for the car-
ers and their interested family members. A large proportion of participants with de-
mentia received home-based exercise training according to individual assessment.
During the first year of the intervention 5 group meetings were arranged to support
dealing with challenging care-giving situations (e.g. behavioural and psychological
symptoms of dementia) at home. Setting: primary care.
Participants received
the usual services from
the municipal social
and healthcare system
and/or the private sec-
tor, depending on their
own initiative. Further-
more, the control fam-
ilies were provided in-
formation and refer-
rals to community re-
sources, written ed-
ucational materials,
and opportunities to
share experiences and
feelings with the study
nurse in baseline as-
sessments and at 6-
and 12-month study fol-
low-ups.
Jansen - Nether-
lands
 
The district nurse case managers made an initial home visit to conduct a structured
assessment (RAI-HC protocol) and develop a care plan based on protocols for 30
possible problems. This was followed up by a second home visit and provision of a
guide to available social and welfare services for carers, and then by further home
visits or telephone calls as considered necessary, but at least 3-monthly. Case man-
agers were available by telephone. They also made referrals to other healthcare
professionals and organised family meetings. They visited the primary care physi-
cians to inform them about the participant's and carer's situation.
Usual care: participants
could access a variety
of healthcare and wel-
fare services on their
own initiative, but had
no structured assess-
ment and care plan, no
access to family meet-
ings, and limited access
to the carers' guide.
Newcomer - US
 
Two case management models were implemented. Model A (low reimbursement
- high caseload) sites operated with a target case manager-to-client ratio of 1:100
and had a monthly community service reimbursement limit or cap from USD 290
through USD 489 per month per participant. Model A sites (Rochester, NY; Urbana,
IL; Memphis, TN; Portland, OR).
Model B (high reimbursement - low caseload) sites had a target case manager-to-
client ratio of 1:30 and a slightly higher reimbursement limit of from USD 430
through USD 699 per month per participant. Model B sites (Cincinnati, OH; Parkers-
burg, WV; Minneapolis, MN; Miami, FL). Case management was provided without
charge. Carer support services (subsidised: participants paid 20% of the price) in-
cluded education and training, support groups, mental health and counselling ser-
vices, and transportation to groups. Services reimbursed by the demonstration (in-
tervention) included adult day care, homemaker, housekeeping, general chore, per-
Participants received
usual care; this is not
described further.
Table 2.   Intervention and control description  (Continued)
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sonal care, minor home repairs, companion services, non-emergency transporta-
tion, adaptive and assistive equipment, consumable care goods, and safety modifi-
cations to the home.
Vickrey - Califor-
nia 
Intervention components based on the chronic care model, emphasized linkages
with community resources and multi-agency coordination. Dementia CMs - key
component along with formal procedures for communication within and between
organizations and agencies. This included adherence to 23 dementia guideline rec-
ommendations, Internet-based CM, collaborative care planning with carers, car-
er self-management support, ongoing follow-up, and provider education. The care
managers performed a structured home assessment, identified problems, initiated
care plan actions, and sent summary to primary care physician/ other designated
providers. CMs provided ongoing follow-up as needed, with in-home reassessments
every 6 months.
Care as usual (mean-
ing they continued to
receive care from their
usual providers) but
were not offered any of
the specialised demen-
tia care management.
Table 2.   Intervention and control description  (Continued)
a See Table 5 Typology of case management interventions in included studies
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Study Description/ conceptual
framework/
Pro-
tocol/
manual
Professional
group of case
manager or
equivalent
Mode of delivery De-
scribed
as case
or care
man-
age-
ment by
trialists
Dura-
tion
(months)
Intensi-
ty: case-
load size
Intensi-
ty: fre-
quency
of con-
tact per
month
Breadth
of case
man-
age-
ment
role
 
Group A)  Studies where the case manager encourages self management of care/empowers carerto arrange own care where possible a
Bass - Ohio
 
Telephone-based coach-
ing programme based on
Chronic Care Model (CCM)
✓ Care consul-
tants (CC) - so-
cial workers
Telephone ✓ 12 Approx
1: 40
1 or 2 A
Chien- Hong
Kong 2008
Dementia CM
programme/education and
support
group for carers
# Nurse Face-to-face visits, groups ✓ 6 - 2 A, B
Chien - Hong
Kong 2001
Dementia Family Care Pro-
gramme
# Nurse Face-to-face visits, tele-
phone, groups
✓ 6 - 2 A, B
Dias - Goa India Home-care support pro-
gramme for
carers
# Unqualified ad-
visor
Face-to-face visits, tele-
phone, groups
# 6 1:20 2+ A, B
Group B) Studies where the case manager ensures appropriate delivery of services (short-term)
Hinchliffe - UK Multi-disciplinary team in-
dividualised plan aiming to
reduce most distressing be-
haviours
# Psychiatrist Face-to-face visits # 4 1: ap-
prox 13
- 20
3 A, B, E
Lam - Hong
Kong
Case management model # Occupational
therapist
Face-to-face visits, tele-
phone
✓ 4 1:59 1 A, B, E
Group C) Studies where the case manager ensures appropriate delivery of services (longer term)
Callahan - Indi-
anapolis
CM by an inter-disciplinary
team led by an advanced
✓ Advanced prac-
tice nurse
Face-to-face visits,  groups ✓ 12 Est 1: <
40 (84
1.2  A, B
Table 3.   Case management intervention characteristics 
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practice nurse working with
the participant’s carer
between
2 CMs
2002 -
2004)
Chu - Canada CM within a comprehensive
home-care programme
# Social worker Face-to-face visits, tele-
phone, groups
✓ 18 - 1 A, B,C, E
Eloniemi-Sulka-
va 2001
Support programme based
on nurse case management
✓ Nurse Face-to-face visits, tele-
phone, groups
✓ Up to 24 - 1+ A, C, E
Eloniemi-Sulka-
va 2009
Multi-component interven-
tion programme including a
family care co-ordinator
✓ Nurse Face-to-face visits, tele-
phone, groups
# Up to 24 1:60 1+ A, B, D, E
Jansen -
Netherlands
Case management ✓ District nurse Face-to-face visits, tele-
phone, groups
✓ 12 - Varied
by case
manager
A, E
Newcomer - US CM and Medicare-sub-
sidised community services
? Social worker Face-to-face visits,
groups
✓ Not clear Model A
1:100;
Model B
1:30
? A, B, C,
D, E
Vickrey - Cali-
fornia
Disease management pro-
gramme led by CMs. com-
prehensive CM  base on CCM
✓ Social worker ? ✓ 18 1:50   A (pri-
mary
care), B,
C, E
 
Table 3.   Case management intervention characteristics  (Continued)
aSee Table 5 'Typology of case management interventions in included studies'
bBreadth of case management role: A: Co-ordination/liaison with outside services; B: Co-ordination/liaison within multi-disciplinary team; C: Manages care network; D: Case
manger holds case management budget; E: Arranges/allocates services
 c The 3 case managers spent a mean time of 10.8 hours (range 0.75 – 28 hours) a year per participant-carer dyad on the case management intervention. The nurses diJered in
mean time spent on the intervention per pair; nurse 1 spent 8.8 hours (range 2 – 26); nurse 2 spent 5.5 hours (range 0.75 – 15), and nurse 3 spent 15.2 hours (range 9.6 – 28); F
= 9.811, P < 0.001.
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  Bass
-
Ohio
Calla-
han
-
In-
di-
anapo-
lis
Chien-
Hong
Kong
2008
Chien
-
Hong
Kong
2001
Chu
-
Cana-
da
Dias
-
Goa
In-
dia
Elonie-
mi-Sulka-
va
2001
Elonie-
mi Sulka-
va
2009
Hinch-
liffe
-
UK
Jansen
-
Nether-
lands
Lam
-
Hong
Kong
New-
com-
er
-
US
Vick-
rey
-
Cal-
i-
for-
nia
CASE MANAGEMENT TASKS                          
Case finding/screening   ✓       ✓   ✓          
Assessment ✓ ✓ ✓ ✓ ✓   ✓ ✓ ✓ ✓ ✓ ✓ ✓
Financial assessment   ✓                   ✓  
Care planning ✓ ✓ ✓ ✓ ✓   ✓ ✓ ✓ ✓ ✓ ✓ ✓
Implementation/management of care plan ✓ ✓ ✓ ✓ ✓   ✓ ✓ ✓ ✓ ✓ ✓ ✓
Arranging/allocating services   ✓     ✓   ✓ ✓ ✓ ✓ ✓ ✓ ✓
Case budget management/budget holding               ✓       ✓  
Monitoring the implementation of the care plan ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓   ✓ ✓ ✓ ✓
Review ✓ ✓     ✓   ?         ? ✓
Case closure   ✓     ✓       ✓       ✓
                           
CASE MANAGEMENT COMPONENTS                          
Participant information and education ✓ ✓     ✓   ✓ ✓ ✓ ✓ ✓ ✓ ✓
Participant advocacy ✓       ✓   ✓ ✓     ✓   ✓
Pharmacy/medications review/management/
prescribing
  ✓       ✓ ✓ ✓ ✓   ✓   ✓
Legal/insurance/benefits/ financial assistance   ✓     ✓ ✓   ✓         ✓
Table 4.   Case management tasks and components 
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CM provides advice re: benefits, financial and legal issues
Provision of emotional/ therapeutic support ✓ ✓   ✓ ✓ ✓ ✓ ✓ ✓ ✓   ✓ ✓
Counselling/therapy         ✓ ✓ ✓ ✓       ✓ ✓
Carer education ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Table 4.   Case management tasks and components  (Continued)
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  Case manager encour-
ages self
management of care/
empowers
carerto arrange own
care
where possible
Case manager
ensures appro-
priate
delivery of ser-
vices
(short-term)
Case manager
ensures appro-
priate
delivery of ser-
vices
(longer-term)
Bass - Ohio; ✓    
Callahan - Indianapolis;     ✓
Chien- Hong Kong 2008; ✓    
Chien - Hong Kong 2001; ✓    
Chu - Canada;     ✓
Dias - Goa India; ✓    
Eloniemi-Sulkava 2001;     ✓
Eloniemi-Sulkava 2009;     ✓
Hinchliffe - UK;   ✓  
Jansen - Netherlands;     ✓
Lam - Hong Kong;   ✓  
Newcomer - US;     ✓
Vickrey - California     ✓
Table 5.   Typology of case management interventions in included studies 
 
 
Outcome Studies re-
porting out-
comes
Name of
Measure /
Source
Description of validated measures used to assess outcomes
Jansen -
Netherlands
Dementia
Quality of
Life
(DQOL)
Brod 1999
The DQOL instrument was developed to assess direct subjective individual experi-
ence explicitly and the scale measures 5 domains: positive affect (6 items), negative
affect (11 items), feelings of belonging (2 items), self esteem (4 items), sense of aes-
thetics (5 items) and a global quality of life rating. The scores are calculated for each
subscale with no overall score. Each item is scored on a 5-point scale, with higher
scores indicating higher quality of life.
Participant
quality of
life
Vickrey - Cal-
ifornia
Health Util-
ities Index
Mark 3,
(HUI3)
The HUI3 is a comprehensive health status classification and health state preference
system, which calculates the desirability or preference for each health state. The
HUI3 health status classification system assesses capacity on 8 dimensions or at-
tributes: vision, hearing, speech, ambulation, dexterity, emotion, cognition (includ-
ing memory and thinking ability), and pain or discomfort. The utility function repre-
Table 6.   Outcome measures from the included studies entered into Review Manager 5 
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Torrance
1996;
Neumann
2000
sents community preferences and scores each unique health state on a scale where
'dead' has a score of 0 and 'perfect health' has a score of 1. Because this score cap-
tures overall morbidity, it can be interpreted as a measure of health-related quali-
ty of life; referred to as the ‘global utility score’. For each attribute, level 1 indicates
full capacity and levels 5 or 6 indicate the lowest capacity. The single-attribute utili-
ty functions provide utility scores for each level with scores ranging between 0 and
1; these scores provide a measure of attribute-specific morbidity.
Lam - Hong
Kong
Personal
Well-being
Index for
Adults
(PWI-A)
Lau 2005,
Lau 2006
The Personal Well-Being Index-Intellectual Disability (PWI-ID): This is a parallel form
of the original adult PWI (a generic and cross-cultural instrument which was adopt-
ed to measure subjective quality of life) designed for use with people who have cog-
nitive impairment PWI-ID (Cummins 2005a; Cummins 2005). A main unique fea-
ture of the ID version is the incorporation of a standardised pretest for determining
the ability of the respondent to cope with testing demands of the PWI. The PWI-ID
demonstrates satisfactory psychometric performance in validation studies conduct-
ed with a wider range of cognitively impaired populations including dementia (Lau
2006). The instrument contains 7 items which ask how satisfied people are with 7
life domains. A 0 - 10 rating scale on satisfaction is used.
Chu - Cana-
da;
Elonie-
mi-Sulkava
2001
Mini Mental
State Exami-
nation
(MMSE)
Folstein 1975
The MMSE is a widely-used screening instrument of cognitive function, which as-
sesses the major cognitive domains affected in Alzheimer’s Disease. It consists of a
brief standardised test of cognitive function that measures orientation, memory and
attention. There is a maximum score of 30, with scores of 0 - 10 commonly described
as severe dementia, 11 - 20 as moderate dementia, and 21 - 24 as mild dementia.
Chien- Hong
Kong 2008
Chien - Hong
Kong 2001
Lam - Hong
Kong
MMSE (Can-
tonese ver-
sion)
Chiu 1994
Chiu 1998
The MMSE translated into Cantonese. As there is a high level of illiteracy among the
Hong Kong elderly with cognitive impairment, a cut-oJ point of ≤ 18 is recommend-
ed for elderly people who are illiterate, ≤ 20 for those with 1 - 2 years of schooling,
and ≤ 22 for those with more than 2 years of education.
Participant
cognition
Callahan - In-
dianapolis
Telephone
Interview for
Cognitive
Status
(TICS)
Brandt 1988
The TICS-M is a brief, 13-item test of cognitive functioning with scores ranging from
0 - 50. Questions include orientation, repetition, naming, and calculations. A 10-item
non-semantically-related word list is recalled both immediately and after a delay of
about 5 minutes filled with distractor questions. Past research has demonstrated
that the TICS-M is as reliable and valid as face-to-face administration. Cut-oJ scores
range from 27 - 30.
Callahan - In-
dianapolis
Chien- Hong
Kong 2008
Chien - Hong
Kong 2001
Dias - Goa In-
dia Elonie-
mi-Sulkava
2009
Neuropsy-
chiatric In-
ventory
(NPI)
Cummings
1994
Cummings
1998
The NPI measures psychopathology in people with dementia and assesses 12 neu-
ropsychiatric symptoms common in dementia: delusions, hallucinations, agita-
tion/aggression, depression/dysphoria, anxiety, apathy/indifference, irritability, ela-
tion/euphoria, disinhibition, aberrant motor behaviour, sleep disturbance and ap-
petite. Where positive responses are given to the screening questions, the frequen-
cy (score 1 - 4) and severity (score 1 - 3) of the behaviour is rated, and these are mul-
tiplied to give a score for each symptom. The NPI calculates scores for the individ-
ual symptom domains and an overall total NPI score, which is scored between 0 and
144. Higher scores indicate increasing severity of behaviour symptoms.
Participant
behaviour
Lam - Hong
Kong
Neuropsy-
chiatric In-
ventory/Chi-
nese version
The Chinese version of the NPI. The NPI with Caregiver Distress Scale is as described
above, plus an additional question for each domain which measures the level of dis-
tress caused to carers for each behaviour present (Kaufer 2000).
Table 6.   Outcome measures from the included studies entered into Review Manager 5  (Continued)
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(NPI)
Leung 2001
Chu - Cana-
da
Revised
Memory &
Behaviour
Checklist
(MBPC)
Teri 1992
Zarit 1983b
The Memory & Behaviour Checklist (MBPC) is a 64-item carer-report measure of ob-
servable behavioural problems in the loved one with dementia (Teri 1992). It pro-
vides a total score plus scores for 3 subscales: Memory-Related Problems, Affective
Distress, and Disruptive Behaviours. Scores are computed for the presence/absence
of each problem first, and then for carer "reaction" or the extent to which carers
were “bothered” or “distressed” by each behaviour. The questions derived from 2
sources: (a) 30 items from Zarit 1983a; Zarit 1986, and Zarit 1987) and (b) 34 items
developed by the authors to include specific behaviours not assessed on the MBPC
and thought to be easily observable and representative of memory-related prob-
lems (e.g. asking repeated questions), depression (e.g., crying), and disruptive be-
haviours (e.g. verbal aggression) in people with dementia. The carer's reaction to
each behaviour, or the extent of distress experienced, were scored as follows: Reac-
tions are assessed by asking how ”upsetting” the behaviour was on a scale of 0 to 4
(0 = Not at all, through to 4 = extremely). Frequency of behaviours is assessed based
on a scale of 0 to 4 (0 = never occurs, through to 4 = occurs daily or more often).
Callahan - In-
dianapolis
Lam - Hong
Kong
Cornell Scale
for Depres-
sion in De-
mentia
(CDSS)
Alexopoulos
1988
An assessment of depression in people with dementia. Depressive signs and symp-
toms are divided into 5 categories in the Cornell scale: mood-related signs: behav-
ioural disturbance; physical signs; cyclic functions; ideational disturbance. There
are 19 items rated on a 3-point scale ranging from absent (0); mild or intermittent
(1); severe (2), with a total score of 8 and over indicating significant depressive
symptoms.
Participant
depression/
mood
Chu - Cana-
da
Geriatric
Depression
Scale
(GDS)
Yesavage
1983a
The GDS is a screening tool for detecting depression in older people, with a predom-
inant focus on the thought processes and emotional symptoms of depressive ill-
ness. There are 15 items and each question has a Yes/No answer. Higher scores indi-
cate greater depressive symptoms and a cut oJ of 6 - 7 indicates depressive illness.
Callahan - In-
dianapolis
Alzheimer’s
Disease Co-
operative
Study / Activ-
ities of Daily
Living Inven-
tory
(ADCS-ADL)
Galasko 1997
The ACDS-ADL evaluates individual performance and autonomy in activities of daily
living, either basic or instrumental. The 23 items measure informant-based observa-
tion of actions or behaviour related to eating, walking, toileting, bathing, grooming,
dressing, telephone use, watching television, conversation, clearing dishes from a
table, finding belongings, preparing food and drinks, garbage disposal, travel, shop-
ping, keeping appointments, being leV alone, knowledge of current events, read-
ing, writing, participation in hobbies, using household appliances. Items 1 - 5 (eat-
ing, walking, toileting, bathing, grooming) provide a choice of best response and
the remaining items consist of a either a yes, no or don't know response followed by
sub-questions, e.g. did the patient select their first set of clothes for the day? If yes,
which best describes their usual performance: 3. without supervision or help; 2. with
supervision; 1. with physical help. The ADCS-ADL can be used to determine levels of
functional ability across the range of dementia severity, which is scored between 0
and 78. Higher scores indicate better functioning with a score of 78 indicating full
function.
Participant
function/
dependency
Dias - Goa In-
dia
Everyday
Abilities
Scale for In-
dia (EASI)
The EASI Scale is a brief 12-item informant-based ADL scale that measures function-
al ability. The scale which was developed for the illiterate elderly population in rural
India covers mobility, instrumental and personal care activities. Responses are cod-
ed 'could' (0) or 'could not' (1). A higher score indicates greater disability.
Table 6.   Outcome measures from the included studies entered into Review Manager 5  (Continued)
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Fillenbaum
1999
Elonie-
mi-Sulkava
2009
Activities of
Daily Living
(Barthel)
Mahoney
1965
There are 10 items which cover eating, mobility, personal hygiene and continence,
which are graded 0, 5 or 10. The scale provides an indication of the dependency of
the person and their need for assistance with individual tasks. ADL needs are ranked
from 0 (very dependent) to 100 (independent). Higher scores indicate better func-
tional ability.
Chu - Cana-
da
Dias - Goa In-
dia
Elonie-
mi-Sulkava
2009
Lam - Hong
Kong
Newcomer -
US
Zarit burden
Interview
scale
(ZBI)
Zarit 1980
Zarit 1983a
Zarit 1986
The ZBI measures subjective burden among carers of adults with dementia. The 22-
item self-report inventory that assesses the level of burden associated with func-
tional/behavioural impairments and the home-care situation. Each item is scored
on a 5-point scale. Response options range from 0 (Never) to 4 (Nearly Always). Total
scores range from 0 (low burden) to 88 (high burden).
Chien- Hong
Kong 2008
Chien - Hong
Kong 2001
Family Care-
giving Bur-
den Invento-
ry
(FCBI)
Chou 2002
The FCBI is a 24-item scale measuring the impact of the burden on carers of cogni-
tively-impaired older people. The multidimensional instrument assesses 5 domains
of burden (time-dependence, developmental, physical, social, and emotional). The
Chinese version of the FCBI was translated and validated by Chou 2002. Items are
rated on a 5-point Likert scale from 0 (totally disagree) to 4 (totally agree). The total
burden score ranges from 0 to 96, with a higher score indicating greater burden.
Carer
burden
Jansen -
Netherlands
Self-Per-
ceived Pres-
sure by Infor-
mal care
(SPPIC)
Pot 1995
The SPPIC is a 9-item self-report Rasch scale that measures self-perceived pressure
from informal care. Items are scored on a 5-point scale: 1 'no!', 2 'no', 3 'more or less',
4 'yes', 5 'yes!'. To score the SPICC, item-scores are dichotomised and summed sub-
sequently. Scores 1 and 2 are recoded into 0 (i.e. not perceiving pressure) and scores
3, 4 and 5 are recoded into 1 (i.e. perceiving pressure). Scores range from 0 to 9 with
higher scores indicating more pressure.
Callahan - In-
dianapolis
Chu - Cana-
da
Dias - Goa In-
dia
Neuropsy-
chiatric In-
ventory
Caregiv-
er Distress
Scale
Cummings
1994
Kaufer 1998
Kaufer 2000
The Caregiver Distress component of the NPI as described above. This comprises
an additional question on each domain which measures the level of distress caused
to carers by each behaviour. Carers are asked ‘How emotionally distressing do you
find this behaviour?’. Items are scored 0 'not at all' through to 5 'very severely or ex-
tremely'. Higher scores indicate greater carer distress.
Carer
distress
Chu - Cana-
da
Revised
Memory &
Behaviour
Checklist
The Memory & Behaviour Checklist (MBPC) is a 64-item carer-report measure of ob-
servable behavioural problems in the loved one with dementia (Teri 1992). It pro-
vides a total score plus scores for 3 subscales: Memory-Related Problems, Affective
Distress, and Disruptive Behaviours. Scores are computed for the presence/absence
Table 6.   Outcome measures from the included studies entered into Review Manager 5  (Continued)
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(MBPC)
Teri 1992
Zarit 1983b
of each problem first, and then for carer "reaction" or the extent to which carers
were “bothered” or “distressed” by each behaviour. The questions derived from 2
sources: (a) 30 items from Zarit 1983a; Zarit 1986, and Zarit 1987) and (b) 34 items
developed by the authors to include specific behaviours not assessed on the MBPC
and thought to be easily observable and representative of memory-related prob-
lems (e.g. asking repeated questions), depression (e.g., crying), and disruptive be-
haviours (e.g. verbal aggression) in people with dementia. The carer's reaction to
each behaviour, or the extent of distress experienced, were scored as follows: Reac-
tions are assessed by asking how ”upsetting” the behaviour was on a scale of 0 to 4
(0 = Not at all, through to 4 = extremely). Frequency of behaviours is assessed based
on a scale of 0 to 4 (0 = never occurs, through to 4 = occurs daily or more often).
Callahan - In-
dianapolis
Patient
Health Ques-
tionnaire-9
(PHQ-9)
Kroenke
2001
The PHQ-9 is the 9-item depression scale of the Patient Health Questionnaire. There
are 2 components of the PHQ-9: assessing symptoms and functional impairment
for diagnosing depression, and deriving a severity score to help select and moni-
tor treatment. The PHQ-9 is based directly on the diagnostic criteria for major de-
pressive disorder and scores each of the 9 DSM-IV criteria as 0 (not at all) to 3 (nearly
every day). The score is the sum of the 9 items. A score of 15 or greater is considered
major depression, 20 or more indicates severe major depression.
Chu - Cana-
da
Jansen -
Netherlands
Centre for
Epidemio-
logical stud-
ies Depres-
sion scale
(CES-D)
RadloJ 1977
RadloJ 1986
The CES-D is a 20-item self-report scale for assessing depressive symptoms. The
questions ask the person to describe how often they had depressive symptoms over
the past week. Items are rated on a 4-point scale from 0 'rarely or none of the time'
to 3 'most or all of the time'. Scores range from 0 to 60, and a cut-oJ score of 16 in-
dicates mild depression, with a score of 23 and above indicating significant depres-
sion. It takes 5 minutes to complete.
Bass - Ohio Centre for
Epidemio-
logical stud-
ies Depres-
sion
(CES-D mod-
ified)
Kohout 1993.
RadloJ 1977
The study used a subset of items from the CES-D scale to measure carer mood. Two
items from the short CES-D, reflecting the interpersonal domain (i.e. ‘people dis-
like me’ and ‘people were unfriendly to me’), were omitted, due to concerns about
the cultural variation in the meaning among Hispanic respondents. Two other items
from the full CES-D are used as substitutes (i.e. "bothered by things that don’t usual-
ly bother me’’ and ‘‘trouble keeping your mind on what you were doing’).
Carer
mood
Newcomer -
US
Geriatric
Depression
Scale
(GDS)
Yesavage
1983b
A screening tool for detecting depression in older people, with a predominant focus
on the thought processes and emotional symptoms of depressive illness. There are
15 items and each question has a Yes/No answer. Higher scores indicate greater de-
pressive symptoms and a cut oJ of 6 - 7 indicates depressive illness.
Carer
Quality of
Life
Chien- Hong
Kong 2008
Chien - Hong
Kong 2001
World Health
Organization
Quality of
Life
(WHO-
QoL-BREF)
The WHOQoL-BREF was modified from the WHOQoL-100 by the World Health Orga-
nization (1995) and translated into Chinese by Leung 1997. The 28-item Chinese ver-
sion is a rigorously-tested culturally valid quality of life instrument. Items are struc-
tured in 4 domains: physical health, psychological, social relationship, and environ-
ment (i.e. 7 items for each subscale). They are rated on a 5-point Likert scale, with a
total score range 28 - 144. High scores indicate better quality of life.
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Leung 1997
Jansen -
Netherlands
Short Form
36-item
health sur-
vey
(SF-36)
McHorney
1993
The SF-36 short form health survey is composed of 36 questions and standardised
response choices, organised into 8 multi-item scales. Besides, 2 summary scales,
the Physical Component Summary (PCS) measure and the Mental Component Sum-
mary (0 - 100) and physical component (0 - 100) of the Medical Outcomes Study
(MOS) 36-item (MCS) measure can be calculated. Only the MCS is used for this study.
Higher scores indicate higher levels of functioning or well-being.
Vickrey - Cal-
ifornia
EuroQol 5-
Dimensions
(EQ-5D)
Kind 1996
EuroQol
1990
A generic Quality of Life utility scale used as a measure of health outcome (EuroQol
1990). Applicable to a wide range of health conditions and treatments, the EQ-5D
provides a simple descriptive profile and a single index value for health status. The
EQ-5D is designed for self completion by respondents and is ideally suited for use in
postal surveys, in clinics and face-to-face interviews. It is cognitively simple, taking
only a few minutes to complete.
Lam - Hong
Kong
Personal
Well-being
index for
adults
(PWI-A)
Lau 2005
Lau 2006
As detailed above for patient quality of life, but used to assess the carer’s quality of
life.
Dias - Goa In-
dia
Lam - Hong
Kong
General
Health Ques-
tionnaire
12-item
(GHQ-12)
Goldberg
1979
A measure of psychological well-being designed for use in community settings.
Completed as a self-report measure, the GHQ assesses and identifies increased risk
for psychiatric disorder. Derived from the original 60-item version of the GHQ, the
GHQ-12 and GHQ-28 scales are used mainly for research purposes and comprise
questions related to: somatic symptoms, anxiety and insomnia, social dysfunction,
and severe depression. Statements related to possible changes in the participant's
psychological state are scored as 0 'not at all', 1 'no more than usual', 2 'rather more
than usual', 3 'much more than usual'. Lower scores indicate better health status.
Carer well-
being
Hinchliffe -
UK
General
Health Ques-
tionnaire
28-item
(GHQ-28)
Goldberg
1979
The 28-item version of the GHQ as detailed above.
Carer
social sup-
port
Chien- Hong
Kong 2008
Chien - Hong
Kong 2001
6 item So-
cial support
question-
naire
(SSQ6)
Sarason
1987
A 6-item Social Support Questionnaire (SSQ6) developed to measure satisfaction
with social support available in their immediate social environment. The items are
rated on a 6-point Likert scale, with higher total scores (0 - 30) indicating more satis-
faction with the available social support. The Chinese version (translated by Chang
1999) indicated satisfactory content validity by expert review and internal consis-
tency (0 - 90 for overall scale) in Chinese families of people with mental illness.
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Vickrey - Cal-
ifornia
Medical Out-
comes Study
(MOS) Social
Support Sur-
vey
Sherbourne
19911
Stewart 1988
Social support was measured using a 2-item scale derived from the Medical Out-
comes Study Social Support Survey, which assesses satisfaction with and availabil-
ity of support over the previous 4 weeks. Social support scores range from 0 - 100
and a higher score indicate more support.
Patient sat-
isfaction
Bass - Ohio Kaiser man-
aged care
services
Satisfaction with quality of Kaiser services comprises 6 items. Factor and reliability
analyses confirm these items form a single dimension representing service satisfac-
tion. This includes:
• I get excellent care• Care for me is done in a rushed way (scoring for this question is reversed)• I get good information about how to care for my health problems• Help for me is given in a caring way• Help for me is provided in a knowledgeable way• I do not get enough support for my health problems (scoring for this question is
reversed)
Bass - Ohio Kaiser man-
aged care
services
Satisfaction with the quality of Kaiser services was measured and comprises 3 sec-
tions which include: satisfaction with types of services, satisfaction with quality of
services and satisfaction with information.
Carer satis-
faction
Callahan - In-
dianapolis
Single Ques-
tion
'Over the last 3 months, how would you rate the quality of care [the participant] has
received over all from the primary care clinic?'
Table 6.   Outcome measures from the included studies entered into Review Manager 5  (Continued)
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Source Search strategy Hits retrieved (in
the February 2012
search)
1. ALOIS
(www.medi-
cine.ox.ac.uk/alois)
"Case Management" OR "care management" OR "multi-component" 31
2. MEDLINE In-
process and oth-
er non-indexed
citations and
MEDLINE 1950-
present (Ovid SP)
1. exp Dementia/
2. Dementia, Multi-Infarct/
3. Dementia, Vascular/
4. Alzheimer Disease/
5. Lewy Body Disease/
6. Delirium/
7. Huntington Disease/
404
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8. "Pick Disease of the Brain"/
9. Kluver-Bucy Syndrome/
10. Wernicke Encephalopathy/
11. Creutzfeldt-Jakob Syndrome/
12. Delirium, Dementia, Amnestic, Cognitive Disorders/
13. dement*.mp.
14. Alzheimer*.mp.
15. (lewy* adj2 bod*).mp.
16. deliri*.mp.
17. ((cognit* or memory* or mental*) adj3 (declin* or impair* or los* or deteriorat*)).mp.
18. (chronic adj2 cerebrovascular).mp.
19. ("organic brain disease" or "organic brain syndrome").mp.
20. "supranuclear palsy".mp.
21. ("normal pressure hydrocephalus" and "shunt*").mp.
22. "benign senescent forgetfulness".mp.
23. (cerebr* adj2 deteriorat*).mp.
24. (cerebral* adj2 insufficient*).mp.
25. (confusion* or confused).mp.
26. (pick* adj2 disease).mp.
27. (creutzfeldt or jcd or cjd).mp.
28. huntington*.mp.
29. binswanger*.mp.
30. korsako*.mp.
31. (mci or "subjective memory complaint" or "episodic memory").mp.
32. ("incipient dementia" or "pre-clinical ad" or "pre-clinical alzheimer*").mp.
33. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18
or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32
34. Patient Care Management/
35. "Case manag*".ti,ab.
36. Case Management/
37. Managed Care Programs/
38. "Managed care".ti,ab.
39. "Care pathway".ti,ab.
40. Outreach.ti,ab.
41. "Crisis resolution".ti,ab.
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42. Disease Management/
43. "Disease management".ti,ab.
44. Intermediate Care Facilities/
45. Care coordination.ti,ab.
46. Community mental health.ti,ab.
47. Community Mental Health Services/
48. Community Mental Health Centers/
49. Home Nursing/
50. Health Services for the Aged/
51. "Geriatric health service*".ti,ab.
52. Home Care Services/
53. Patient Care Team/
54. Admiral nursing.ti,ab.
55. (carer* or caregiver*).mp. adj2 support.ti,ab.
56. Family-based therapy.ti,ab.
57. or/34-56
58. randomized controlled trial.pt.
59. controlled clinical trial.pt.
60. (Randomized or randomised).ti,ab.
61. Randomly.ti,ab.
62. Comparative Study/
63. "Interrupted time series".ti,ab.
64. "ITS design".ti,ab.
65. Intervention*.ti,ab.
66. Evaluat*.ti,ab.
67. Placebo*.ti,ab.
68. Groups.ti,ab.
69. or/58-68
70. 69 and 57 and 33
71. (2010* or 2011* or 2012*).ed.
72. 70 and 71
3. EMBASE
1980-2012 week 5
(Ovid SP)
1. exp dementia/
2. exp multiinfarct dementia/
3. exp multiinfarct dementia/
211
  (Continued)
Case management approaches to home support for people with dementia (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
132
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
4. exp Alzheimer disease/
5. exp diffuse Lewy body disease/
6. exp Huntington chorea/
7. exp Pick presenile dementia/
8. exp Kluver Bucy syndrome/
9. Wernicke encephalopathy/
10. Creutzfeldt Jakob disease/
11. dement*.mp.
12. Alzheimer*.mp.
13. (lewy* adj2 bod*).mp.
14. deliri*.mp.
15. ((cognit* or memory* or mental*) adj3 (declin* or impair* or los* or deteriorat*)).mp.
16. (chronic adj2 cerebrovascular).mp.
17. ("organic brain disease" or "organic brain syndrome").mp.
18. "supranuclear palsy".mp.
19. ("normal pressure hydrocephalus" and "shunt*").mp.
20. "benign senescent forgetfulness".mp.
21. (cerebr* adj2 deteriorat*).mp.
22. (creutzfeldt or jcd or cjd).mp.
23. huntington*.mp.
24. binswanger*.mp.
25. korsako*.mp.
26. (mci or "subjective memory complaint" or "episodic memory").mp.
27. ("incipient dementia" or "pre-clinical ad" or "pre-clinical alzheimer*").mp.
28. or/1-27
29. "old* people".ti,ab.
30. Elder*.ti,ab.
31. Aging/
32. or/29-31
33. Patient Care/
34. "Case manag*".ti,ab.
35. "Care manag*".ti,ab.
36. Case Management/
37. "Managed care".ti,ab.
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38. "Care pathway".ti,ab.
39. Outreach.ti,ab.
40. Crisis Intervention/
41. "Crisis resolution".ti,ab.
42. "Disease management".ti,ab.
43. Disease Management/
44. "Intermediate care facilit*".ti,ab.
45. "Care coordination".ti,ab.
46. "Community mental health".ti,ab.
47. Community Mental Health Services/
48. Mental Health Services/
49. Community Mental Health Centers/
50. Home Care Services/
51. "Geriatric care".ti,ab.
52. "Home care servic*".ti,ab.
53. "Patient care team".ti,ab.
54. "Admiral nursing".ti,ab.
55. (carer* or caregiver*).mp. and support.ti,ab. [mp=title, abstract, subject headings,
heading word, drug trade name, original title, device manufacturer, drug manufacturer,
device trade name, keyword]
56. "Family-based therapy".ti,ab.
57. or/33-56
58. Randomized Controlled Trial/
59. Double-Blind Method/
60. Single-Blind Method/
61. Random*.ti,ab.
62. Cross-Over Studies/
63. (time adj series).ti,ab.
64. "ITS design".ti,ab.
65. Intervention*.ti,ab.
66. Evaluat*.ti,ab.
67. Compar*.ti,ab.
68. ("pre test" or pretest or "post test" or posttest).ti,ab.
69. "control group".ab.
70. or/58-69
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71. 28 and 32 and 57 and 70
72. (2010* or 2011* or 2012*).em.
73. 71 and 72
4. PSYCINFO
1806-February
week 5 2012 (Ovid
SP)
1. exp Dementia/
2. Vascular Dementia/
3. exp Alzheimers Disease/
4. Dementia with Lewy Bodies/
5. Delirium/
6. exp Huntingtons Disease/
7. Picks Disease/
8. Kluver Bucy Syndrome/
9. Wernickes Syndrome/
10. Creutzfeldt Jakob Syndrome/
11. Cognitive Impairment/
12. dement*.mp.
13. Alzheimer*.mp.
14. (lewy* adj2 bod*).mp.
15. deliri*.mp.
16. ((cognit* or memory* or mental*) adj3 (declin* or impair* or los* or deteriorat*)).mp.
17. (chronic adj2 cerebrovascular).mp.
18. ("organic brain disease" or "organic brain syndrome").mp.
19. "supranuclear palsy".mp.
20. ("normal pressure hydrocephalus" and "shunt*").mp.
21. "benign senescent forgetfulness".mp.
22. (cerebr* adj2 deteriorat*).mp.
23. (cerebral* adj2 insufficient*).mp.
24. (confusion* or confused).mp.
25. (pick* adj2 disease).mp.
26. (creutzfeldt or jcd or cjd).mp.
27. huntington*.mp.
28. binswanger*.mp.
29. korsako*.mp.
30. (mci or "subjective memory complaint" or "episodic memory").mp.
31. ("incipient dementia" or "pre-clinical ad" or "pre-clinical alzheimer*").mp.
147
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32. or/1-31
33. Patient care/
34. "Case manag*".ti,ab.
35. "Care manag*".ti,ab.
36. Case management/
37. "Managed care".ti,ab.
38. "Care pathway".ti,ab.
39. Outreach.ti,ab.
40. Crisis intervention/
41. "Crisis resolution".ti,ab.
42. Disease management/
43. "Intermediate care facilit*".ti,ab.
44. "Care coordination".ti,ab.
45. Community mental health services/
46. "Community mental health".ti,ab.
47. Community mental health nursing/
48. "Home care servic*".ti,ab.
49. "Admiral nursing".ti,ab.
50. ((carer* or caregiver*) adj2 support).ti,ab.
51. "Family-based therapy".ti,ab.
52. or/33-51
53. exp Clinical Trials/
54. "Randomi?ed controlled trial*".ti,ab.
55. Random*.ti,ab.
56. (time adj series).ti,ab.
57. "ITS design".ti,ab.
58. Intervention*.ti,ab.
59. Evaluat*.ti,ab.
60. Posttesting/ or Pretesting/
61. or/53-60
62. 32 and 52 and 61
63. (2010* or 2011* or 2012*).up.
64. 62 and 63
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5. CINAHL (EBSCO-
host)
S1 (MH "Dementia+")
S2 (MH "Delirium") or (MH "Delirium, Dementia, Amnestic, Cognitive Disorders")
S3 (MH "Wernicke's Encephalopathy")
S4 TX dement*
S5 TX alzheimer*
S6 TX lewy* N2 bod*
S7 TX deliri*
S8 TX chronic N2 cerebrovascular
S9 TX "organic brain disease" or "organic brain syndrome"
S10 TX "normal pressure hydrocephalus" and "shunt*"
S11 TX "benign senescent forgetfulness"
S12 TX cerebr* N2 deteriorat*
S13 TX cerebral* N2 insufficient*
S14 TX pick* N2 disease
S15 TX creutzfeldt or jcd or cjd
S16 TX huntington*
S17 TX binswanger*
S18 TX korsako*
S19 TX mci or "subjective memory complaint" or "episodic memory"
S20 TX "incipient dementia" or "pre-clinical ad" or "pre-clinical alzheimer*"
S21 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 or
S15 or S16 or S17 or S18 or S19 or S20
S22 (MH "Patient Care")
S23 AB "Case manag*"
S24 TX Care manag*
S25 (MH "Case Management")
S26 TX "Managed care"
S27 TX "Care pathway"
S28 TX Outreach
S29 TX Crisis intervention
S30 (MH "Crisis Intervention")
S31 TX "Crisis resolution"
S32 (MH "Disease Management")
S33 TX "Intermediate care facilit*"
286
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S34 TX "Care coordination"
S35 (MH "Community Mental Health Services")
S36 TX "Community mental health"
S37 (MH "Community Mental Health Nursing")
S38 (MH "Home Health Care")
S39 (MH "Home Nursing")
S40 (MH "Gerontologic Care")
S41 TX "Home care servic*"
S42 (MH "Multidisciplinary Care Team")
S43 TX "Admiral nursing"
S44 TX "carer* support" or "caregiver support"
S45 TX "Family-based therapy"
S46 S23 or S24 or S25 or S26 or S27 or S28 or S29 or S30 or S31 or S32 or S33 or S34 or S35
or S36 or S37 or S38 or S39 or S40 or S41 or S42 or S43 or S44 or S45
S47 (MH "Clinical Trials")
S48 TX Random*
S49 (MH "Double-Blind Studies") or (MH "Single-Blind Studies")
S50 (MH "Comparative Studies")
S51 TX "time series"
S52 TX ITS design
S53 TX Intervention*
S54 TX Evaluat*
S55 (MH "Pretest-Posttest Design") or (MH "Pretest-Posttest Control Group Design") or
(MH "Crossover Design")
S56 S48 or S49 or S50 or S51 or S52 or S53 or S54 or S55
S57 S21 and S46 and S56
S58 EM 2010
S59 EM 2011
S60 EM 2012
S61 S58 or S59 or S60
S62 S57 and S61
6. Web of Science
(1945-present): ISI
Web of Knowledge
Topic=("Patient Care" OR "Case manag*" OR "Care manag*" OR "Managed care" OR "Care
pathway" OR Outreach OR "Crisis intervention" OR "Crisis Intervention" OR "Crisis resolu-
tion" OR "Disease Management" OR "Intermediate care facilit*" OR "Care coordination"
OR "Home Health Care" OR "Home Nursing" OR "Home care servic*" OR "Multidiscipli-
nary Care Team") AND Topic=(dementia* OR alzheimer* OR AD) AND Topic=(random* or
placebo or "double-blind" or trial OR groups OR "controlled study" OR "time series" OR
"Comparative Study" OR "Pretest-Posttest Design") AND Year Published=(2010-2012)
72
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Timespan=All Years. Databases=SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH.
Lemmatization=On
7. CENTRAL (The
Cochrane Library)
(Issue 4 of 4, Oct
2011)
#1 MeSH descriptor Dementia explode all trees
#2 MeSH descriptor Delirium, this term only
#3 MeSH descriptor Wernicke Encephalopathy, this term only
#4 MeSH descriptor Delirium, Dementia, Amnestic, Cognitive Disorders, this term only
#5 dement*
#6 alzheimer*
#7 "lewy* bod*"
#8 deliri*
#9 "chronic cerebrovascular"
#10 "organic brain disease" or "organic brain syndrome"
#11 "normal pressure hydrocephalus" and "shunt*"
#12 "benign senescent forgetfulness"
#13 "cerebr* deteriorat*"
#14 "cerebral* insufficient*"
#15 "pick* disease"
#16 creutzfeldt or jcd or cjd
#17 huntington*
#18 binswanger*
#19 korsako*
#20 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13
OR #14 OR #15 OR #16 OR #17 OR #18 OR #19)
#21 rivastigmin* OR Exelon* OR “SDZ ENA 713”
#22 #21 AND #20
26
8. ICTRP Search
Portal (http://
apps.who.int/tri-
alsearch) [in-
cludes: Australian
New Zealand Clini-
cal Trials Registry;
ClinicalTrilas.gov;
ISRCTN; Chinese
Clinical Trial Reg-
istry; Clinical Tri-
als Registry – In-
dia; Clinical Re-
search Informa-
tion Service – Re-
public of Korea;
Advanced search: "Case Management" OR "care management" OR "multi-component"
AND (dementia or Alzheimers) AND Status: ALL AND date reg: 01/01/12-07/02/12
34
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German Clinical
Trials Register;
Iranian Registry
of Clinical Trials;
Japan Primary
Registries Net-
work; Pan African
Clinical Trial Reg-
istry; Sri Lanka
Clinical Trials Reg-
istry; The Nether-
lands National Tri-
al Register]
TOTAL before de-duplication Original search:
10440
Feb 2012: 1211
Feb 2013: 820
Dec 2013: 11
(7 identified
through other
sources)
TOTAL after de-dupe and first-assess 9159
  (Continued)
 
Appendix 2. Frequency of contacts with case managers
Bass - Ohio Follow-up started as biweekly, then reduced to monthly, then three-monthly unless more visits were needed. The duration
of telephone-based case management was 12 months. The initial paper published in 2003 (Bass 2003) reported that on average care
consultants have 12 direct communication contacts with patients and caregivers per year. A subsequent paper (Judge 2011) reported
that on average care co-ordinators and dyads had 24.6 contacts during the 12-month study period (standard deviation (SD) = 15.4) or
approximately two contacts per month. The median number of contacts was 23.
Callahan - Indianapolis Caregivers and participants were seen by the care manager in the primary care clinic bimonthly initially, and then
contacts were lengthened to monthly for a period of one year. The mean number of contacts with the care manager was 14.4 (SD 8.9) over
12 months (range 0 - 51). Approximately half of these contacts were face-to-face and half were telephone contacts.
Chien- Hong Kong 2008 12 sessions were held every other week and lasted two hours each. The programme consists of 12 two-hour
sessions, held once every two weeks. One session concentrated on orientation to dementia care. Three sessions were designed as
workshops on dementia care. Six sessions covered family roles and strength rebuilding. One session addressed community support
resources and the last session was for a programme review and evaluation. The intervention lasted for six months and was delivered by a
multidisciplinary team of a psychiatrist, a social worker and a case manager (nurse).
Chien - Hong Kong 2001The family and the case manager met biweekly, for a total of 10 two-hour sessions. AVer one month’s needs
assessment and preparation, the Dementia Family Care Programme (DFCP) was conducted for individual families, lasting about five
months.
Chu - Canada The case manager made monthly contact by phone or home visit. The frequency of contacts increased as needed.
Dias - Goa India The minimum frequency of visits was at least once a fortnight for six months. The maximum frequency of visits was based
on needs as assessed by the home care advisor (HCA). Thus, the visits could be more frequent depending on the need of that particular
family. In the intervention arm, the mean number of visits by the HCA was 12.3 (SD = 3.1). Average time spent on each visit was 45 minutes
(SD = 15). The mean number of phone consultations was 1.3 (SD = 2.1). A total of nine support group meetings were arranged for the
caregivers during the intervention period.
Eloniemi-Sulkava 2001 The frequency of contacts varied from once a month to five times a day, depending on the situation of the
participants and their caregivers.
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Eloniemi-Sulkava 2009; A process evaluation was conducted. Data were presented to show that 337 home visits were made over the 24
months (mean 5.35 ; range 1 - 43); 23 oJice visits (mean 0.37; range 1 - 4); 90 visits to care sites/providers (mean 1.43; range 1-40); 2192
telephone calls to /from families (mean 34.79; range 1-91); 1928 telephone calls to other health care professionals/care providers (mean
30.60; range 1 - 97). Sample size calculations were based on the feasibility shown in the earlier study by the same authors that one family
care co-ordinator in partnership with a geriatrician could support a maximum of about 50 - 60 couples (Eloniemi-Sulkava 2001).
HinchliJe - UK During the 16-week intervention period, each participant and carer received a mean of 12 visits (6 - 19) lasting an average
of 58 minutes (31 - 87).
Lam - Hong Kong Although not reported in the results, the authors indicate that relatively low minimum requirements for caregiver visits
in this study (one visit per month) by the case manage might have limited the intensity of caregiver input and sensitivity of the intervention
to modulate caregiver stress. The participants also had access to a telephone hotline during working hours (Monday to Saturday).
Jansen - Netherlands- the three case managers spent a mean time of 10.8 hours (range 0.75 – 28 hours) a year per participant-carer dyad
on the case management intervention. The nurses diJered in mean time spent on the intervention per pair; nurse 1 spent 8.8 hours (range
2 – 26); nurse 2 spent 5.5 hours (range 0.75 – 15), and nurse 3 spent 15.2 hours (range 9.6 – 28); F = 9.811, P < .001.
Newcomer - US Two case management models were implemented which varied in the ratio of treatments-to-case managers, and in the
amount of Medicare coverage available each month for treatment benefits. Model A (low reimbursement - high caseload) sites operated
with a target case manager-to-client ratio of 1:100. Model B (high reimbursement - low caseload) sites had a target case manager-to-client
ratio of 1:30.
Vickrey - California77% of the dyads received an initial visit from a care manager and 55% had a formal reassessment. Reasons for lower
rates of reassessment included participant death from disease progression and the care manager’s perception that a formal reassessment
was not needed (for example, because of continuous awareness of dyad status as a result of frequent telephone contacts). The median
number of assessment and reassessment visits was two. There were an average of 15 (median 12) follow-up telephone calls from a care
manager per dyad; these calls occurred every 30 days on average.
Appendix 3. E=ects of interventions: service use and costs (detailed version)
Case management compared to usual care: (service use and cost secondary outcomes)
3.1 Use of community-based services (participants)
(Analysis 3.1)
Four RCTs reported on diJerent aspects of community-based services usage (Chu - Canada; Lam - Hong Kong; Newcomer - US; Vickrey -
California). All significant diJerence favoured greater use of services in the case management group, apart from one service - assisted living
housing use at 12 months (Newcomer - US). The intervention group were significantly more likely to receive: home care use at 12 and 18
months, day care use at 4 and 12 months, respite care at 12 months, domestic paid helper use at 4 and 12 months, personal care use at 12
months, professional home health aide use at 18 months, services or information from local Alzheimers Association at 18 months, services
or information from care-givers resource centre at 18 months and participation in a caregiver support group at 18 months.
3.1.1 Homecare use at 3 - 4 months
Within the first three to four months there was no diJerence between both groups in the use of home care services (OR 2.67, 95% CI 0.79
to 8.95, n = 174, P = 0.08).
3.1.2 Homecare use at 12 months
Data were provided from three studies (Chu - Canada; Lam - Hong Kong; Newcomer - US). The results showed that there were a significantly
greater number of participants in the intervention group who used home care services at 12 months (OR 2.28, 95% CI 2.03 to 2.56, n = 5376,
I2 = 30%, P < 0.0001). When we excluded Chu - Canada (a low-quality study) and reanalysed the data to test the robustness of our findings
the results were unchanged but the I2 increased to 46%.
3.1.3 Homecare use at 18 months
The results in one study (Chu - Canada) showed that there were a significantly greater number of participants in the intervention group
who used home care services at 18 months (OR 5.63, 95% CI 2.07 to 15.29, n = 74, P = 0.0007).
3.1.4 Day care use at four months
A greater use of day care was evident in the intervention group in one study (Vickrey - California) at the four-month follow-up (OR 4.51,
95% CI 1.89 to 10.77, n = 99, P = 0.0007).
3.1.5 Day care use at 12 months
A greater use of day care was also evident in the intervention group in two studies (Lam - Hong Kong; Newcomer - US) at the 12-month
follow-up (OR 2.23, 95% CI 1.98 to 2.52, n = 5301, P < 0.00001).
Case management approaches to home support for people with dementia (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
141
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
3.1.6 Day care use at 18 months
At 18 months we found no diJerence in the one study which reported day care use (Vickrey - California) (OR 1.80, 95% CI 0.92 to 3.51, n
= 353, P = 0.09).
3.1.7 Respite care use at four month
The use of respite care was low in both groups in Lam - Hong Kong, with no significant diJerence at four months (OR: 2.26, 95% CI 0.09
to 56.78, n = 99, P = 0.62).
3.1.8 Respite care use at 12 months
Results from two studies (Lam - Hong Kong; Newcomer - US) showed a significant increase in the respite care use within the case
management groups at 12 months (OR 2.24, 95% CI 1.98 to 2.53, n = 5301, P < 0.00001).
3.1.9 Domestic paid helper use at four months
There was a greater use of domestic helpers in the intervention group (Lam - Hong Kong) at four months (OR 5.40, 95% CI 1.97 to 14.81,
n = 99, P = 0.001).
3.1.10 Domestic paid helper use at 12 months
This study (Lam - Hong Kong also found greater use of domestic helpers in the intervention group at 12 months (OR 3.00, 95% CI 1.12 to
8.04, n = 92, P = 0.03).
3.1.11 Personal care use at 12 months
Results from two studies (Chu - Canada; Newcomer - US) showed a greater use of personal care in the intervention group at the 12 month
follow-up (OR 1.57, 95% CI 1.40 to 1.75, n = 5284, I2 = 68%, P < 0.00001).
3.1.12 Services from a professional home health aide at 18 months
The intervention group in Vickrey - California used significantly more services from a professional home health aide at 18 months (OR 1.81,
95% CI 1.05 to 3.13, n = 353, P = 0.03).
3.1.13 Services from a paid professional care-giver at 18 months
There were no diJerences in services from a professional care-giver at 18 months in Vickrey - California (OR 1.48, 95% CI 0.85 to 2.59, n
= 353, P = 0.17).
3.1.14 In home, volunteer, or paid respite care services at 18 months
There were no diJerences in in-home, volunteer, or paid respite care services at 18 months in Vickrey - California (OR 1.54, 95% CI 0.98
to 2.41, n = 353, P = 0.06).
3.1.15 Assisted living housing use at 12 months
We found a greater use of assisted living housing use in the control group in the Newcomer - US study (OR 0.70, 95% CI 0.56 to 0.87, n =
5209, P = 0.001).
3.1.16 Services or information from local Alzheimers Association at 18 months
The participants in the intervention group in Vickrey - California received more services or information from local Alzheimers Association
at 18 months (OR 2.40, 95% CI 1.56 to 3.69, n = 360, P < 0.0001).
3.1.17 Services or information from care-givers resource centre at 18 months
The participants in the intervention group in Vickrey - California received more services or information from the care-givers resource centre
at 18 months (OR 2.88, 95% CI 1.77 to 4.69, n = 360, P < 0.0001).
3.1.18 Services or information on meals on wheels at 18 months
There were no diJerences in services or information on meals on wheels at 18 months in Vickrey - California (OR 0.97, 95% CI 0.53 to 1.77,
n = 360, P = 0.92).
3.1.19 Participation in a care-giver support group at 18 months
The participants in the intervention group in Vickrey - California participated more in a care-giver support group at 18 months (OR 1.64,
95% CI 1.00 to 2.68, n = 356, P = 0.05).
3.2 Health service use by participants (number of participants)
(Analysis 3.2)
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3.2.1 Emergency department visits at 18 months
There were no diJerences in the emergency visits reported by Vickrey - California at 18 months (96/170 versus 66/126) (OR 1.18, 95% CI
0.74 to 1.87, n = 296, P = 0.48). See also 3.3.1 and 3.3.2 Emergency department visits at 12 and 18 months.
3.2.2 Direct care (occupational therapy, physical therapy, social work, nursing and respiratory therapy) at 18 months
There were no diJerences in the direct care reported by Chu - Canada at 18 months (OR 1.31, 95% CI 0.51 to 3.35, n = 75, P = 0.57).
3.3 Health service use by participants (continuous outcomes)
(Analysis 3.3)
Four RCTs reported data on health services usage for participants (Bass - Ohio; Callahan - Indianapolis; Jansen - Netherlands; Vickrey -
California). There were no diJerences between groups on most outcomes apart from a significantly lower number of physician or nurse
visits, in the intervention group (3.3.5).
3.3.1 Emergency department visits at 12 months
There were no diJerences in the emergency visits reported by Bass - Ohio (which was rated at high risk of bias) at 12 months (MD -0.17,
95% CI -0.63 to 0.29, n = 157, P = 0.47).
3.3.2 Emergency department visits at 18 months
There were no diJerences in the emergency visits reported by Vickrey - California at 18 months (MD 0.18, 95% CI -0.11 to 0.47, n = 296, P
= 0.23). See also 3.7 emergency department visits for carers below.
3.3.3 Physician visits (per month) at six months
We found no significant diJerence between groups in the one study (Vickrey - California) that reported the number of visits to a physician
(per month) at six months (MD 0.08, 95% CI -1.28 to 1.44, n = 296, P = 0.91).
3.3.4 Physician visits at 12 months
There was no significant diJerence between groups in the pooled results for three studies (Bass - Ohio; Callahan - Indianapolis; Jansen -
Netherlands) that reported the number of visits to a physician at 12 months (SMD 0.14, 95% CI -0.07 to 0.35, n = 353, P = 0.20). The Callahan
- Indianapolis study combined cumulative physician or nurse visits.
3.3.5 Physician or nurse visits at 18 months
We found a significant diJerence between groups in the one study (Callahan - Indianapolis) that reported the number of visits to a physician
or nurse visits at 18 months (MD 5.40, 95% CI 0.51 to 10.29, n = 113, P = 0.03).
3.3.6 Outpatients geriatric/psychiatric team /diagnostic service at 12 months (number of consultations)
There was no significant diJerence between groups in the one study (Jansen - Netherlands) that reported the number of outpatients
geriatric/psychiatric team /diagnostic service consultations at 12 months (MD 0.30, 95% CI -1.61 to 2.21, n = 70, P = 0.76).
3.3.7 Medical specialist over 12 months (number of consultations)
There was no significant diJerence between groups in the one study (Jansen - Netherlands) that reported the number of medical specialist
consultations at 12 months (MD -0.60, 95% CI -6.35 to 5.15, n = 70, P = 0.84).
3.3.8 Physiotherapist over 12 months (number of consultations)
We detected no significant diJerence between groups in the one study (Jansen - Netherlands) that reported the number of physiotherapist
consultations at 12 months (MD 0.00, 95% CI -28.18 to 28.18, n = 70, P = 1.00).
3.3.9 Social worker over 12 months (number of consultations)
There was no significant diJerence between groups in the one study (Jansen - Netherlands) that reported the number of social worker
consultations at 12 months (MD 0.02, 95% CI -0.52 to 0.56, n = 70, P = 0.94).
3.4 - 3.7 Cost of services (participants)
Three studies (Eloniemi-Sulkava 2009; Newcomer - US; Vickrey - California) reported data on healthcare costs.
3.4.1 Total health and social care costs (1000 euros; excluding intervention) at 12 months
Eloniemi-Sulkava 2009 compared both total health and social costs between the groups at 12 months. Costs were lower in the intervention
group but this diJerence was borderline significant (OR -7.99, 95% CI -16.86 to 0.89, n = 125, P = 0.08).
3.5 Healthcare costs (USD)
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One study (Vickrey - California) reported data on healthcare costs. Results showed no significant diJerence between case management
and control group.
3.5.1 Payer perspective, including nursing home cost at 18 months (USD)
In Vickrey - California, there was no significant between-group diJerence in the healthcare cost (from the payer perspective) including
nursing-home cost at 18 months, (MD -260.00, 95% CI -1177.99 to 657.99, P = 0.58).
3.5.2 Payer perspective, excluding nursing home at 18 months (USD)
In Vickrey - Californiathere was no significant between-group diJerence in the healthcare cost (from the payer perspective) excluding
nursing-home cost at 18 months (MD -272.00, 95% CI -1153.49 to 609.49, P = 0.55).
3.5.3 Societal perspective cost at 18 months (USD)
In Vickrey - California there was no significant between-group diJerence in the healthcare cost (from the societal perspective) at 18 months
(MD -365.00, 95% CI -1290.30 to 560.30, P = 0.44).
3.5.4 Total health and social care costs at 12 months (1000 Euros; excluding intervention)
3.5.4 Total health and social care costs at 12 months (1000 Euros; excluding intervention)
In Eloniemi-Sulkava 2009 there was no significant between-group diJerence in total health and social care costs (excluding intervention)
at 12 months (MD -7.99, 95% CI -16.86 to 0.88, P = 0.08).
3.6 Health services costs (Medicare expenditures) (community services usage) in dollars or euros
(Analysis 3.6)
Newcomer - US reported the eJects of case management application on Medicare community services expenditures in year one, year
two and year three, and for the total three-year period. Eloniemi-Sulkava 2009 reported total healthcare costs between the groups at 12
months. We have used the SMD (to accommodate the two currencies (dollars and Euros)) for year one.
3.6.1 At year one
When we pooled data from two studies (Eloniemi-Sulkava 2009; Newcomer - US) at 12 months, we found a significant reduction in the total
cost of services between the groups (SMD -0.07, 95% CI -0.12 to -0.02, n = 5276. P = 0.01).
3.6.2 At year two
The lower expenditure did not reach statistical significant diJerence for year two in the Newcomer - US study (MD -654.00, 95% CI -1462.80
to 154.80, n = 3665, P = 0.11).
3.6.3 At year three
The lower expenditure did not reach a statistically significant diJerence for year three in the Newcomer - US study (MD -779.00 95% CI
-1976.72 to 418.72, n = 2255, P = 0.20).
3.6.4 Total three-year follow-up
The lower expenditure in the pooled case management groups was significantly lower than in the control group for the total three years
in the Newcomer - US study (MD -705.00, 95% CI -1170.31 to -239.69, n = 5170, P = 0.003).
3.7 Health service use by carers (dichotomous outcomes)
(Analysis 3.7)
One study (Newcomer - US) estimated the impact of the case management intervention on health services usage for care-givers. Care-
givers' utilisation of services was reported for one of the sites (Illinois) in the Newcomer - US study (Shelton 2001). Data on hospitalisation
rate and emergency visits were collected over a three-year period.
3.7.1 Hospitalised during three years (number of carers)
The risk of hospitalisation for the carers in the intervention group was significantly lower than in the control group (OR 0.51, 95% CI 0.33
to 0.81, n = 412, P = 0.005).
3.7.2 Emergency department visits during three years (number of carers)
The emergency department visits were also significantly lower in the intervention group (OR 0.58, 95% CI 0.38 to 0.89, n = 412, P = 0.01).
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3.8 Health service use by carers (continuous outcomes)
(Analysis 3.8)
Carer health service utilisation and Medicare expenditure data were presented for one of the sites (Illinois) for the Newcomer - US study
(Shelton 2001). One other study also reported the use of services by carers (Jansen - Netherlands). There were no significant diJerences
on any of the continuous outcomes reported.
3.8.1 Annual hospital length of stay
We found no significant diJerence between groups in the annual hospital length of stay (MD 0.90, 95% CI -0.23 to 2.03, P = 0.12) (Shelton
2001) (Newcomer - US).
3.8.2 Number of admissions over 12 months
There was no significant diJerence between groups (Newcomer - US) in the number of admissions over 12 months (MD 0.15, 95% CI -0.20
to 0.50, n = 412, P = 0.40) (Shelton 2001).
3.8.3 Primary care physician over 12 months (number of consultations)
We found no significant diJerence between groups (Jansen - Netherlands) in the number of consultations with a primary care physician
over 12 months (MD 0.00, 95% CI -5.26 to 5.26, n = 69, P = 1.00).
3.8.4 Outpatients geriatric/psychiatric team over 12 months (number of consultations)
We detected no significant diJerence between groups (Jansen - Netherlands) in the number of consultations with outpatients geriatric/
psychiatric team over 12 months (MD -0.77, 95% CI -5.33 to 3.79, n = 69, P = 0.74).
3.8.5 Medical specialist over 12 months (number of consultations)
There was no significant diJerence between groups (Jansen - Netherlands in the number of consultations with a medical specialist over
12 months (MD 0.10, 95% CI -5.93 to 6.13, n = 69, P = 0.97).
3.8.6 Physiotherapist over 12 months (number of consultations)
We found no significant diJerence between groups (Jansen - Netherlands) in the number of consultations with a physiotherapist over 12
months (MD 1.70, 95% CI -13.06 to 16.46, n = 69, P = 0.82).
3.9 Informal care-giver time (hours)
(Analysis 3.9)
3.9.1 Informal costs (paid unskilled time spent care-giving (hours) at 6 months:
There was no significant diJerence in the time for paid unskilled care-givers between the groups (Vickrey - California) (MD -5.10, 95% CI
-789.73 to 779, n = 296, P = 0.99).
3.9.2 Informal costs(unpaid unskilled time spent care-giving (hours) at 6 months:
There was no significant diJerence in the time for unpaid unskilled care-givers between the groups (Vickrey - California) (MD 30.70, 95%
CI -388.03 to 449.43, n = 296, P = 0.89).
3.10 - 3.11 Cost of services (carers)
3.10 Medicare expenditure (community services usages) in dollars
(Analysis 3.10)
In the Newcomer - US study, Medicare Part A expenditure (inpatient hospital, emergency department visits and skilled nursing home
inpatient care) were based on the allowed amounts from Medicare claims for the period the Alzheimer's disease participant was enrolled
in the demonstration. For most claims, this included the amount paid by Medicare, plus additional amounts paid by individuals. We report
results in US dollars (USD).
3.10.1 At year one
The Medicare Part A expenditure at the one-year follow-up for the case management group (combining A and B models) did not diJer
significantly from standard care (MD -229 .00, 95% CI -489.48 to 31.48, P = 0.08).
3.10.2 At year two
The Medicare Part A expenditure at the two-year follow-up for the case management group (combining A and B models) did not diJer
significantly from standard care (MD 17.00, 95% CI -943.97 to 977.97, P = 0.97).
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3.10.3 At year three
The Medicare Part A expenditure at the three-year follow-up for the case management group did not diJer significantly from standard care
(MD -325.00, 95% CI -770.89 to 120.89, P = 0.15].
3.10.4 Total three-year follow-up
There was no diJerence in expenditure for the case management group (combining A and B models) in comparison to controls for the
entire three-year follow-up combining all demonstration sites (MD -167.00, 95% CI -946.28 to 612.28, P = 0.67).
In one of the eight sites, Illinois, in which the delivery of care management was facilitated via nurse care managers rather than social
workers, the total cost was not much lower than in other sites. A total reduction (-USD 436, 95% CI -2321 to 1049) was achieved compared
to controls over three years.
3.11 Medicare Part A expenditure in comparison to control
(Analysis 3.11)
Although the average annualised Medicare reimbursement (annual health service cost) during the Newcomer - US study for care-givers in
the intervention group (combining A and B models) was lower, the diJerence was not statistically significant (MD -681.00, 95% CI -1382.40
to 20.40, n = 412, P = 0.06). The lower expenditure did not reach statistical significance for any of the separate years or for the total three-
year follow-up period.
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28 August 2015 Amended Correction to the plain English summary - one word in the last
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C O N T R I B U T I O N S   O F   A U T H O R S
SR: developing title and draVing and editing protocol; selecting studies, extracting data, writing the review.
CM: draVing protocol, commenting on and editing protocol, selecting studies, extracting data, contributing to writing the review.
JH: commenting on and editing protocol/review, selecting studies, extracting data, contributing to writing the review.
RM: extracting data, interpreting results, support and advice, contributing to writing the review.
ST: commenting on and editing protocol/review, helping in studies selection, data extraction.
DC: developing title, commenting on and editing protocol/review, selecting studies.
MO: commenting on and editing protocol/review, helping in studies selection.
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University of Manchester, Manchester and University of Lancaster, Lancaster• Claudia Miranda, UK.
University College London, London• Juanita Hoe, UK.
University College London, London
Case management approaches to home support for people with dementia (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
146
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
• David Challis, UK.
University of Manchester, Manchester• Martin Orrell, UK.
University College London, London• Reem Malouf, UK.
University of Oxford, Oxford
External sources• National Institute for Health Research, UK.
NIHR programme grant: Support at Home - Interventions to Enhance Life in Dementia (SHIELD) Application No RP-PG-0606-1083• National Institute of Health Research School for Primary Care Research, UK.
Siobhan Reilly's training fellowship award from National Institute of Health Research School for Primary Care Research at the University
of Manchester.
D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
Title
We changed the title from 'Case/care management approaches to home support for people with dementia'.
Method
We stated in the protocol that we would follow the Cochrane EJective Practice and Organisation of Care (EPOC) Group guidelines for the
inclusion of controlled before-and-aVer (CBA) studies and interrupted time series (ITS) designs. There were suJicient RCTs not to warrant
including CBA and ITS designs. Thus we made a number of changes to the protocol:
• We removed reference to non-randomised studies from the 'Types of studies' considered for review section• We removed a sentence from 'Selection of studies' section• We removed references to EPOC data checklist based on the number of quality criteria in the assessment of risk of bias in included
studies section• We revised the assessment of risk of bias in light of the above
We stated in the protocol that the primary outcomes were maintenance of community residence/avoidance of institutionalisation
(measured by rate of institutional care (hospital/long-term care home post-intervention), numbers of admissions (to hospital, nursing and
residential care), length of hospital stay and participant quality of life/ ell-being (self-reported or carer-reported, measured by a recognised
and validated scale or tool) measured aVer at least three months follow-up.
We expanded the primary outcomes to cover carer outcomes, including quality of life and carer burden, to reflect the high proportion of
studies which reported this as a primary goal of the intervention and its importance in dementia care policies internationally.
We had used broad categories for some of the secondary outcomes, for example, service use. With hindsight, we should have specified
which outcomes we would report, as the diJerent types of outcomes categorised under these headings were extensive and not oVen
reported in more than a few studies. The original list of outcomes were as follows:
Primary outcomes
The primary outcomes were maintenance of community residence/avoidance of institutionalisation (measured by rate of institutional care
(hospital/long term care home post-intervention), numbers of admissions (to hospital, nursing and residential care), length of hospital stay
and patient quality of life/well-being (self-reported or carer-reported, measured by a recognised and validated scale or tool) measured at
least aVer 3 months follow-up.
Secondary outcomes
Secondary outcome measures included:
(i) Clinical Outcomes
For the patient:
• Cognitive Functioning
Case management approaches to home support for people with dementia (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
147
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
• Neuropsychiatric/behavioural and psychological symptoms of dementia (rated by clinician or carers)• Mood (self-reported, clinically-rated or carer-reported)• Activities of daily living/dependence (rated by clinician or carers)• Social engagement/social networks/social support (rated by clinician or carers)
For the carer:
• Carer well-being/quality of life/mood
(ii) Social Outcome• Patient’s social engagement/social networks/social support (rated by clinician or carers)
(iii) Satisfaction• Patient satisfaction• Carer satisfaction• StaJ satisfaction (the staJ providing the care management)
(iv) Services• Patient’s use of services• Carer’s use of services
(v) Measures of cost• Inpatient care/nursing and residential home care• All health and social care (including the above plus the costs of all other medical and psychiatric care such as: out-patient care and
specialist service; and community-based health and social services• Costs of informal care• Total costs (including types of costs above plus the costs of accommodation)
(vi) Mortality/ survival time.
We also added the following:
To facilitate comparison between trials we converted variables that could be reported in diJerent metrics, such as days in hospital (mean
days per year, per week or per month) to a common metric (e.g. mean days per month).
I N D E X   T E R M S
Medical Subject Headings (MeSH)
*Case Management  [economics];  Alzheimer Disease  [nursing];  Caregivers  [psychology]  [statistics & numerical data];  Dementia
 [*nursing];  Depression  [epidemiology];  Health Care Costs;  Home Nursing  [economics]  [*methods];  Hospitalization  [statistics &
numerical data];  Long-Term Care  [economics]  [methods];  Randomized Controlled Trials as Topic;  Time Factors
MeSH check words
Humans
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